Processing 00000000.tx.1: Annexin 24from Capsicum annuum X-RAY STRUCTURE AND BIOCHEMICAL CHARACTERIZATION* Andreas Hofmann, Jezabel Proust, Anja Dorowski, Rodolphe Schantz, and Robert Huber From the Max-Planck-Institut fr Biochemie, Abt. 

Phrase: "Annexin 24from Capsicum annuum X-RAY STRUCTURE"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0081595:Annexin X [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0034571:X-ray [Functional Concept]
   818   C0043299:X-ray, NOS [Diagnostic Procedure]
   818   C0043309:X-ray [Natural Phenomenon or Process]
   818   C1306645:X-ray [Diagnostic Procedure]
   818   C1962945:X-ray [Diagnostic Procedure]
   795   C0086894:ray [Fish]
   795   C0678594:Structure [Spatial Concept]
   795   C0851346:ray [Natural Phenomenon or Process]
   795   C2314876:ray [Fish]

Phrase: "AND"

Phrase: "BIOCHEMICAL CHARACTERIZATION"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: "* Andreas Hofmann,"

Phrase: "Jezabel Proust,"

Phrase: "Anja Dorowski,"

Phrase: "Rodolphe Schantz,"

Phrase: "and"

Phrase: "Robert Huber From the Max-Planck-Institut fr Biochemie,"

Phrase: "Abt."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045246:abt [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.2: Strukturforschung, 82152Martinsried, Germany and Institut de Biologie Moleculaire des Plantes, 67084Strasbourg, France  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES This work provides the first three-dimensional structure of a member of the plant annexin family and correlates these findings with biochemical properties of this protein. 

Phrase: "Strukturforschung,"

Phrase: "82152Martinsried,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "and"

Phrase: "Institut de Biologie Moleculaire des Plantes,"

Phrase: "67084Strasbourg,"

Phrase: "France  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "the first three-dimensional structure of a member of the plant annexin family"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C0450363:3-Dimensional [Spatial Concept]
   749   C0680034:family structure [Family Group]
   749   C2713306:Plant structure [Plant]
   735   C0205449:Three [Quantitative Concept]
   735   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "correlates"

Phrase: "these findings with biochemical properties of this protein."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   750   C0428132:Biochemical finding [Laboratory or Test Result]
   744   C2607943:findings [Functional Concept]
   744   C2926606:Findings [Clinical Attribute]
   744   C3539655:Findings [Intellectual Product]
   711 E C0037088:Finding [Sign or Symptom]
   711 E C0243095:Finding [Finding]
   711 E C2825141:Finding [Finding]
Processing 00000000.tx.3: Annexin 24(Ca32) from Capsicum annuum was purified as a native protein from bell pepper and was also prepared by recombinant techniques. 

Phrase: "Annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "from Capsicum annuum"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0522463:Capsicum annuum [Plant]
   861   C0006932:Capsicum [Plant]
   861   C1095803:Capsicum [Organic Chemical,Pharmacologic Substance]
   861   C1123028:Capsicum [Food]
   805 E C0007480:Cayenne Pepper [Food]
   805 E C0697049:Cayenne pepper [Plant]
   805 E C1256217:cayenne pepper [Pharmacologic Substance]
   805 E C2362311:Cayenne Pepper [Food]

Phrase: "was"

Phrase: "purified as a native protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0302891:Native [Functional Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "from bell pepper"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0446306:Bell Pepper [Food]
   861   C0453397:Pepper [Plant]
   861   C1123063:Pepper [Food]
   861   C1706917:Bell [Manufactured Object]

Phrase: "and"

Phrase: "was"

Phrase: "also"

Phrase: "prepared by recombinant techniques."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025664:techniques [Intellectual Product]
   770   C0449851:Techniques [Functional Concept]
   770   C1514798:recombinant [Organism]
   737   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.4: To overcome the problem of precipitation of the recombinant wild-type protein in crystallization trials, two mutants were designed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "the problem of precipitation of the recombinant wild-type protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0033213:Problem [Finding]

Phrase: "in crystallization trials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008976:Trial [Research Activity]

Phrase: "two mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "designed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]
Processing 00000000.tx.5: Whereas an N-terminal truncation mutant turned out to be an unstable protein, the N-terminal His-tagged annexin 24(Ca32) was crystallized, and the three-dimensional structure was determined by x-ray diffraction at 2.8resolution. 

Phrase: "Whereas"

Phrase: "an N-terminal truncation mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "be"

Phrase: "an unstable protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the N-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "His-tagged annexin 24"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   827   C1708632:Tagged [Qualitative Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "was"

Phrase: "crystallized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444626:Crystallized [Chemical Viewed Structurally]

Phrase: ","

Phrase: "and"

Phrase: "the three-dimensional structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0450363:3-Dimensional [Spatial Concept]
   827   C0205449:Three [Quantitative Concept]
   827   C0678594:Structure [Spatial Concept]
   755   C0439534:Dimension [Quantitative Concept]
   755   C1707753:Dimensionality [Spatial Concept]

Phrase: "was"

Phrase: "determined by x-ray diffraction at 2.8resolution."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0043301:X-Ray Diffraction [Laboratory Procedure]
   770   C0034571:X-ray [Functional Concept]
   770   C0043299:X-ray, NOS [Diagnostic Procedure]
   770   C0043309:X-ray [Natural Phenomenon or Process]
   770   C1306645:X-ray [Diagnostic Procedure]
   770   C1962945:X-ray [Diagnostic Procedure]
   744   C0086894:ray [Fish]
   744   C0851346:ray [Natural Phenomenon or Process]
   744   C2314876:ray [Fish]
Processing 00000000.tx.6: The structure refined to an R-factor of 0.216adopts the typical annexin fold; 

Phrase: "The structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "refined to an R-factor of 0.216adopts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0034471:R factor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0602449:R-factor [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205090:R- [Spatial Concept]
   744   C0684010:R. [Professional or Occupational Group]
   744   C1521761:Factor [Functional Concept]
   744   C2603358:R' [Clinical Attribute]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "the typical annexin fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.7: the detailed structure, however, is different from non-plant annexins, especially in domains I and III and in the membrane binding loops on the convex side. 

Phrase: "the detailed structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "however,"

Phrase: "is"

Phrase: "different from non-plant annexins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "especially in domains I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "and in the membrane binding loops"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0025255:Membrane [Tissue]
   753   C0181687:loops [Medical Device]
   753   C0243122:binding [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1515981:And [Idea or Concept]
   753   C1706182:Membrane [Manufactured Object]
   719 E C0419518:Loop [Medical Device]
   719 E C0445022:Loop [Spatial Concept]

Phrase: "on the convex side."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]
Processing 00000000.tx.8: Within the unit cell there are two molecules per asymmetric unit, which differ in conformation of the IAB-loop. 

Phrase: "Within the unit cell there"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "two molecules per asymmetric unit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0567416:molecules [Substance]

Phrase: "which"

Phrase: "differ in conformation of the IAB-loop."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0026377:Conformation [Spatial Concept]
   748   C0419518:Loop [Medical Device]
   748   C0445022:Loop [Spatial Concept]
Processing 00000000.tx.9: Both conformers show Trp-35 on the surface. 

Phrase: "Both conformers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0180093:Conformer [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "Trp-35 on the surface."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.10: The loop-out conformation is stabilized by tight interactions of this tryptophan with residue side chains of a symmetry-related molecule and enforced by a bound sulfate. 

Phrase: "The loop-out conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "is"

Phrase: "stabilized by tight interactions of this tryptophan"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0184512:Stabilized [Qualitative Concept]
   748   C0439816:Tight [Qualitative Concept]
   748   C0453911:tight [Manufactured Object]
   714   C1704675:Interaction [Functional Concept]

Phrase: "with residue side chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0337112:chains [Manufactured Object]
   827   C0441987:Side [Spatial Concept]
   827   C1524075:Chains [Idea or Concept]

Phrase: "of a symmetry-related molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "enforced by a bound sulfate."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   762   C0332297:Bounded by [Spatial Concept]
           bound
   760   C0038720:Sulfate [Inorganic Chemical]
   760   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]
   760   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.11: Characterization of this plant annexin using biophysical methods revealed calcium-dependent binding to phospholipid vesicles with preference for phosphatidylcholine over phosphatidylserine and magnesium-dependent phosphodiesterase activity in vitro as shown with adenosine triphosphate as the substrate. 

Phrase: "Characterization of this plant annexin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "biophysical methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "calcium-dependent binding to phospholipid vesicles"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   851   C1148643:calcium-dependent phospholipid binding [Molecular Function]
   783   C1148642:Phospholipid Binding [Molecular Function]
   783   C1516144:Calcium Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "with preference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0558295:preference [Idea or Concept]
  1000   C1549513:Preference [Idea or Concept]

Phrase: "for phosphatidylcholine"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "over phosphatidylserine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "and"

Phrase: "magnesium-dependent phosphodiesterase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1753334:phosphodiesterase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "as"

Phrase: "shown with adenosine triphosphate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0001480:Adenosine Triphosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0146894:triphosphate [Inorganic Chemical]
   737   C1547282:Show [Intellectual Product]

Phrase: "as the substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.12: A comparative unfolding study of recombinant annexin 24(Ca32) wild type and of the His-tag fusion protein indicates higher stability of the latter. 

Phrase: "A comparative unfolding study of recombinant annexin 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0009491:Comparative Study [Intellectual Product]
   767   C1579762:comparative study [Research Activity]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "His-tag fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "indicates"

Phrase: "higher stability of the latter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205360:Stability [Qualitative Concept]
   760   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.13: The effect of this N-terminal modification is also visible from CD spectra. 

Phrase: "The effect of this N-terminal modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "also visible from CD spectra."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]
Processing 00000000.tx.14: Both proteins were subjected to a FURA-2-based calcium influx assay, which gave high influx rates for the wild-type but greatly reduced influx rates for the fusion protein. 

Phrase: "Both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "subjected to a FURA-2-based calcium influx assay,"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   764   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   762   C0596235:Calcium 2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0006726:Calcium [Inorganic Chemical]
   742   C0243073:assay [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   742   C2936886:Calcium [Pharmacologic Substance]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708 E C1880279:Base [Biomedical or Dental Material]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "which"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "high influx rates for the wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "but"

Phrase: "greatly reduced influx rates for the fusion protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.15: We therefore conclude that the N-terminal domain is indeed a major regulatory element modulating different annexin properties by allosteric mechanisms.  

Phrase: "We therefore"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the N-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "indeed"

Phrase: "a major regulatory element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   827   C1705248:Element [Conceptual Entity]

Phrase: "modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "different annexin properties by allosteric mechanisms."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]
Processing 00000000.tx.16: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Annexins have been a focus of research for nearly 20years, and a large amount of data has accumulated especially for mammalian members of this protein family although annexin proteins are abundant throughout all species but yeast. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "a focus of research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205234:Focus [Spatial Concept]
   770   C1285542:focus [Functional Concept]

Phrase: "for nearly 20years,"

Phrase: "and"

Phrase: "a large amount of data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "has"

Phrase: "accumulated"

Phrase: "especially for mammalian members of this protein family"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0015576:Family [Family Group]
   744   C0024660:Mammalian [Mammal]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0680022:members [Population Group]
   744   C1704727:Family [Conceptual Entity]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "although"

Phrase: "annexin proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "abundant throughout all species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "but"

Phrase: "yeast."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.17: In 1989,the first annexin-like proteins in plants were identified (1), and it is now well established that annexins are just as ubiquitous in the plant kingdom as elsewhere. 

Phrase: "In 1989,"

Phrase: "the first annexin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in plants"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plants [Plant]
   900 E C0006038:Botany [Occupation or Discipline]
   884 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "now well established"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205170:Well [Qualitative Concept]
   827   C0443211:Established [Qualitative Concept]
   827   C1272684:Established [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "that annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "just as ubiquitous"

Phrase: "in the plant kingdom"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708611:Kingdom [Classification]

Phrase: "as"

Phrase: "elsewhere."
Processing 00000000.tx.18: The amount of annexin in plant cells makes up to 0.1% of the total protein content (2). 

Phrase: "The amount of annexin in plant cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "makes up to 0.1% of the total protein content"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0555903:Total protein [Laboratory Procedure]
   760   C1261360:total protein [Laboratory or Test Result]
   757 E C0439177:Protein.total [Quantitative Concept]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0423896:Content [Mental Process]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C0456205:Content [Conceptual Entity]
   739   C1881534:Make [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: As deduced from amino acid sequences, plant-type and vertebrate annexins show similarities up to 40%, whereas the plant-type members share up to 97% similarity with each other (see Table I). 

Phrase: "As"

Phrase: "deduced from amino acid sequences,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   862   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C0202406:Acid [Laboratory Procedure]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "plant-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "vertebrate annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "similarities up to 40%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2348205:Similarity [Qualitative Concept]

Phrase: "whereas"

Phrase: "the plant-type members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680022:members [Population Group]
   793 E C2698041:Member [Professional or Occupational Group]

Phrase: "share up to 97% similarity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237876:Share [Social Behavior]
   760   C0439073:97 [Intellectual Product]
   760   C0439082:>97 [Quantitative Concept]
   760   C2348205:Similarity [Qualitative Concept]

Phrase: "with each other"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.20: A more detailed analysis of the phylogenetic aspects led to the conclusion that within the overall annexin family a unique subset is made up by the plant-type members. 

Phrase: "A more detailed analysis of the phylogenetic aspects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1519068:Phylogenetic Analysis [Research Activity]
   750   C1524024:analysis aspect [Functional Concept]
           analysis
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]

Phrase: "led to the conclusion"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C1707478:Conclusion [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that within the overall annexin family"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0015576:Family [Family Group]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0282416:Overall [Intellectual Product]
   753   C1561607:Overall [Qualitative Concept]
   753   C1704727:Family [Conceptual Entity]

Phrase: "a unique subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1515021:Subset [Classification]

Phrase: "is"

Phrase: "made up by the plant-type members."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1881534:Make [Functional Concept]
Processing 00000000.tx.21: In contrast to mammalian and vertebrate tissues, where varying amounts of different annexin proteins are expressed, plants possess only two different annexins, often described as p32/p35/p38 for bell pepper (p34/p35 for tomato, p33/p35 for maize, etc.). 

Phrase: "In contrast to mammalian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammalian [Mammal]

Phrase: "and"

Phrase: "vertebrate tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "where varying amounts of different annexin proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]

Phrase: "are"

Phrase: "expressed"

Phrase: ","

Phrase: "plants"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plants [Plant]
   900 E C0006038:Botany [Occupation or Discipline]
   884 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "only two different annexins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "described as p32/p35/p38"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0069881:P-32 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0851287:P-32 [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0914908:p32 [Immunologic Factor]
   760   C1552738:described [Idea or Concept]
   760   C3539715:p35 [Gene or Genome]
   760   C3540595:p32 [Gene or Genome]

Phrase: "for bell pepper"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0446306:Bell Pepper [Food]
   861   C0453397:Pepper [Plant]
   861   C1123063:Pepper [Food]
   861   C1706917:Bell [Manufactured Object]

Phrase: "(p34/p35 for tomato,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3539715:p35 [Gene or Genome]

Phrase: "p33/p35 for maize,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3539715:p35 [Gene or Genome]

Phrase: "etc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.22: Following a recent classification, we are denoting annexin 24(Ca32) as the name for the annexin p32 from Capsicum annuum. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a recent classification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0008902:Classification [Classification]
   861   C0008903:classification [Functional Concept]
   861   C0678229:classification [Occupational Activity]

Phrase: "we"

Phrase: "are"

Phrase: "denoting annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "as the name"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027365:Name [Intellectual Product]
  1000   C1547383:Name [Intellectual Product]

Phrase: "for the annexin p32"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0069881:P-32 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0851287:P-32 [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0914908:p32 [Immunologic Factor]
   861   C3540595:p32 [Gene or Genome]

Phrase: "from Capsicum annuum."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0522463:Capsicum annuum [Plant]
   861   C0006932:Capsicum [Plant]
   861   C1095803:Capsicum [Organic Chemical,Pharmacologic Substance]
   861   C1123028:Capsicum [Food]
   805 E C0007480:Cayenne Pepper [Food]
   805 E C0697049:Cayenne pepper [Plant]
   805 E C1256217:cayenne pepper [Pharmacologic Substance]
   805 E C2362311:Cayenne Pepper [Food]
Processing 00000000.tx.23: Due to their high sequence similarity, it was supposed recently that three annexins from tobacco, tomato, and bell pepper, namely Anx(Nt32), Anx(Le34), and Anx24(Ca32), might constitute a distinct type of annexins, which were called Sp32 annexins (3) (see Table I).  

Phrase: "Due to their high sequence similarity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1710052:Sequence Similarity [Quantitative Concept]
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "it"

Phrase: "was"

Phrase: "supposed"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that three annexins from tobacco,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "tomato,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242772:Tomato [Food]
  1000   C0885519:tomato [Pharmacologic Substance]
  1000   C1140676:Tomato [Plant]

Phrase: "and"

Phrase: "bell pepper,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0446306:Bell Pepper [Food]
   861   C0453397:Pepper [Plant]
   861   C1123063:Pepper [Food]
   861   C1706917:Bell [Manufactured Object]

Phrase: "namely Anx(Nt32"

Phrase: ")"

Phrase: ","

Phrase: "Anx(Le34"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: ","

Phrase: "might"

Phrase: "constitute"

Phrase: "a distinct type of annexins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "which"

Phrase: "were"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "Sp32 annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.24: View this table: [in this window] [in a new window]  Table I Sequence homology of annexin 24(Ca32) with other annexins Homology calculations were performed using the program BESTFIT of the GCG software package (36). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Sequence homology of annexin 24"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0162775:Sequence Homology [Quantitative Concept]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1334043:Homology [Gene or Genome]
   748   C1519249:Sequence [Functional Concept]
   748   C2697616:Homology [Qualitative Concept]
   728 E C0162774:Sequence Homolog [Molecular Sequence]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "with other annexins Homology calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1441506:Calculation [Activity]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the program BESTFIT of the GCG software package"

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.25: Structurally, the highly conserved annexin core is made up by four similar domains with about 70amino acids each. 

Phrase: "Structurally,"

Phrase: "the highly conserved annexin core"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0444669:Core [Spatial Concept]
   812   C1167518:core [Cell Component]
   812   C1706352:Core [Medical Device]
   812   C1882467:Core [Manufactured Object]
   812   C3274653:Core [Body Substance]

Phrase: "is"

Phrase: "made up by four similar domains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1881534:Make [Functional Concept]

Phrase: "with about 70amino acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "each."
Processing 00000000.tx.26: From comparison of primary structures between vertebrate and plant-type annexins, the most prominent differences are observed in the loop regions between the second and third domain and within the third domain (Fig. 1). 

Phrase: "From comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "of primary structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C0678594:structures [Spatial Concept]

Phrase: "between vertebrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042567:Vertebrate [Vertebrate]

Phrase: "and"

Phrase: "plant-type annexins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the most prominent differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "observed in the loop regions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
   760   C1441672:Observed [Functional Concept]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "between the second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "third domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "and within the third domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205437:Third [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.27: The putative calcium binding sites of plant annexins are of particular interest, as in most cases the typical endonexin fold (4) is only conserved within the first domain. 

Phrase: "The putative calcium binding sites of plant annexins"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0005456:Binding Sites [Receptor]
   770   C1516144:Calcium Binding [Molecular Function]
   754   C2945843:Site of [Qualitative Concept]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0205145:Sites [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C2936886:Calcium [Pharmacologic Substance]
   737 E C0682969:Binding Site [Amino Acid Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "are of particular interest,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543488:Interest [Mental Process]
   770   C1551058:Are [Quantitative Concept]

Phrase: "as in most cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "the typical endonexin fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(4"

Phrase: ")"

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "conserved within the first domain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.28: The interaction of these annexins with calcium and calcium/phospholipids is therefore expected to be different from that of the known vertebrate annexins. 

Phrase: "The interaction of these annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "and"

Phrase: "calcium/phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   827 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "is"

Phrase: "therefore"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "different from that of the known vertebrate annexins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.29: In recent publications (5, 6) annexins from Medicago sativa and Lycopersicon esculentum were reported to have the conserved endonexin fold present in two domains. 

Phrase: "In recent publications"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0034036:Publications [Intellectual Product,Manufactured Object]
   827 E C0034037:Publication [Occupational Activity]
   827 E C1704324:Publication [Intellectual Product]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")"

Phrase: "annexins from Medicago sativa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Lycopersicon esculentum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1140676:Lycopersicon esculentum [Plant]
   861   C0331205:Lycopersicon [Plant]

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "the conserved endonexin fold present in two domains."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]
Processing 00000000.tx.30: The calcium dependence of phospholipid binding of the tomato annexin was investigated, including the effects of mutations within the (putative) membrane binding loops (6). 

Phrase: "The calcium dependence of phospholipid binding of the tomato annexin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C1148643:calcium-dependent phospholipid binding [Molecular Function]
   739   C0011546:Dependence [Mental Process]
   739   C0439857:Dependence [Mental or Behavioral Dysfunction]
   739   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "was"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the effects of mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "within the (putative"

Phrase: ")"

Phrase: "membrane binding loops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0181687:loops [Medical Device]
   793 E C0419518:Loop [Medical Device]
   793 E C0445022:Loop [Spatial Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.31: This study also confirmed the ability of tomato annexin to interact with membranes in a calcium-dependent manner; 

Phrase: "This study also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the ability of tomato annexin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "interact with membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "in a calcium-dependent manner"

Phrase: ";"
Processing 00000000.tx.32: however, much higher calcium concentrations were required than in the case of vertebrate annexins. 

Phrase: "however,"

Phrase: "much higher calcium concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "required than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1514873:Required [Functional Concept]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of vertebrate annexins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.33: The present study was aimed at elucidation of structure-function relationships of bell pepper annexin 24(Ca32) using x-ray crystallography and various biophysical methods. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "aimed at elucidation of structure-function relationships of bell pepper annexin 24"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   753   C0446306:Bell Pepper [Food]
   736   C0031843:function [Physiologic Function]
   736   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0439849:Relationships [Qualitative Concept]
   736   C0453397:Pepper [Plant]
   736   C0542341:Function [Functional Concept]
   736   C0678594:Structure [Spatial Concept]
   736   C0700205:FUNCTION [Classification]
   736   C1123063:Pepper [Food]
   736   C1705273:Function [Intellectual Product]
   736   C1706917:Bell [Manufactured Object]
   703 E C1705630:Relationship [Idea or Concept]
   703 E C1706279:Relationship [Idea or Concept]
   703   C1947946:Aim [Idea or Concept]
   703   C2948600:Aim [Pharmacologic Substance]
   703   C3540471:AIM [Gene or Genome]
   703   C3540472:AIM [Functional Concept]
   703 E C3540605:Relationship [Intellectual Product]
   700   C2700217:Functional Relationship [Conceptual Entity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "x-ray crystallography"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0206755:Crystallography, X-Ray [Laboratory Procedure]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0010424:Crystallography [Laboratory Procedure]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C2314876:ray [Fish]

Phrase: "and"

Phrase: "various biophysical methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.34: The first three-dimensional structure of a plant annexin shows clearly the high structural conservation of the annexin fold for members of this protein family throughout all kingdoms. 

Phrase: "The first three-dimensional structure of a plant annexin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0450363:3-Dimensional [Spatial Concept]
   762   C2713306:Plant structure [Plant]
   742   C0205449:Three [Quantitative Concept]
   742   C0678594:Structure [Spatial Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "clearly"

Phrase: "the high structural conservation of the annexin fold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2347858:Conservation [Qualitative Concept]

Phrase: "for members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680022:members [Population Group]
   966 E C2698041:Member [Professional or Occupational Group]

Phrase: "of this protein family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "throughout all kingdoms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708611:Kingdom [Classification]
Processing 00000000.tx.35: However, the membrane binding mechanism is significantly different from other annexin proteins. 

Phrase: "However,"

Phrase: "the membrane binding mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "significantly different from other annexin proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.36: The structure presented here particularly demonstrates the unique feature of a membrane binding loop in the first domain of annexin 24(Ca32) being able to adopt different conformations similar to the IIIAB-loop of annexin V.

Phrase: "The structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here particularly"

Phrase: "demonstrates"

Phrase: "the unique feature of a membrane binding loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]

Phrase: "in the first domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "being"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "different conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "similar to the IIIAB-loop of annexin V."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.37: Moreover, the attachment of the N-terminal region to the protein core, as observed in the present structure, has not been observed in any other annexin crystal structure to date.  

Phrase: "Moreover,"

Phrase: "the attachment of the N-terminal region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0185023:Attachment [Therapeutic or Preventive Procedure]
   748   C1947904:Attachment [Activity]
   748   C1999228:Attachment [Intellectual Product]

Phrase: "to the protein core,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "as"

Phrase: "observed in the present structure,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0678594:Structure [Spatial Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "observed in any"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "other annexin crystal structure to date."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   753   C0427896:Crystal [Body Substance]
   753   C0678594:Structure [Spatial Concept]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]
Processing 00000000.tx.38: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Purification of Native Protein-- Bell pepper leaves and fruits of mature plants were washed, crushed manually, and ground in a Waring Blendor by adding glass pearls (0.25-0.5 mm). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Purification of Native Protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0597301:protein purification [Laboratory Procedure]
   770   C0243114:purification [Functional Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "--"

Phrase: "Bell pepper leaves"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0242724:Leaves [Plant]
   793 E C1552865:Leaf [Idea or Concept]
   734   C0446306:Bell Pepper [Food]

Phrase: "and"

Phrase: "fruits of mature plants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016767:Fruit [Food]
   770   C0032098:Plants [Plant]
   770   C0205286:Mature [Temporal Concept]
   770   C1509510:fruit [Food]
   770   C3255628:FRUIT [Pharmacologic Substance]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "crushed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185060:crushed [Therapeutic or Preventive Procedure]

Phrase: "manually,"

Phrase: "and"

Phrase: "ground in a Waring Blendor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0185051:grind [Therapeutic or Preventive Procedure]

Phrase: "by adding glass pearls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1709628:PEARL [Health Care Related Organization]

Phrase: "(0.25-0.5 mm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0444499:0/5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.39: Per 1kg of raw material, 1liter of buffer A (0.15M NaCl, 5mM benzamidinium hydrochloride, 10mM EDTA, 2mM -mercaptoethanol, 0.25mM phenylmethylsulfonyl fluoride, 0.1mg/ml DNase, 0.1mg/ml RNase, 10mM HEPES, pH 7.4) was added. 

Phrase: "Per 1kg"

Phrase: "of raw material,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "1liter of buffer A (0.15M NaCl,"

Phrase: "5mM benzamidinium hydrochloride,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "2mM -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "0.25mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.1mg/ml DNase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "0.1mg/ml RNase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "10mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.40: To prevent heating, liquid nitrogen was added to the blender. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "heating,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018851:Heating [Environmental Effect of Humans]

Phrase: "liquid nitrogen"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
  1000   C1550121:Liquid nitrogen [Intellectual Product]
   861   C0028158:Nitrogen [Element, Ion, or Isotope]
   861   C0302908:Liquid [Substance]
   861   C1304698:Liquid [Finding]
   861   C1546699:Liquid NOS [Intellectual Product]
   861   C1550581:nitrogen [Human-caused Phenomenon or Process]
   861   C1561501:Liquid NOS [Substance]

Phrase: "was"

Phrase: "added to the blender."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.41: Glass pearls and solid components were separated by filtration over a Perlon net, and the resulting suspension was centrifuged for 1h at 100,000g. 

Phrase: "Glass pearls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709628:PEARL [Health Care Related Organization]

Phrase: "and"

Phrase: "solid components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "separated by filtration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016107:filtration [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "over a Perlon net,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   805   C0439739:Reticular [Spatial Concept]
   777 E C1423506:NETS [Gene or Genome]
   768 E C1709931:Reticle [Medical Device]

Phrase: "and"

Phrase: "the resulting suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038960:Suspension [Biomedical or Dental Material]
   861   C1382107:Suspension [Substance]
   861   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "centrifuged for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1442450:1H [Temporal Concept]
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 100,"

Phrase: "000g."
Processing 00000000.tx.42: The resulting supernatant was dialyzed against PEG 40,000to concentrate it, again dialyzed against buffer B (5mM benzamidinium hydrochloride, 2mM -mercaptoethanol, 0.25mM phenylmethylsulfonyl fluoride, 20mM Tris, pH 8.0) to remove salt, and fractionated in 0.5-liter portions. 

Phrase: "The resulting supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "dialyzed against PEG 40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439509:/40 [Temporal Concept]

Phrase: "000to"

Phrase: "concentrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1880310:Concentrate [Manufactured Object]
  1000   C2003864:Concentrate [Substance]

Phrase: "it,"

Phrase: "again"

Phrase: "dialyzed against buffer B (5mM benzamidinium hydrochloride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2mM -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "0.25mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "salt,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0036140:Salt [Chemical Viewed Structurally]
  1000   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C0206136:Salt [Food,Inorganic Chemical]
   928 E C1537053:salty [Qualitative Concept]
   900 E C0678584:saltiness [Qualitative Concept]

Phrase: "and"

Phrase: "fractionated in 0.5-liter portions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0475211:liter [Quantitative Concept]
   753   C1979893:Fractionated [Qualitative Concept]
   719   C0449719:Portion [Spatial Concept]
Processing 00000000.tx.43: The extract was stored at 20C. 

Phrase: "The extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "stored at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.44: A series of chromatographic steps was used to purify native annexin 24(Ca32) from the crude extract. 

Phrase: "A series of chromatographic steps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "native annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0302891:Native [Functional Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "from the crude extract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]
Processing 00000000.tx.45: Starting with anion exchange chromatography with DE52 at pH 8.0,the fractions of interest were dialyzed and applied to a Q-Sepharose column at pH 6.5.

Phrase: "Starting with anion exchange chromatography"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0439659:Start [Temporal Concept]

Phrase: "with DE52"

Phrase: "at pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "the fractions of interest"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   816   C1264633:Fraction of [Quantitative Concept]
           Fractions
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "dialyzed"

Phrase: "and"

Phrase: "applied to a Q-Sepharose column"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0036681:Sepharose [Carbohydrate]
   753   C0185125:Applied [Health Care Activity]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "at pH 6.5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.46: Hydrophobic interaction chromatography with phenyl-Sepharose and a final anion exchange with Q-Sepharose, pH 8.0,yielded reasonable pure protein. 

Phrase: "Hydrophobic interaction chromatography with phenyl-Sepharose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0678607:hydrophobic interaction [Molecular Function]
   783   C0008552:Chromatography, Sepharose [Laboratory Procedure,Research Activity]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0598629:Hydrophobic [Qualitative Concept]
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "a final anion exchange with Q-Sepharose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678640:exchange [Social Behavior]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "yielded"

Phrase: "reasonable pure protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.47: Amino acid sequencing of natively purified annexin 24was carried out after proteolytic cleavage with LysC. 

Phrase: "Amino acid sequencing of natively purified annexin 24was"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0751971:Amino Acid Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   744   C1553778:Sequencing [Intellectual Product]
   744   C1561491:Sequencing [Functional Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out after proteolytic cleavage"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0010813:cleavage [Cell Function]
   770   C0439787:Out [Spatial Concept]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C0597304:Proteolytic [Molecular Function]
   770   C0849355:Out [Qualitative Concept]
   770   C1330957:cleavage [Cell Function]
   770   C1947941:proteolytic [Enzyme]

Phrase: "with LysC."
Processing 00000000.tx.48: Purification of Recombinant Protein-- Annexin 24from C.annuum (Anx24-Ca32) was subcloned from the clone E511 (7) by polymerase chain reaction methods using primers C3 (5'-d(CATGCCATGGCAAGTCTAACCGTTCCAGC)-3') and C2 (5'-d(CCGGAATTCAGTCCTCCTCTTGTCCAAGC)-3'); 

Phrase: "Purification of Recombinant Protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0597301:protein purification [Laboratory Procedure]
   770   C0243114:purification [Functional Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "--"

Phrase: "Annexin 24from C.annuum"

Phrase: "(Anx24-Ca32"

Phrase: ")"

Phrase: "was"

Phrase: "subcloned from the clone E511"

Phrase: "(7"

Phrase: ")"

Phrase: "by polymerase chain reaction methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers C3"

Phrase: "(5'-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "d("

Phrase: "CATGCCATGGCAAGTCTAACCGTTCCAGC"

Phrase: ")-"

Phrase: "3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "C2 (5'-"

Phrase: "d("

Phrase: "CCGGAATTCAGTCCTCCTCTTGTCCAAGC"

Phrase: ")-"

Phrase: "3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.49: primers C7 (5'-d(CATGCCATGGCCCACCATCACCATCACCATATGGCAAGTCTAACCG)-3') and C2 yielded the His-tag fusion protein. 

Phrase: "primers C7 (5'-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "d("

Phrase: "CATGCCATGGCCCACCATCACCATCACCATATGGCAAGTCTAACCG"

Phrase: ")-"

Phrase: "3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "C2"

Phrase: "yielded"

Phrase: "the His-tag fusion protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.50: Best results were obtained using Pfu polymerase and 10% Me2SO in the polymerase chain reaction mixture. 

Phrase: "Best results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Pfu polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0136227:Pfu polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "10% Me2SO in the polymerase chain reaction mixture."
Processing 00000000.tx.51: The amplified DNA was ligated into pRSET5d (8) via NcoI and EcoRI restriction sites. 

Phrase: "The amplified DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "ligated into pRSET5d"

Phrase: "(8"

Phrase: ")"

Phrase: "via NcoI"

Phrase: "and"

Phrase: "EcoRI restriction sites."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.52: Positive clones were obtained by transformation into Escherichia coli DH5, selection via ampicillin resistance and DNA sequencing. 

Phrase: "Positive clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "obtained by transformation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0040682:Transformation [Cell Function]
   790   C1301820:Obtained [Functional Concept]
   790   C1510411:Transformation [Pathologic Function]
   790   C1705163:Transformation [Research Activity]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "into Escherichia coli DH5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0014834:Escherichia coli [Bacterium]

Phrase: "selection via ampicillin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036576:selection [Genetic Function]

Phrase: "and"

Phrase: "DNA sequencing."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162326:DNA sequencing [Nucleotide Sequence]
  1000   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.53: Expression was carried out in E.coli BL21(DE3). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in E.coli BL21"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0014834:E coli [Bacterium]
   760   C0439787:Out [Spatial Concept]
   760   C0450615:BL21 [Body Location or Region]
   760   C0849355:Out [Qualitative Concept]

Phrase: "(DE3"

Phrase: ")."
Processing 00000000.tx.54: A 1-liter culture of transformed BL21(DE3) was grown overnight at 37C in LB medium containing 50mg/liter ampicillin. 

Phrase: "A 1-liter culture of transformed BL21"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0010453:Culture [Idea or Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C2242979:Culture [Laboratory Procedure]

Phrase: "(DE3"

Phrase: ")"

Phrase: "was"

Phrase: "grown"

Phrase: "overnight at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]

Phrase: "in LB medium containing 50mg/liter ampicillin."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0002680:Ampicillin [Antibiotic,Organic Chemical]
   743 E C0700944:Polycillin [Antibiotic,Organic Chemical]
   743 E C0700946:Omnipen [Antibiotic,Organic Chemical]
Processing 00000000.tx.55: The overnight culture was diluted into 10liters of LB medium (50mg/liter ampicillin) and grown at 37C until the absorbance at 600nm reached values above 1.0.

Phrase: "The overnight culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "was"

Phrase: "diluted into 10liters of LB medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "(50mg/liter ampicillin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0002680:Ampicillin [Antibiotic,Organic Chemical]
   771 E C0700944:Polycillin [Antibiotic,Organic Chemical]
   771 E C0700946:Omnipen [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "grown at 37C"

Phrase: "until the absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1268822:Absorbance [Clinical Attribute]
  1000   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 600nm reached values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "above 1.0."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.56: Isopropyl-1-thio--D-galactopyranoside was then added to a final concentration of 0.5mM, and the concentration of ampicillin was increased 4-fold. 

Phrase: "Isopropyl-1-thio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412102:THIO [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactopyranoside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to a final concentration of 0.5mM,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0086045:Concentration [Mental Process]
   744   C0205088:Final [Temporal Concept]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1524062:Added [Functional Concept]
   744   C1546485:Final [Idea or Concept]
   711 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the concentration of ampicillin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "4-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.57: Cell growth was continued for 4h. 

Phrase: "Cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "continued for 4h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0549178:Continued [Idea or Concept]
   790   C1292426:4H [Temporal Concept]
Processing 00000000.tx.58: The protein purification is based on reversible calcium-dependent binding of annexins to phospholipid membranes and follows well documented protocols (9). 

Phrase: "The protein purification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597301:protein purification [Laboratory Procedure]
   861   C0243114:purification [Functional Concept]
   861   C1998793:Purification [Functional Concept]

Phrase: "is"

Phrase: "based on reversible calcium-dependent binding of annexins"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   767   C1516144:Calcium Binding [Molecular Function]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205343:Reversible [Functional Concept]
   744   C0243122:binding [Functional Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1527178:Based [Functional Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1705938:Based [Idea or Concept]
   744   C2936886:Calcium [Pharmacologic Substance]
   744   C3244310:dependent [Functional Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "to phospholipid membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "well documented protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0442711:Protocols [Intellectual Product]
   793 E C1507394:Protocol [Intellectual Product]
   793 E C1522729:Protocol [Intellectual Product]
   793 E C2348563:Protocol [Intellectual Product]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.59: After harvesting the cells and preparing spheroblasts by resuspending the cell pellet in diluted D2 buffer (750mM saccharose, 0.5mM EDTA, 200mM Tris, pH 8.0) (1:1), the spheroblasts were lysed by osmotic shock in low salt D1 buffer (3mM MgCl2, 100mM NaCl, 5mM benzamidinium chloride, 1mM phenylmethylsulfonyl fluoride, 0.5g/ml pepstatin A, 0.1% Triton X-100, 20mM Tris, pH 8.0). 

Phrase: "After"

Phrase: "harvesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "preparing spheroblasts by resuspending"

Phrase: "the cell pellet in diluted D2 buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441436:Pellet [Manufactured Object]
   748   C0993610:Pellet [Biomedical or Dental Material]
   748   C1998480:Pellet [Quantitative Concept]

Phrase: "(750mM saccharose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038636:Saccharose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   805 E C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "0.5mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "200mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "the spheroblasts"

Phrase: "were"

Phrase: "lysed by osmotic shock"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0524680:Osmotic Shock [Natural Phenomenon or Process]
   770   C0024348:lysed [Pathologic Function]
   770   C0029391:osmotic [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0311417:Osmotic [Functional Concept]

Phrase: "in low salt D1 buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(3mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "5mM benzamidinium chloride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008203:Chloride, NOS [Inorganic Chemical]
   827   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "1mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.5g/ml pepstatin A,"

Phrase: "0.1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.60: Insoluble components were separated by overnight Ultracentrifugation at 100,000g. 

Phrase: "Insoluble components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "separated by overnight Ultracentrifugation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0041609:Ultracentrifugation [Laboratory Procedure]
   770   C0086972:Separated [Finding]
   770   C0439583:Overnight [Temporal Concept]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]

Phrase: "at 100,"

Phrase: "000g."
Processing 00000000.tx.61: The supernatant was applied to liposomes made from bovine brain extract (Sigma) and resuspended in liposome buffer (100mM NaCl, 3mM MgCl2, 20mM Tris, pH 8.0). 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "applied to liposomes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0023828:Liposomes [Lipid]
   790   C0185125:Applied [Health Care Activity]
   756 E C1632850:Apply [Functional Concept]
   756 E C1879355:Apply [Functional Concept]

Phrase: "made from bovine brain extract"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0007452:Bovine [Mammal]
   760   C1140701:bovine [Mammal]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C2828366:Extract [Substance]
   726   C1881534:Make [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "resuspended in liposome buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0023828:Liposome [Lipid]

Phrase: "(100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "3mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.62: Calcium was added to a final concentration of 20mM. 

Phrase: "Calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "was"

Phrase: "added to a final concentration of 20mM."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0086045:Concentration [Mental Process]
   748   C0205088:Final [Temporal Concept]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1524062:Added [Functional Concept]
   748   C1546485:Final [Idea or Concept]
   714 E C1883712:Add [Functional Concept]
Processing 00000000.tx.63: After washing the liposomes with D3 buffer (8mM CaCl2, 100mM NaCl, 3mM MgCl2, 20mM Tris, pH 8.0) containing 8mM calcium, the protein was detached from the vesicles using D4 buffer (15mM EDTA, 100mM NaCl, 10mM MgCl2, 20mM Tris, pH 8.0) and D5 buffer (10mg/ml Chelex (Sigma) in D4 buffer). 

Phrase: "After"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "the liposomes with D3 buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023828:Liposomes [Lipid]

Phrase: "(8mM CaCl2,"

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "3mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing 8mM calcium,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detached from the vesicles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C0687118:Detached [Functional Concept]
   770   C1561504:detached [Idea or Concept]
   737 E C1622418:vesicle [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "D4 buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(15mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "D5 buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10mg/ml Chelex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0055279:chelex [Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "in D4 buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.64: Crystallization-- Protein from the native purification grew in different crystal forms, small square boxes or cubes, large plates, and parallelepipedic boxes. 

Phrase: "Crystallization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010423:Crystallization [Natural Phenomenon or Process]

Phrase: "--"

Phrase: "Protein from the native purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0597301:protein purification [Laboratory Procedure]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "grew in different crystal forms,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   760   C0427896:Crystal [Body Substance]
   760   C0444626:Crystal [Chemical Viewed Structurally]
   760   C1533132:Crystal [Body Substance]
   760   C1704641:Crystal [Manufactured Object]
   760   C1705242:Different [Qualitative Concept]
   726 E C1522492:Form [Functional Concept]

Phrase: "small square boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0179400:boxes [Manufactured Object]
   827   C1638312:Boxes [Quantitative Concept]
   793 E C1533124:Box [Medical Device]

Phrase: "or"

Phrase: "cubes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1880194:Cube [Spatial Concept]
   966   C1880195:Cube [Biomedical or Dental Material]

Phrase: "large plates,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1139930:plates [Medical Device]
   827 E C0005971:Plate [Medical Device]
   827 E C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "parallelepipedic boxes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]
Processing 00000000.tx.65: Crystallization trials with recombinant Anx24(Ca32) and a broad variety of different screenings did not succeed, as precipitation and spherolytic deposition occurred. 

Phrase: "Crystallization trials with recombinant Anx24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0008976:Trial [Research Activity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "and"

Phrase: "a broad variety of different screenings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "succeed"

Phrase: ","

Phrase: "as"

Phrase: "precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032931:Precipitation [Natural Phenomenon or Process]
  1000   C0032932:Precipitation [Molecular Function]
  1000   C1642401:% precipitation [Quantitative Concept]
  1000   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "spherolytic deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "occurred."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.66: 150mg of protein were used for crystallization trials with 40g of recombinant annexin 24(Ca32)/drop. 

Phrase: "150mg of protein"

Phrase: "were"

Phrase: "used for crystallization trials"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0010423:Crystallization [Natural Phenomenon or Process]
   770   C1273517:used [Finding]
   737   C0008976:Trial [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "with 40g"

Phrase: "of recombinant annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514798:recombinant [Organism]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "/drop."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1321095:Drop [Quantitative Concept]
  1000   C1705648:Drop [Activity]
  1000   C2347093:Drop [Quantitative Concept]
  1000   C2348338:Drop [Quantitative Concept]
Processing 00000000.tx.67: From the recombinant fusion protein His-Anx24(Ca32), hexagonal prisms and cubes grew within 6to 8weeks from 1.7M (NH4)2SO4, 2mM CaCl2, 0.1M sodium acetate, pH 5.0. 

Phrase: "From the recombinant fusion protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "His-Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: ","

Phrase: "hexagonal prisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0814195:prisms [Intellectual Product]
   789 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "cubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1880194:Cube [Spatial Concept]
   966   C1880195:Cube [Biomedical or Dental Material]

Phrase: "grew within 6to 8weeks"

Phrase: "from 1.7M"

Phrase: "(NH4"

Phrase: ")"

Phrase: "2SO4,"

Phrase: "2mM CaCl2,"

Phrase: "0.1M sodium acetate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 5.0."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.68: Data Collection-- In-house data, mostly limited to a resolution of 3.8-4.0 , were measured on a MAR image plate system (MAR Research, Hamburg) mounted on a Rigaku rotating anode generator (= 1.5418). 

Phrase: "Data Collection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0010995:Data Collection [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   861   C3245479:data [Medical Device]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "--"

Phrase: "In-house data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "limited to a resolution of 3.8-4.0 ,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   742   C0439801:Limited [Functional Concept]
   742   C1514893:Resolution [Idea or Concept]
   742   C1706463:Resolution [Quantitative Concept]
   742   C2699488:Resolution [Conceptual Entity]
   742   C3542948:Limited [Intellectual Product]
   708 E C1549649:Limit [Idea or Concept]
   708 E C2349209:Limit [Conceptual Entity]

Phrase: "were"

Phrase: "measured on a"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "MAR"

Phrase: "image plate system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "("

Phrase: "MAR"

Phrase: "Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Hamburg"

Phrase: ")"

Phrase: "mounted on a Rigaku rotating anode generator"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0003103:Anode [Manufactured Object]
   748   C0231458:rotating [Spatial Concept]
   748   C0237638:Generator [Manufactured Object]
   748   C0449878:mounted [Finding]
   714 E C0181909:Mount [Medical Device]

Phrase: "("

Phrase: "= 1.5418"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.69: Cryo data sets were collected with in-house equipment mounted on the image plate system. 

Phrase: "Cryo data sets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0150098:data sets [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "collected with in-house equipment"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0014672:Equipment [Manufactured Object]
   760   C0220824:equipment [Manufactured Object]
   760   C0442519:house [Conceptual Entity]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1523994:Equipment [Manufactured Object]
   760   C2003847:House [Manufactured Object]
   760   C2827396:Equipment [Manufactured Object]
   704 E C1706469:Gear [Qualitative Concept]
   704 E C1706470:GEARS [Manufactured Object]

Phrase: "mounted on the image plate system."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C0005971:Plate [Medical Device]
   753   C0449878:mounted [Finding]
   753   C0449913:System [Functional Concept]
   753   C1139930:plate [Medical Device]
   753   C1553451:System [Manufactured Object]
   753   C1704254:Image [Intellectual Product]
   753   C1704459:System [Medical Device]
   753   C1704922:Image [Entity]
   753   C3537155:Plate [Manufactured Object]
   753   C3542466:Image [Intellectual Product]
   719 E C0181909:Mount [Medical Device]
Processing 00000000.tx.70: The crystals were prepared for cryo data collection by soaking for 1-2 min in the cryo buffer (1.7M (NH4)2SO4, 0.1M sodium acetate, pH 5.0,30% glycerin). 

Phrase: "The crystals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0427896:Crystals [Body Substance]
  1000   C0444626:Crystals [Chemical Viewed Structurally]
  1000   C1378554:Crystals [Biomedical or Dental Material]
  1000   C1533132:Crystals [Body Substance]
  1000   C2699477:Crystals [Laboratory Procedure]
   966 E C1704641:Crystal [Manufactured Object]

Phrase: "were"

Phrase: "prepared for cryo data collection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0010995:Data Collection [Research Activity]
   760   C1511726:Data [Idea or Concept]
   760   C1516698:Collection [Functional Concept]
   760   C1704814:Collection [Idea or Concept]
   760   C3245479:data [Medical Device]
   726   C1521827:Prepare [Functional Concept]

Phrase: "by soaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0204774:soaking [Therapeutic or Preventive Procedure]
   966 E C1549544:Soak [Functional Concept]

Phrase: "for 1-2 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0702093:/min [Temporal Concept]
   734   C0580272:1/2 [Intellectual Product]
   734   C1519043:1-2 [Research Activity]

Phrase: "in the cryo buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(1.7M"

Phrase: "(NH4"

Phrase: ")"

Phrase: "2SO4,"

Phrase: "0.1M sodium acetate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 5.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "30% glycerin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017861:Glycerin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   861   C0886275:glycerine [Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.71: Aimed for higher resolution, a data set at beamline BW6 (DESY, Hamburg) was collected at a wavelength of = 1.07with a MAR CCD detection system. 

Phrase: "Aimed for higher resolution,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   816   C1719039:High resolution [Laboratory Procedure]
   770   C1514893:Resolution [Idea or Concept]
   770   C1706463:Resolution [Quantitative Concept]
   770   C2699488:Resolution [Conceptual Entity]
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C1947946:Aim [Idea or Concept]
   737   C2700149:HIGH [Intellectual Product]
   737   C2948600:Aim [Pharmacologic Substance]
   737   C3540471:AIM [Gene or Genome]
   737   C3540472:AIM [Functional Concept]

Phrase: "a data set at beamline BW6"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0150098:Data Set [Intellectual Product]
   790   C1706233:Dataset [Intellectual Product]
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C3245479:data [Medical Device]

Phrase: "(DESY,"

Phrase: "Hamburg"

Phrase: ")"

Phrase: "was"

Phrase: "collected at a wavelength of = 1.07with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449819:Wavelength [Quantitative Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]

Phrase: "a"

Phrase: "MAR"

Phrase: "CCD detection system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.72: Data analysis was performed with the MOSFLM program package (10), and data reduction was performed with SCALA from the CCP4 program suite (11). 

Phrase: "Data analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "performed with the MOSFLM program package"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1704709:Program Package [Intellectual Product]
   753   C0013194:Package [Medical Device]
   753   C0884358:Performed [Functional Concept]
   753   C1709697:Program [Conceptual Entity]
   753   C2700580:Package [Manufactured Object]
   753   C2728259:Program [Pharmacologic Substance]
   753   C3484370:Program [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "data reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed with SCALA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from the CCP4 program suite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553446:Suite [Intellectual Product]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.73: Statistics for different data sets are summarized in Table II.  

Phrase: "Statistics for different data sets"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C2828391:Statistic (data) [Quantitative Concept]
       E   Statistic
   760   C0038215:Statistics [Occupation or Discipline]
   760   C0600673:Statistics [Intellectual Product]
   726 E C2348149:Statistic [Quantitative Concept]

Phrase: "are"

Phrase: "summarized in Table II."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.74: View this table: [in this window] [in a new window]  Table II Data sets p-ClHg-bz-acid, p-chloromercury benzoic acid. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II Data sets p-ClHg-bz-acid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0001128:Acid [Chemical]
   793   C0202406:Acid [Laboratory Procedure]

Phrase: "p-chloromercury benzoic acid."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0053225:Benzoic Acid [Organic Chemical,Pharmacologic Substance]
           benzoic
   861   C1161334:benzoic acid [Organic Chemical,Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.75: Spacegroup Determination and Patterson Search Methods-- Indexing of diffraction patterns was successful with a trigonal space group. 

Phrase: "Spacegroup Determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "Patterson Search Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "--"

Phrase: "Indexing of diffraction patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021200:Indexing [Occupational Activity]

Phrase: "was"

Phrase: "successful with a trigonal space group."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1272703:Successful [Qualitative Concept]
Processing 00000000.tx.76: Starting with P3, self-rotation functions were calculated with GLRF (12), indicating the presence of crystallographic 2-fold axes (=180) at =30 and 90. 

Phrase: "Starting with P3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0439659:Start [Temporal Concept]

Phrase: "self-rotation functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: "were"

Phrase: "calculated with GLRF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "the presence of crystallographic 2-fold axes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "=180"

Phrase: ")"

Phrase: "at =30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: "and"

Phrase: "90."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]
Processing 00000000.tx.77: Additionally, the intensities of reflections along the direction [00l] show high values only for l=3n. 

Phrase: "Additionally,"

Phrase: "the intensities of reflections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:intensities [Qualitative Concept]

Phrase: "along the direction"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0449738:Direction [Spatial Concept]
   900 E C1707761:Directionality [Functional Concept]
   900 E C3274524:Directionality [Functional Concept]

Phrase: "[00l"

Phrase: "]"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "high values only for l=3n."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.78: Therefore the space group was determined to be either P3121 or P3221. 

Phrase: "Therefore"

Phrase: "the space group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1883067:Space [Spatial Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "either P3121"

Phrase: "or"

Phrase: "P3221."
Processing 00000000.tx.79: The Matthews parameter of 3.193/Da, equivalent to a solvent content of 61%, indicated the presence of two monomers. 

Phrase: "The Matthews parameter of 3.193/Da,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0549193:Parameter [Spatial Concept]
   748   C1704769:Parameter [Conceptual Entity]
   748   C2350001:Parameter [Quantitative Concept]

Phrase: "equivalent to a solvent content of 61%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205163:Equivalent [Qualitative Concept]
   748   C0439185:equivalent [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the presence of two monomers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.80: For the Patterson search, a library of 81annexin models was constructed consisting of annexins I, III, IV, V, VIa, VIb, and XII as full models, poly(Ala) models either with or without the N-terminal domain, and single modules (domains I/IV and II/III). 

Phrase: "For the Patterson search,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552603:search [Intellectual Product]
   861   C1706202:Search [Activity]

Phrase: "a library of 81annexin models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023621:Library [Manufactured Object,Organization]
   760   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "consisting of annexins I,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C0103403:Annexin I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   816   C1412417:ANNEXIN I [Gene or Genome]
   770   C0021966:I- [Inorganic Chemical]
   770   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "IV,"

Phrase: "V,"

Phrase: "VIa,"

Phrase: "VIb,"

Phrase: "and"

Phrase: "XII as full models,"

Phrase: "poly(Ala)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]
   768 E C0043189:Wing [Body Part, Organ, or Organ Component]

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "either with"

Phrase: "or without the N-terminal domain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "single modules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709061:Module [Conceptual Entity]
   755 E C1031041:Modulus [Eukaryote]

Phrase: "(domains I/IV"

Phrase: "and"

Phrase: "II/III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.81: The calculations were carried out with the programs AMoRe (13) and BLANC (14); 

Phrase: "The calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441506:Calculation [Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with the programs AMoRe"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0376691:Programs [Intellectual Product]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C3484370:Programs [Functional Concept]
   726 E C1709697:Program [Conceptual Entity]
   726 E C2728259:Program [Pharmacologic Substance]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "BLANC"

Phrase: "(14"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.82: however, only the former gave suitable results with poly(Ala)-annexin VIa (without the N-terminal tail) as the search model. 

Phrase: "however,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "suitable results with poly(Ala)-annexin VIa ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "without the N-terminal tail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "as the search model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]
Processing 00000000.tx.83: Also at this stage, it became evident that the final space group had to be P3221 (highest correlation coefficient: 0.634), since there was no equivalent Patterson solution within space group P3121 (highest correlation coefficient: 0.497). 

Phrase: "Also at this stage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]

Phrase: "it"

Phrase: "became"

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the final space group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1883067:Space [Spatial Concept]

Phrase: "had"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "P3221"

Phrase: "(highest correlation coefficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1707429:*Coefficient [Quantitative Concept]
   827   C1707520:Correlation [Qualitative Concept]

Phrase: ":"

Phrase: "0.634"

Phrase: ")"

Phrase: ","

Phrase: "since"

Phrase: "there"

Phrase: "was"

Phrase: "no equivalent Patterson solution within space group P3121"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037633:Solution [Substance]
   744   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(highest correlation coefficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1707429:*Coefficient [Quantitative Concept]
   827   C1707520:Correlation [Qualitative Concept]

Phrase: ":"

Phrase: "0.497"

Phrase: ")."
Processing 00000000.tx.84: The crystal packing in the unit cell showed a reasonable arrangement of molecules; 

Phrase: "The crystal packing in the unit cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0184967:Packing [Therapeutic or Preventive Procedure]
   748   C1289829:Packing [Medical Device]
   748   C2828395:Packing [Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a reasonable arrangement of molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449830:Arrangement [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.85: therefore, a first 2FoFc map was calculated. 

Phrase: "therefore,"

Phrase: "a first 2FoFc map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0024779:Map [Manufactured Object]
   827   C1706473:Map [Conceptual Entity]

Phrase: "was"

Phrase: "calculated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.86: About 75% of the Ala residues were successively replaced by annexin 24(Ca32) residues according to the sequence X93308 using a MAIN-averaged electron density map (15) calculated from the A2414 data set. 

Phrase: "About 75%"

Phrase: "of the Ala residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "successively"

Phrase: "replaced by annexin 24"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C1299987:Replaced by [Functional Concept]
           replaced
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0559956:Replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "residues according to the sequence X93308"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a MAIN-averaged electron density map (15"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   827   C0596488:electron density [Molecular Sequence]
   799   C0013852:Electron [Quantitative Concept]
   799   C0024779:Map [Manufactured Object]
   799   C0178587:density [Quantitative Concept]
   799   C0205225:Main [Qualitative Concept]
   799   C1542147:Main [Qualitative Concept]
   799   C1706473:Map [Conceptual Entity]
   799   C3463986:Electron [Bird]
   766   C1510992:Average [Quantitative Concept]
   766   C2825518:AVERAGE [Quantitative Concept]
   727 E C0013850:Electronic [Manufactured Object]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C1547561:Electronic [Idea or Concept]

Phrase: ")"

Phrase: "calculated from the A2414 data set."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0150098:Data Set [Intellectual Product]
   790   C1706233:Dataset [Intellectual Product]
   753   C0036849:Set [Mental Process]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1442518:Set [Functional Concept]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1511726:Data [Idea or Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C3245479:data [Medical Device]
Processing 00000000.tx.87: Three averaging runs were made with 5,25,and 100cycles, respectively. 

Phrase: "Three averaging runs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0600140:Runs [Finding]
   793 E C0035953:run [Daily or Recreational Activity]
   793 E C1704688:Run [Functional Concept]
   793 E C2346414:Run [Finding]

Phrase: "were"

Phrase: "made with 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1881534:Make [Functional Concept]

Phrase: "25,"

Phrase: "and"

Phrase: "100cycles,"

Phrase: "respectively."
Processing 00000000.tx.88: The electron density was converted into FRODO (16) format and used for model building. 

Phrase: "The electron density"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0596488:electron density [Molecular Sequence]
   861   C0013852:Electron [Quantitative Concept]
   861   C0178587:density [Quantitative Concept]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0439794:Dense [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: "was"

Phrase: "converted into FRODO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1425059:FRODO [Gene or Genome]

Phrase: "(16"

Phrase: ")"

Phrase: "format"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301627:Format [Intellectual Product]

Phrase: "and"

Phrase: "used for model building."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1273517:used [Finding]
   770   C1547706:Building [Functional Concept]
   770   C1999269:Building [Manufactured Object]
   770   C3161035:Model [Intellectual Product]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.89: The resulting model was subjected to rigid body refinement and served as a starting model for the following refinement. 

Phrase: "The resulting model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "subjected to rigid body refinement"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0026837:Rigid [Sign or Symptom]
   760   C0231517:Rigid [Individual Behavior]
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]
   760   C1882952:RIGID [Phenomenon or Process]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "served as a starting model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C3161035:Model [Intellectual Product]
   726   C0439659:Start [Temporal Concept]

Phrase: "for the following refinement."
Processing 00000000.tx.90: Structure Determination and Refinement-- For refinement and map calculation, X-PLOR (17) and CNS (18) were used. 

Phrase: "Structure Determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "Refinement"

Phrase: "-"

Phrase: "-"

Phrase: "For refinement"

Phrase: "and"

Phrase: "map calculation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1441506:Calculation [Activity]

Phrase: "X-PLOR"

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "CNS (18"

Phrase: ")"

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.91: The NCS operator was determined with X-PLOR and LSQMAN (O software package (19)) and revealed no special relation between the two molecules in the asymmetric unit. 

Phrase: "The NCS operator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1705273:Operator [Intellectual Product]
   861   C1705274:Operator [Human]
   861   C1705275:Operator [Human]
   861   C2827501:Operator [Intellectual Product]

Phrase: "was"

Phrase: "determined with X-PLOR"

Phrase: "and"

Phrase: "LSQMAN"

Phrase: "(O software package"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013194:Package [Medical Device]
   827   C2700580:Package [Manufactured Object]

Phrase: "(19"

Phrase: ")"

Phrase: ")"

Phrase: "and"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no special relation between the two molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0080103:Relation [Family Group]
   748   C0869014:relation [Social Behavior]

Phrase: "in the asymmetric unit."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.92: Iterative rounds of model building and refinement consisted of a rigid body minimization with the two molecules as defined rigid bodies. 

Phrase: "Iterative rounds of model building"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332490:Round [Spatial Concept]

Phrase: "and"

Phrase: "refinement"

Phrase: "consisted of a rigid body minimization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0026837:Rigid [Sign or Symptom]
   753   C0231517:Rigid [Individual Behavior]
   753   C0242821:body [Human]
   753   C0460148:Body [Anatomical Structure]
   753   C1268086:Body [Anatomical Structure]
   753   C1882952:RIGID [Phenomenon or Process]
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "with the two molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "as defined rigid bodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0242821:bodies [Human]
   827   C1995017:Bodies [Cell Component]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.93: As the density from the A2414 data set was very poor due to the limited resolution of 3.8, NCS-averaging was attempted to improve phasing. 

Phrase: "As the density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "from the A2414 data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0150098:Data Set [Intellectual Product]
   901   C1706233:Dataset [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "very poor due to the limited resolution of 3.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C3641766:Very Poor [Intellectual Product]
   739   C0032854:Poor [Group Attribute]
   739   C0542537:Poor [Qualitative Concept]
   739   C2700379:Poor [Qualitative Concept]

Phrase: "NCS-averaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1510992:Average [Quantitative Concept]
   827   C2825518:AVERAGE [Quantitative Concept]

Phrase: "was"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "improve"

Phrase: "phasing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.94: Cyclic averaging yielded back-transformation R-factors of 16%, and the averaged electron density was of much sharper appearance than the non-averaged one. 

Phrase: "Cyclic averaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1510992:Average [Quantitative Concept]
   827   C2825518:AVERAGE [Quantitative Concept]

Phrase: "yielded"

Phrase: "back-transformation R-factors of 16%,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0034471:R Factors [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756 E C0602449:R-factor [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205090:R- [Spatial Concept]
   753   C0684010:R. [Professional or Occupational Group]
   753   C2603358:R' [Clinical Attribute]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "the averaged electron density"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0596488:electron density [Molecular Sequence]
   827   C0013852:Electron [Quantitative Concept]
   827   C0178587:density [Quantitative Concept]
   827   C3463986:Electron [Bird]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0439794:Dense [Qualitative Concept]
   755 E C1547561:Electronic [Idea or Concept]

Phrase: "was of much sharper appearance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0233426:Appearance [Organism Attribute]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0700364:Appearance [Qualitative Concept]
   760   C1421478:WAS [Gene or Genome]
   726   C1444775:Sharp [Finding]
   726   C1539835:SHARP [Gene or Genome]

Phrase: "than the non-averaged one."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]
Processing 00000000.tx.95: Once the data set A2412 was available, model building and refinement were carried out with these data. 

Phrase: "Once"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "the data set A2412"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0150098:Data Set [Intellectual Product]
   734   C1706233:Dataset [Intellectual Product]

Phrase: "was"

Phrase: "available, model building"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547706:Building [Functional Concept]
   827   C1999269:Building [Manufactured Object]

Phrase: "and"

Phrase: "refinement"

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with these data."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
Processing 00000000.tx.96: Several rounds of refinement with inspection and manual adjustment of the model were performed at a resolution range of 12.0to 3.0. 

Phrase: "Several rounds of refinement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0332490:Round [Spatial Concept]

Phrase: "with inspection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0199219:Inspection [Functional Concept]

Phrase: "and"

Phrase: "manual adjustment of the model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0376209:Adjustment [Individual Behavior]
   760   C0456081:Adjustment [Functional Concept]
   760   C0683269:adjustment [Individual Behavior]

Phrase: "were"

Phrase: "performed at a resolution range of 12.0to 3.0."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   739   C0884358:Performed [Functional Concept]
   739   C1514721:Range [Quantitative Concept]
   739   C1514893:Resolution [Idea or Concept]
   739   C1706463:Resolution [Quantitative Concept]
   739   C2348147:Range [Quantitative Concept]
   739   C2699488:Resolution [Conceptual Entity]
   739   C3542016:Range [Intellectual Product]
   706 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.97: For further refinement, only the CNS program was used. 

Phrase: "For further refinement,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the CNS program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.98: Iteratively, the model was subjected to simulated annealing slow cool protocols in torsion space, positional refinement, and B-factor refinement using the parameter set derived from Engh and Huber (20). 

Phrase: "Iteratively,"

Phrase: "the model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "subjected to simulated annealing slow cool protocols"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   748   C0284447:simulated [Biomedical or Dental Material]
   748   C0439834:Slow [Qualitative Concept]
   748   C0442711:Protocols [Intellectual Product]
   748   C1548792:Cool [Qualitative Concept]
   714   C0681850:Subject [Group]
   714 E C1507394:Protocol [Intellectual Product]
   714 E C1522729:Protocol [Intellectual Product]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714 E C2348563:Protocol [Intellectual Product]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "in torsion space,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883067:Space [Spatial Concept]

Phrase: "positional refinement,"

Phrase: "and"

Phrase: "B-factor refinement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0033453:b factor [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   734   C0046774:B-factor [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the parameter set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "derived from Engh"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "Huber"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.99: NCS restraints were released slowly, and the resolution range was increased to 50,2.8. 

Phrase: "NCS restraints"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337184:Restraints [Medical Device]
   861   C2708180:Restraints [Clinical Attribute]

Phrase: "were"

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "slowly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "and"

Phrase: "the resolution range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "increased to 50,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "2.8."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]
Processing 00000000.tx.100: The observed structure factors were scaled anisotropically (tensor: B11=9.624; 

Phrase: "The observed structure factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678594:Structure [Spatial Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "were"

Phrase: "scaled"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0175659:Scale [Medical Device]
   966   C0349674:Scale [Intellectual Product]
   966   C1947916:Scale [Activity]
   966   C3536777:Scale [Manufactured Object]

Phrase: "anisotropically"

Phrase: "(tensor"

Phrase: ":"

Phrase: "B11"

Phrase: "=9.624"

Phrase: ";"
Processing 00000000.tx.101: B22=9.624; 

Phrase: "B22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417641:B22 [Gene or Genome]

Phrase: "=9.624"

Phrase: ";"
Processing 00000000.tx.102: B33=19.247; 

Phrase: "B33"

Phrase: "=19.247"

Phrase: ";"
Processing 00000000.tx.103: B12=7.677; 

Phrase: "B12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1417635:B12 [Gene or Genome]
  1000   C1420797:B12 [Gene or Genome]
  1000   C3538796:B12 [Gene or Genome]

Phrase: "=7.677"

Phrase: ";"
Processing 00000000.tx.104: B13=0.000,B23=0.000), and a bulk solvent correction was applied (limiting resolution 6.0). 

Phrase: "B13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417625:B13 [Gene or Genome]

Phrase: "=0.000,"

Phrase: "B23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334894:B23 [Gene or Genome]
  1000   C1704851:B23 [Gene or Genome]

Phrase: "=0.000"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a bulk solvent correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1705565:CORRECTION [Intellectual Product]
   827   C1947976:Correction [Functional Concept]

Phrase: "was"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "(limiting resolution 6.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439801:limiting [Functional Concept]
   812   C1514893:Resolution [Idea or Concept]
   812   C1706463:Resolution [Quantitative Concept]
   812   C2699488:Resolution [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.105: 2FoFc maps and FoFc difference maps were calculated for inspection and model building on an Evans and Sutherland graphics terminal with the program FRODO (16) and also O (19) running on an SGI indigo2. 

Phrase: "2FoFc maps"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024779:Map [Manufactured Object]
   861   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "FoFc difference maps"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024779:Map [Manufactured Object]
   827   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1706473:Map [Conceptual Entity]

Phrase: "were"

Phrase: "calculated for inspection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0199219:Inspection [Functional Concept]
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "and"

Phrase: "model building on an Evans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1547706:Building [Functional Concept]
   760   C1999269:Building [Manufactured Object]

Phrase: "and"

Phrase: "Sutherland graphics"

Phrase: "terminal with the program FRODO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205088:Terminal [Temporal Concept]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "also O (19"

Phrase: ")"

Phrase: "running on an SGI indigo2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035953:Running [Daily or Recreational Activity]
   760   C2346414:Running [Finding]
Processing 00000000.tx.106: Model geometry was verified with PROCHECK (21). 

Phrase: "Model geometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449829:Geometry [Spatial Concept]

Phrase: "was"

Phrase: "verified with PROCHECK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1711411:Verified [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.107: Refinement results are summarized in Table III. 

Phrase: "Refinement results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "summarized in Table III."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C0439070:III [Intellectual Product]
   770   C1705160:III [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.108: Coordinates and structure factors have been submitted to the Protein Data Bank with accession code 1dk5.  

Phrase: "Coordinates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427184:coordinates [Finding]
  1000   C0700114:coordinates [Functional Concept]
  1000   C1707511:Coordinates [Spatial Concept]

Phrase: "and"

Phrase: "structure factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678594:Structure [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "submitted to the Protein Data Bank"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1705318:Protein Data Bank [Intellectual Product]
   790   C0242356:Data Bank [Intellectual Product]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0442598:Bank [Manufactured Object]
   753   C0872261:Bank [Manufactured Object]
   753   C1511726:Data [Idea or Concept]
   753   C1515023:Submitted [Functional Concept]
   753   C3245479:data [Medical Device]

Phrase: "with accession code 1dk5."
Processing 00000000.tx.109: View this table: [in this window] [in a new window]  Table III Refinement statistics r.m.s., root mean square. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table III Refinement statistics r.m.s.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0439493:m/s [Quantitative Concept]
   818   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   818   C1513009:M.S. [Intellectual Product]
   795   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0441923:M+ [Intellectual Product]

Phrase: "root mean square."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C2347976:Root Mean Square [Quantitative Concept]
   827   C0040452:Root [Body Part, Organ, or Organ Component]
   827   C0205120:Square [Spatial Concept]
   827   C0242726:Root [Plant]
   827   C0444504:Mean [Quantitative Concept]
   827   C1318154:Root [Body Part, Organ, or Organ Component]
   827   C1552595:Square [Intellectual Product]
   827   C1705917:Root [Idea or Concept]
   827   C2347634:Mean [Quantitative Concept]
   827   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.110: R=F0||FC/|F0|, where F0 and FC are the observed and the calculated structure factors, respectively. 

Phrase: "R=F0||FC/|F0|,"

Phrase: "where F0"

Phrase: "and"

Phrase: "FC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983605:FC [Activity]

Phrase: "are"

Phrase: "the observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "the calculated structure factors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678594:Structure [Spatial Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "respectively."
Processing 00000000.tx.111: Rfree is from Brnger (37). 

Phrase: "Rfree"

Phrase: "is from Brnger"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.112: Mass Spectrometry-- Mass spectra of diluted acidified samples (~1 mg/ml) were obtained from a Perkin-Elmer API 165mass spectrometer equipped with an electrospray application device. 

Phrase: "Mass Spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "--"

Phrase: "Mass spectra of diluted acidified samples"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0037813:Mass Spectrum [Laboratory Procedure]
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "(~1 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from a Perkin-Elmer API 165mass spectrometer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0183395:Spectrometer [Medical Device]
   744   C1301820:Obtained [Functional Concept]
   744   C1710143:Spectrometer [Manufactured Object]
   711 E C1706701:Obtain [Activity]

Phrase: "equipped with an electrospray application device."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025080:Device [Medical Device]
   753   C0185125:Application [Health Care Activity]
   753   C0699733:Device [Manufactured Object]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.113: The native purified annexin 24(Ca32) yielded a molecular mass of 35,848g/mol (theoretical: 35,850g/mol). 

Phrase: "The native purified annexin 24"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0302891:Native [Functional Concept]
   812   C1998793:Purified [Functional Concept]
   719 E C1947930:Cleanse [Activity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "yielded"

Phrase: "a molecular mass of 35,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   797   C0577559:A mass [Finding]
           Mass
   760   C1306372:*Mass [Quantitative Concept]

Phrase: "848g/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]

Phrase: "(theoretical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871935:Theoretical [Idea or Concept]

Phrase: ":"

Phrase: "35,"

Phrase: "850g/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]

Phrase: ")."
Processing 00000000.tx.114: For the recombinant proteins, values of 35,759g/mol were obtained for annexin 24(Ca32) wild type and 36,790g/mol for the His-tagged fusion protein. 

Phrase: "For the recombinant proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514798:recombinant [Organism]

Phrase: "values of 35,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "759g/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]

Phrase: "were"

Phrase: "obtained for annexin 24"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "36,"

Phrase: "790g/mol for the"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0027960:Mole [Neoplastic Process]
   770   C0324740:Mole [Mammal]
   770   C0439189:Mole [Quantitative Concept]
   770   C1456781:mole [Neoplastic Process]
   770   C1824986:mol [Gene or Genome]

Phrase: "His-tagged fusion protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.115: This indicates that in both cases the starting methionine is processed, and a calcium (Anx24 wild-type) or two sodium ions (His-Anx24) are associated with the proteins. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that in both cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "the starting methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: ","

Phrase: "and"

Phrase: "a calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(Anx24"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "two sodium ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0597484:sodium ions [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0022023:Ions [Element, Ion, or Isotope]
   793 E C1700702:ION [Functional Concept]

Phrase: "("

Phrase: "His-Anx24"

Phrase: ")"

Phrase: "are"

Phrase: "associated with the proteins."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.116: Fluorescence Spectroscopy-- Fluorescence spectra of recombinant annexin 24(Ca32) wild type and fusion protein were recorded on a Perkin-Elmer LS 50B using a 500-l sample with 0.3mM to 0.5mM protein in 5mM Tris, pH 8.0.

Phrase: "Fluorescence Spectroscopy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242506:Fluorescence Spectroscopy [Laboratory Procedure]
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "--"

Phrase: "Fluorescence spectra of recombinant annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "recorded on a Perkin-Elmer LS 50B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0034869:Record [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 500-l sample with 0.3mM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]

Phrase: "to 0.5mM protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in 5mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.117: For elucidation of calcium-dependent annexin interaction with liposomes, the samples additionally contained PS1/PE (3:1) liposomes with a total lipid content of 0.5nmol and the appropriate concentration of CaCl2. 

Phrase: "For elucidation"

Phrase: "of calcium-dependent annexin interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704675:Interaction [Functional Concept]

Phrase: "with liposomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: "the samples additionally contained PS1/PE (3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332256:contained [Functional Concept]
   799   C1418985:PS1 [Gene or Genome]
   799   C2700400:Contained [Activity]
   799   C2986918:PS1 [Gene or Genome]
   766   C0370003:Sample [Substance]
   766   C2347026:Sample [Conceptual Entity]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes with a total lipid content of 0.5nmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0023828:Liposomes [Lipid]

Phrase: "and"

Phrase: "the appropriate concentration of CaCl2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.118: Circular Dichroism-- To elucidate the secondary structure of recombinant annexin 24(Ca32) and the fusion protein His-Anx24, their circular dichroic spectra were recorded with a Jobin-Yvon Auto-Dichrograph Mark IV. 

Phrase: "Circular Dichroism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the secondary structure of recombinant annexin 24"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0162807:Secondary Structure [Spatial Concept]
   748   C0027627:secondary [Neoplastic Process]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0678594:Structure [Spatial Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "and"

Phrase: "the fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "His-Anx24,"

Phrase: "their circular dichroic spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded with a Jobin-Yvon Auto-Dichrograph Mark IV."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0522501:mark [Qualitative Concept]
   742   C1441488:Auto [Laboratory Procedure]
   708   C0034869:Record [Intellectual Product]
Processing 00000000.tx.119: The samples had a concentration of 0.15mg/ml in 5mM Tris, pH 8.0. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "had"

Phrase: "a concentration of 0.15mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "in 5mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.120: Immunoblot-- To test the cross-reaction of recombinant annexin 24(Ca32) with anti-annexin V antibodies, human recombinant annexin V and Anx24(Ca32) were applied to SDS-PAGE (12%) and blotted onto a polyvinylidene difluoride membrane. 

Phrase: "Immunoblot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the cross-reaction of recombinant annexin 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0010357:Cross Reaction [Molecular Function]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C2828360:Cross [Conceptual Entity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "with anti-annexin V antibodies,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0432636:Anti V [Laboratory or Test Result]
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   844   C0370124:V Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "human recombinant annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332095:ANNEXIN V [Gene or Genome]
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "were"

Phrase: "applied to SDS-PAGE (12%"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0185125:Applied [Health Care Activity]
   760   C1704732:Page [Intellectual Product]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "blotted onto a polyvinylidene difluoride membrane."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0071710:polyvinylidene difluoride [Organic Chemical]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.121: After the first immunoreaction staining was performed by adding anti-rabbit antibody (alkaline phosphate conjugate of anti-rabbit IgG; Sigma), the samples were washed several times and transferred into staining solution containing nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate. 

Phrase: "After the first immunoreaction staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed by adding anti-rabbit antibody"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C1550369:Performed By [Qualitative Concept]
   790   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0034493:Rabbit [Mammal]
   753   C0884358:Performed [Functional Concept]
   719   C1883712:Add [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(alkaline phosphate conjugate of anti-rabbit IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0301869:Conjugate [Immunologic Factor]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "several times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "transferred into staining solution"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0037633:Solution [Substance]
   770   C0348011:transferred [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C1704680:Staining [Finding]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "nitro blue tetrazolium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028147:Nitroblue Tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0039704:tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C1260957:Blue [Qualitative Concept]

Phrase: "and"

Phrase: "5-bromo-4-chloro-3-indolyl phosphate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0049082:5-bromo-4-chloro-3-indolyl phosphate [Organic Chemical]
   795   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   795   C0031701:phosphate [Organophosphorus Compound]
   795   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.122: The procedure followed standard protocols for Western blot techniques. 

Phrase: "The procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "standard protocols for Western blot techniques."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0442711:Protocols [Intellectual Product]
   719 E C1507394:Protocol [Intellectual Product]
   719 E C1522729:Protocol [Intellectual Product]
   719 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.123: For immunodetection of native and recombinant annexin 24(Ca), wild-type polyclonal antibodies against p33/p35 from maize were used, kindly provided by Prof. 

Phrase: "For immunodetection"

Phrase: "of native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302891:Native [Functional Concept]

Phrase: "and"

Phrase: "recombinant annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514798:recombinant [Organism]

Phrase: "(Ca), wild-type polyclonal antibodies against p33/p35"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   767   C0449565:antibodies type [Qualitative Concept]
   750 E C1384505:Antibody type [Intellectual Product]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "from maize"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010028:Maize [Plant]
  1000   C1138842:Maize [Food]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "kindly"

Phrase: "provided by Prof."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0599518:Prof. [Professional or Occupational Group]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.124: N.H.Battey (University of Reading, UK). 

Phrase: "N.H.Battey"

Phrase: "(University of Reading,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034754:Reading [Daily or Recreational Activity]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1705179:Reading [Finding]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.125: Liposome Preparation for Binding, Stability, and Calcium Influx Assay-- Phospholipid vesicles were prepared following the protocol of Reeves and Dowben (22) by mixing phosphatidylserine and phosphatidylethanolamine (Avanti Polar Lipids) at a molar ratio of 3:1 in CHCl3. 

Phrase: "Liposome Preparation for Binding,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "Stability,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "Calcium Influx Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "--"

Phrase: "Phospholipid vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the protocol of Reeves"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442711:Protocol [Intellectual Product]
   770   C1507394:Protocol [Intellectual Product]
   770   C1522729:Protocol [Intellectual Product]
   770   C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "Dowben"

Phrase: "(22"

Phrase: ")"

Phrase: "by mixing phosphatidylserine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]

Phrase: "and"

Phrase: "phosphatidylethanolamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "(Avanti Polar Lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023779:Lipids [Lipid]

Phrase: ")"

Phrase: "at a molar ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2825550:Molar Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "of 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1 in CHCl3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]
Processing 00000000.tx.126: The total amount of lipids used for the centrifugation assay was 10mol, but only 1mol was used for the carboxyfluorescein leakage assay and the calcium influx assay. 

Phrase: "The total amount of lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "used for the centrifugation assay"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1510438:Assay [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "10mol,"

Phrase: "but"

Phrase: "only 1mol"

Phrase: "was"

Phrase: "used for the carboxyfluorescein leakage assay"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0015376:Leakage [Pathologic Function]
   753   C0108453:carboxyfluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0243073:assay [Qualitative Concept]
   753   C1273517:used [Finding]
   753   C1510438:Assay [Laboratory Procedure]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "the calcium influx assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.127: For the leakage assay 5(6)-carboxyfluorescein diacetate (Sigma) and, for the influx assay, the pentasodium salt of FURA-2 (Calbiochem) was enclosed into the vesicles. 

Phrase: "For the leakage assay 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0015376:Leakage [Pathologic Function]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(6"

Phrase: ")-"

Phrase: "carboxyfluorescein diacetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054736:carboxyfluoresceindiacetate [Organic Chemical]
   861   C0108453:carboxyfluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0369114:Diacetate [Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "for the influx assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "the pentasodium salt of FURA-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0206136:Salt [Food,Inorganic Chemical]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "was"

Phrase: "enclosed into the vesicles."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205380:Enclosed [Spatial Concept]
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]
Processing 00000000.tx.128: A detailed description of the procedure is given in Hofmann et al. 

Phrase: "A detailed description of the procedure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0807506:Procedure description [Intellectual Product]
   753   C0678257:Description [Idea or Concept]

Phrase: "is"

Phrase: "given in Hofmann et al."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1550718:given [Idea or Concept]
   760   C3244317:given [Intellectual Product]
   726 E C1947971:Give [Functional Concept]
Processing 00000000.tx.129: (23). 

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.130: Binding to Phospholipid Vesicles (Centrifugation Assay)-- Calcium-dependent binding of recombinant annexin 24(Ca32) to phospholipid vesicles was elucidated by a centrifugation assay. 

Phrase: "Binding to Phospholipid Vesicles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1148642:Phospholipid Binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "(Centrifugation Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: ")"

Phrase: "--"

Phrase: "Calcium-dependent binding of recombinant annexin 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1516144:Calcium Binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "to phospholipid vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "was"

Phrase: "elucidated by a centrifugation assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.131: A sample with the total volume of 500l contained a 20-l aliquot of liposome suspension, an appropriate amount of CaCl2, and F4 buffer (180mM saccharose, 10mM HEPES, pH 7.4). 

Phrase: "A sample with the total volume of 500l"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0427785:Volume of sample [Laboratory Procedure]
   744   C0370003:Sample [Substance]
   744   C2347026:Sample [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a 20-l aliquot of liposome suspension,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510844:Aliquot [Quantitative Concept]

Phrase: "an appropriate amount of CaCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "F4 buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(180mM saccharose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038636:Saccharose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   805 E C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "10mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.132: After the addition of 2nmol of annexin, the sample was incubated for 15min and then centrifuged for 30min at 130,000g (Beckman Airfuge). 

Phrase: "After the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 2nmol"

Phrase: "of annexin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "incubated for 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged for 30min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 130,"

Phrase: "000g"

Phrase: "(Beckman Airfuge"

Phrase: ")."
Processing 00000000.tx.133: The fraction of unbound protein was determined by UV absorption at 280nm of the supernatant. 

Phrase: "The fraction of unbound protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "determined by UV absorption"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0000854:Absorption [Natural Phenomenon or Process]
   770   C0041625:UV [Natural Phenomenon or Process]
   770   C0220777:absorption [Functional Concept]
   770   C1961129:uV [Quantitative Concept]
   770   C2347023:Absorption [Phenomenon or Process]
   770   C2347080:Absorption [Phenomenon or Process]
   770   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   770   C2825050:Absorption [Phenomenon or Process]

Phrase: "at 280nm"

Phrase: "of the supernatant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.134: Data were normalized with respect to a calcium-free sample. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "normalized with respect to a calcium-free sample."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0596235:Free Calcium [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0332296:free [Functional Concept]
   744   C0370003:Sample [Substance]
   744   C0679133:respect [Social Behavior]
   744   C1880497:Free [Qualitative Concept]
   744   C1882115:Normalized [Research Activity]
   744   C1996904:Free [Qualitative Concept]
   744   C2347026:Sample [Conceptual Entity]
   744   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.135: All experiments were carried out three times independently. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out three times independently."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0871938:out time [Mental Process]
   812   C0040223:times [Temporal Concept]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.136: Liposome Stability Assay and Calcium Influx Assay-- Protein-induced leakage of phospholipid vesicles was monitored by using carboxyfluorescein in self-quenching concentrations enclosed into liposomes. 

Phrase: "Liposome Stability Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "Calcium Influx Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "--"

Phrase: "Protein-induced leakage of phospholipid vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015376:Leakage [Pathologic Function]

Phrase: "was"

Phrase: "monitored by"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0030695:monitor [Health Care Activity]
   799   C0150369:monitor [Health Care Activity]
   799   C0181904:Monitor [Medical Device]
   799   C0596972:Monitor [Medical Device]
   799   C1521743:Monitor [Professional or Occupational Group]
   799   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "carboxyfluorescein in self-quenching concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0108453:carboxyfluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "enclosed into liposomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023828:Liposomes [Lipid]
   790   C0205380:Enclosed [Spatial Concept]
Processing 00000000.tx.137: If leakage occurred, the fluorescence dye was diluted into the buffer, and the fluorescence intensity increased (24). 

Phrase: "If"

Phrase: "leakage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015376:Leakage [Pathologic Function]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "the fluorescence dye"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   964   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]
   861   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "diluted into the buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "the fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.138: To investigate membrane permeabilization activity of recombinant wild-type annexin 24(Ca32) and the His-tagged fusion protein, a calcium influx assay based on previous reports was used (23, 25, 26). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "membrane permeabilization activity of recombinant wild-type annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C0459205:Type of activity [Intellectual Product]
   762   C0596897:membrane activity [Cell Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "and"

Phrase: "the His-tagged fusion protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "a calcium influx assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "based on previous reports"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0205156:Previous [Temporal Concept]
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   770   C1527178:Based [Functional Concept]
   770   C1552607:previous [Temporal Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C3273238:Report [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.139: The calcium-sensitive fluorescence dye FURA-2 was enclosed in large unilamellar liposomes, and the protein-induced calcium influx was monitored by a change in the fluorescence signal (27). 

Phrase: "The calcium-sensitive fluorescence dye FURA-2"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   895   C0596235:Calcium 2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   839   C1610316:dye 2 [Organic Chemical]
   827   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   799   C0016315:Fluorescence [Natural Phenomenon or Process]
   799   C0332324:Sensitive [Functional Concept]
   799   C1550474:sensitive [Idea or Concept]
   799   C2936886:Calcium [Pharmacologic Substance]
   791   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]
   727 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "enclosed in large unilamellar liposomes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1721091:Unilamellar Liposomes [Lipid]
   760   C0023828:Liposomes [Lipid]
   760   C0205380:Enclosed [Spatial Concept]
   760   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "the protein-induced calcium influx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0805431:protein calcium [Quantitative Concept]

Phrase: "was"

Phrase: "monitored by a change"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "in the fluorescence signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.140: Calcium influx is characterized by the slopes (15-35 min) and (t=4min) of the influx curves, which were converted into an activity parameter according to the following equation. 

Phrase: "Calcium influx"

Phrase: "is"

Phrase: "characterized by the slopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0807955:slopes [Quantitative Concept]
   770   C1880022:Characterized [Activity]

Phrase: "(15-35 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "and ("

Phrase: "t=4min"

Phrase: ")"

Phrase: "of the influx curves,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]

Phrase: "which"

Phrase: "were"

Phrase: "converted into an activity parameter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0549193:Parameter [Spatial Concept]
   760   C1561536:*Activity [Idea or Concept]
   760   C1704769:Parameter [Conceptual Entity]
   760   C2350001:Parameter [Quantitative Concept]

Phrase: "according to the following equation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]
Processing 00000000.tx.141: (Eq.1) The activity parameter of each measurement was normalized with respect to a control measurement without protein (0). 

Phrase: "(Eq.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:EQ [Qualitative Concept]
   861   C0439185:Eq [Quantitative Concept]

Phrase: ")"

Phrase: "The activity parameter of each measurement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0549193:Parameter [Spatial Concept]
   753   C1704769:Parameter [Conceptual Entity]
   753   C2350001:Parameter [Quantitative Concept]

Phrase: "was"

Phrase: "normalized with respect to a control measurement"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0242485:Measurement [Functional Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0679133:respect [Social Behavior]
   748   C1550141:Control [Substance]
   748   C1882115:Normalized [Research Activity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "without protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(0"

Phrase: ")."
Processing 00000000.tx.142: We expressively note that the assay is validated by the above-mentioned stability assay. 

Phrase: "We expressively"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "validated by the above-mentioned stability assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0205360:Stability [Qualitative Concept]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.143: Experimental procedures follow the protocols described (23). 

Phrase: "Experimental procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "the protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.144: All experiments were carried out three times independently. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out three times independently."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0871938:out time [Mental Process]
   812   C0040223:times [Temporal Concept]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.145: Test of ATPase Activity-- To test ATPase activity of recombinant annexin 24(Ca32), 10g of protein were incubated in ATPase buffer (3mM MgCl2, 50mM KCl, 5mM MES, pH 6.0) for 5min at room temperature. 

Phrase: "Test of ATPase Activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "ATPase activity of recombinant annexin 24"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1148926:ATPase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: ","

Phrase: "10g of protein"

Phrase: "were"

Phrase: "incubated in ATPase buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(3mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "50mM KCl,"

Phrase: "5mM MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0265215:MES [Congenital Abnormality]
   861   C1417092:MES [Gene or Genome]

Phrase: "pH 6.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 5min"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.146: To start the reaction 3mM Na2ATP were added to yield a final sample volume of 200l. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "start"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "the reaction 3mM Na2ATP"

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "a final sample volume of 200l."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C0427785:Volume of sample [Laboratory Procedure]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.147: After incubation for either 0.5,1,and 2h at room temperature, the enzyme reaction was stopped by the addition of Ames solution (6ml of 10mM (NH4)6Mo7O24 in 0.5M H2SO4, 1ml of 500mM ascorbic acid) (28). 

Phrase: "After incubation"

Phrase: "for either 0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0444499:0/5 [Quantitative Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2h at room temperature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1292425:2H [Temporal Concept]

Phrase: "the enzyme reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of Ames solution"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1272691:stopped [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   714 E C1947925:Stop [Activity]
   714 E C2746065:Stop [Temporal Concept]

Phrase: "(6ml of 10mM"

Phrase: "(NH4"

Phrase: ")"

Phrase: "6Mo7O24 in 0.5M H2SO4,"

Phrase: "1ml of 500mM ascorbic acid"

Phrase: ")"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.148: The coloring reaction was allowed to proceed for 20min. 

Phrase: "The coloring reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0853041:color reaction [Disease or Syndrome]
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "proceed for 20min."
Processing 00000000.tx.149: Then the samples were centrifuged (15,000g, 1min), and the absorption at 820nm was determined. 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(15,"

Phrase: "000g,"

Phrase: "1min"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the absorption at 820nm"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0000854:Absorption [Natural Phenomenon or Process]
   770   C0220777:absorption [Functional Concept]
   770   C2347023:Absorption [Phenomenon or Process]
   770   C2347080:Absorption [Phenomenon or Process]
   770   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   770   C2825050:Absorption [Phenomenon or Process]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.150: The method is based on determination of free phosphate produced by the enzyme reaction. 

Phrase: "The method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "based on determination of free phosphate"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0332296:free [Functional Concept]
   753   C1148554:determination [Laboratory Procedure]
   753   C1527178:Based [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   753   C1705938:Based [Idea or Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "produced by the enzyme reaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.151: With Ames solution a blue molybdenum phosphate complex was formed. 

Phrase: "With Ames solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "a blue molybdenum phosphate complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "formed."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]
Processing 00000000.tx.152: The reaction was carried out at pH 6.0,since Calvert and co-workers (29) localized the optimal pH for the phosphodiesterase activity of tomato annexin at this value. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at pH 6.0,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C0849355:Out [Qualitative Concept]

Phrase: "since"

Phrase: "Calvert"

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(29"

Phrase: ")"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "the optimal pH for the phosphodiesterase activity of tomato annexin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0020283:[pH] [Quantitative Concept]
   739   C0450407:ph+ [Finding]
   739   C0450408:ph++ [Finding]
   739   C0450409:ph+++ [Finding]

Phrase: "at this value."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]
Processing 00000000.tx.153: If additives like lipids, CaCl2 or EDTA were used, the amount of H2O was adjusted to obtain a sample volume of 200l. 

Phrase: "If"

Phrase: "additives like lipids,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0442796:Additives [Qualitative Concept]
   756 E C1550602:Additive [Substance]

Phrase: "CaCl2"

Phrase: "or"

Phrase: "EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "the amount of H2O"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a sample volume of 200l."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0427785:Volume of sample [Laboratory Procedure]
   760   C0449468:*Volume [Quantitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.154: The specific ATPase activity is calculated as "amount of released phosphate per mass of enzyme and time," with []=1molmg1h1. 

Phrase: "The specific ATPase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1148926:ATPase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as ""amount of released phosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "per mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0577559:Mass [Finding]
  1000   C1306372:*Mass [Quantitative Concept]
  1000   C3152252:Mass [Quantitative Concept]

Phrase: "of enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: """"

Phrase: "with"

Phrase: "["

Phrase: "]"

Phrase: "=1molmg1h1."
Processing 00000000.tx.155: To obtain the amount of released phosphate from the absorption at 820nm, a calibration curve was measured first using KH2PO4 in the range from 0to 100M. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of released phosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "from the absorption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0000854:Absorption [Natural Phenomenon or Process]
  1000   C0220777:absorption [Functional Concept]
  1000   C2347023:Absorption [Phenomenon or Process]
  1000   C2347080:Absorption [Phenomenon or Process]
  1000   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
  1000   C2825050:Absorption [Phenomenon or Process]

Phrase: "at 820nm,"

Phrase: "a calibration curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "KH2PO4 in the range"

Phrase: "from 0to 100M."
Processing 00000000.tx.156: A linear regression curve could be determined according to to following equation. 

Phrase: "A linear regression curve"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0023733:Linear Regression [Quantitative Concept]
   901   C2346679:Linear Regression [Intellectual Product]
   827   C0205132:Linear [Spatial Concept]
   827   C0205134:Curve [Spatial Concept]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]

Phrase: "could"

Phrase: "be"

Phrase: "determined according to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:according [Social Behavior]

Phrase: "to"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "equation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0552449:Equation [Conceptual Entity]
Processing 00000000.tx.157: (Eq.2) All experiments were carried out as triplicate. 

Phrase: "(Eq.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:EQ [Qualitative Concept]
   861   C0439185:Eq [Quantitative Concept]

Phrase: ")"

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "triplicate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]
Processing 00000000.tx.158: Urea-induced Unfolding-- Determination of the folding stability of wild-type and mutant protein was carried out by monitoring intrinsic protein fluorescence at varying concentrations of urea. 

Phrase: "Urea-induced Unfolding"

Phrase: "--"

Phrase: "Determination of the folding stability of wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by monitoring intrinsic protein fluorescence"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0150369:Monitoring [Health Care Activity]
   753   C0205102:Intrinsic [Spatial Concept]
   753   C0439674:Intrinsic [Functional Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C1516647:monitoring [Research Activity]

Phrase: "at varying concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of urea."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   944 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.159: If the denaturing reaction is a two-state process, the data can be analyzed according to the method of Pace (30), finally yielding the free stability energy of the hypothetical denaturation in aqueous solution, G(H2O), and the degree of interaction of the denaturing reagent with the protein, m. 

Phrase: "If"

Phrase: "the denaturing reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "is"

Phrase: "a two-state process,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "can"

Phrase: "be"

Phrase: "analyzed according to the method of Pace"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0025663:Method [Intellectual Product]
   748   C0287990:PACE [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0449851:Method [Functional Concept]
   748   C0680240:according [Social Behavior]
   748   C0871511:METHOD [Intellectual Product]
   748   C0936012:Analyzed [Research Activity]
   748   C1552930:Pace [Quantitative Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "finally"

Phrase: "yielding"

Phrase: "the free stability energy of the hypothetical denaturation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0678591:Free Energy [Natural Phenomenon or Process]
   744   C0424589:Energy [Finding]
   744   C0542479:Energy [Natural Phenomenon or Process]
   744   C1442080:Energy [Quantitative Concept]

Phrase: "in aqueous solution,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3255993:aqueous solution [Pharmacologic Substance]
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
   861   C0599956:Aqueous [Qualitative Concept]

Phrase: "G(H2O"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the degree of interaction of the denaturing reagent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0441889:Degree [Qualitative Concept]
   744   C0449286:Degree [Quantitative Concept]
   744   C0542560:Degree [Intellectual Product]
   744   C1561545:degree [Quantitative Concept]
   744   C2348088:Degree [Quantitative Concept]

Phrase: "with the protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.160: Fluorescence emission spectra were recorded for every sample with excitation wavelengths set at exc=280nm and exc=295nm. 

Phrase: "Fluorescence emission spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded for every sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
   737   C0034869:Record [Intellectual Product]

Phrase: "with excitation wavelengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449819:wavelengths [Quantitative Concept]

Phrase: "set at exc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "=280nm"

Phrase: "and"

Phrase: "exc"

Phrase: "=295nm."
Processing 00000000.tx.161: The data were analyzed with respect to the wavelength at the maximum of the emission spectrum and the emission intensity at that maximum, respectively. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed with respect to the wavelength"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449819:Wavelength [Quantitative Concept]
   753   C0679133:respect [Social Behavior]
   753   C0936012:Analyzed [Research Activity]

Phrase: "at the maximum"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0806909:Maximum [Quantitative Concept]
  1000   C1552615:maximum [Quantitative Concept]
  1000   C2826546:MAXIMUM [Quantitative Concept]
   928 E C0205289:Maximal [Qualitative Concept]

Phrase: "of the emission spectrum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0233929:Emission [Body Substance]
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2349995:Emission [Substance]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "and"

Phrase: "the emission intensity at"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "that maximum,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0806909:Maximum [Quantitative Concept]
  1000   C1552615:maximum [Quantitative Concept]
  1000   C2826546:MAXIMUM [Quantitative Concept]
   928 E C0205289:Maximal [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.162: All fluorescence spectra were corrected against buffer-only samples, and three independent unfolding series were performed.  

Phrase: "All fluorescence spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "corrected against buffer-only samples,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0205171:Only [Quantitative Concept]
   760   C0205202:Corrected [Qualitative Concept]
   760   C1720467:Only [Intellectual Product]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]
   726 E C2349182:Correct [Qualitative Concept]

Phrase: "and"

Phrase: "three independent unfolding series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.163: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Native Annexins from C.annuum-- Annexin 24(Ca32) like all annexins comprises a tetrad repeat of approximately 70amino acids and has all of the highly conserved residues generally found in other annexins involved in salt bridge interactions. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Native Annexins from C.annuum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "--"

Phrase: "Annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "like all annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "a tetrad repeat of approximately 70amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205341:Repeat [Functional Concept]
   748   C1547730:Repeat [Temporal Concept]
   748   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "has"

Phrase: "all of the highly conserved residues generally"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205250:Highly [Qualitative Concept]
   748   C0444868:All [Quantitative Concept]
   748   C3539085:All [Idea or Concept]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "found in other annexins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "involved in salt bridge interactions."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0036140:Salt [Chemical Viewed Structurally]
   760   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0206136:Salt [Food,Inorganic Chemical]
   760   C0456378:Bridge [Medical Device]
   760   C1314939:Involved [Functional Concept]
   726   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.164: The endonexin fold, typical for non-plant annexins where it is present in the AB-loops of domains I, II, and IV, is only restored in the IAB loop of annexin 24(Ca32) (see Fig. 1). 

Phrase: "The endonexin fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "typical for non-plant annexins where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3538928:Typical [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "present in the AB-loops of domains I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "II,"

Phrase: "and"

Phrase: "IV,"

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "restored in the IAB loop of annexin 24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0419518:Loop [Medical Device]
   744   C0445022:Loop [Spatial Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.165: A prominent feature of plant-type annexins was the existence of (at least) two annexin proteins in every plant species investigated so far (29, 31-33); 

Phrase: "A prominent feature of plant-type annexins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "was"

Phrase: "the existence of (at least"

Phrase: ")"

Phrase: "two annexin proteins in every plant species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0032089:Plant Proteins [Amino Acid, Peptide, or Protein]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "(29,"

Phrase: "31-33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.166: thus, a second annexin, Anx(Ca38), is found in C.annuum. 

Phrase: "thus,"

Phrase: "a second annexin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Anx(Ca38"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "found in C.annuum."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.167: The two proteins Anx24(Ca32) and Anx(Ca38) differ not only in their primary structure but also in their migration behavior on SDS-PAGE, despite having nearly the same molecular weights. 

Phrase: "The two proteins Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "and"

Phrase: "Anx(Ca38"

Phrase: ")"

Phrase: "differ"

Phrase: "not only in their primary structure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205171:Only [Quantitative Concept]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C0678594:Structure [Spatial Concept]
   753   C1518422:Not [Functional Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also in their migration behavior"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004927:Behavior [Individual Behavior]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]
   760   C2707008:Behavior [Clinical Attribute]

Phrase: "on SDS-PAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "despite"

Phrase: "having"

Phrase: "nearly"

Phrase: "the same molecular weights."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0026385:Molecular weights [Quantitative Concept]
   827   C0043100:Weights [Quantitative Concept]
   827   C1521991:Molecular [Qualitative Concept]
   793 E C0005910:weight [Organism Attribute]
   793 E C1305866:weight [Diagnostic Procedure]
   793 E C1705104:Weight [Idea or Concept]
   755 E C0567416:Molecule [Substance]
Processing 00000000.tx.168: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.169: 2A shows a SDS-PAGE of annexin (Ca) purified from red bell pepper fruits, clearly indicating the presence of two different proteins, p32 and p38. 

Phrase: "2A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a SDS-PAGE of annexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1704732:Page [Intellectual Product]

Phrase: "(Ca)"

Phrase: "purified from red bell pepper fruits,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0446306:Bell Pepper [Food]
   753   C0016767:fruits [Food]
   753   C0453397:Pepper [Plant]
   753   C1123063:Pepper [Food]
   753   C1706917:Bell [Manufactured Object]
   753   C1998793:Purified [Functional Concept]
   719 E C1509510:fruit [Food]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]
   719 E C3255628:FRUIT [Pharmacologic Substance]

Phrase: "clearly"

Phrase: "indicating"

Phrase: "the presence of two different proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "p32"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0069881:P-32 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0851287:P-32 [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
  1000   C0914908:p32 [Immunologic Factor]
  1000   C3540595:p32 [Gene or Genome]

Phrase: "and"

Phrase: "p38."
Processing 00000000.tx.170: Additionally, proteolytic digestion with V8 protease reveals distinct differences between both proteins. 

Phrase: "Additionally,"

Phrase: "proteolytic digestion with V8 protease"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0012238:Digestion [Organism Function]
   760   C2349986:Digestion [Research Activity]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "distinct differences between both proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.171: View larger version (100K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(100K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.172: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.173: Sequence alignment of vertebrate and plant annexins. 

Phrase: "Sequence alignment of vertebrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   770   C1706765:Alignment [Quantitative Concept]

Phrase: "and"

Phrase: "plant annexins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.174: Numbers in the third row refer to the amino acid numbering of His-Anx24(Ca32). 

Phrase: "Numbers in the third row"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "refer to the amino acid numbering of His-Anx24"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0546742:Acid number [Laboratory Procedure]
   742   C0001128:Acid [Chemical]
   742   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0205543:refer [Functional Concept]
   742   C0449788:numbering [Quantitative Concept]
   742   C1412323:HIS [Gene or Genome]
   708 E C0237753:*Number [Quantitative Concept]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.175: Endonexin sequences are boxed, and amino acids of the four AB loops and the corresponding 38-residue positions upstream are colored (light green, domain I; light yellow, domain II; green, domain III; yellow, domain IV). 

Phrase: "Endonexin sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "boxed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]

Phrase: ","

Phrase: "and"

Phrase: "amino acids of the four AB loops"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "the corresponding 38-residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "upstream"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522505:Upstream [Spatial Concept]

Phrase: "are"

Phrase: "colored"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0522507:colored [Qualitative Concept]
   966 E C0009393:Color [Natural Phenomenon or Process]
   966 E C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   966 E C1705245:Color [Pharmacologic Substance]

Phrase: "(light green, domain I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "; light yellow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0221205:Yellow [Qualitative Concept]

Phrase: "domain II"

Phrase: "; green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "domain III"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "; yellow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: "domain IV"

Phrase: ")."
Processing 00000000.tx.176: Strictly conserved residues (red) and highly conserved residues (light red) are also marked. 

Phrase: "Strictly conserved residues (red)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "highly conserved residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "(light red"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "also"

Phrase: "marked."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]
Processing 00000000.tx.177: Helix assignments are based on the crystal structures. 

Phrase: "Helix assignments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516050:Assignment [Functional Concept]

Phrase: "are"

Phrase: "based on the crystal structures."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   773   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   760   C0427896:Crystal [Body Substance]
   760   C0678594:structures [Spatial Concept]
   760   C1527178:Based [Functional Concept]
   760   C1533132:Crystal [Body Substance]
   760   C1704641:Crystal [Manufactured Object]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.178: The upper assignments refer to annexin 24(Ca32), and the lower assignments refer to annexin V (AV). 

Phrase: "The upper assignments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516050:Assignment [Functional Concept]

Phrase: "refer to annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205543:refer [Functional Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the lower assignments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516050:Assignment [Functional Concept]

Phrase: "refer to annexin V (AV)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332095:ANNEXIN V [Gene or Genome]
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205543:refer [Functional Concept]
Processing 00000000.tx.179: Conserved residues are numbered above the helix assignment according to annexin V numbering. 

Phrase: "Conserved residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "numbered above the helix assignment"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0018882:Helix [Eukaryote]
   760   C0229304:Helix [Body Part, Organ, or Organ Component]
   760   C0449788:numbered [Quantitative Concept]
   760   C1516050:Assignment [Functional Concept]
   760   C1704821:Helix [Spatial Concept]
   760   C1705682:Helix [Anatomical Structure]
   726 E C0237753:*Number [Quantitative Concept]

Phrase: "according to annexin V numbering."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449788:numbering [Quantitative Concept]
   793 E C0237753:*Number [Quantitative Concept]
   734   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332095:ANNEXIN V [Gene or Genome]
Processing 00000000.tx.180: The figure was prepared with ALSCRIPT (39). 

Phrase: "The figure"

Phrase: "was"

Phrase: "prepared with ALSCRIPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.181: View larger version (29K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.182: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.183: Native annexin 24(Ca). 

Phrase: "Native annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0302891:Native [Functional Concept]

Phrase: "(Ca)."
Processing 00000000.tx.184: A, recombinant Ca32 and Ca38 were digested with V8 protease (+) and subjected to SDS-PAGE (15%) together with native purified annexin from red bell pepper fruits (native). 

Phrase: "A,"

Phrase: "recombinant Ca32"

Phrase: "and"

Phrase: "Ca38"

Phrase: "were"

Phrase: "digested with V8 protease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0163582:protease V8 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0507130:V8 [Body Part, Organ, or Organ Component]
   770   C0868946:digested [Physiologic Function]
   770   C1416372:V8 [Gene or Genome]
   770   C1947941:Protease [Enzyme]

Phrase: "(+"

Phrase: ")"

Phrase: "and"

Phrase: "subjected to SDS-PAGE (15%"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1704732:Page [Intellectual Product]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "together with native purified annexin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from red bell pepper fruits"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0016767:fruits [Food]
   779 E C1509510:fruit [Food]
   779 E C3255628:FRUIT [Pharmacologic Substance]

Phrase: "(native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302891:Native [Functional Concept]

Phrase: ")."
Processing 00000000.tx.185: Approximate molecular weights are indicated on the left. 

Phrase: "Approximate molecular weights"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0026385:Molecular weights [Quantitative Concept]
   827   C0043100:Weights [Quantitative Concept]
   827   C1521991:Molecular [Qualitative Concept]
   793 E C0005910:weight [Organism Attribute]
   793 E C1305866:weight [Diagnostic Procedure]
   793 E C1705104:Weight [Idea or Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "are"

Phrase: "indicated on the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1552822:left [Functional Concept]
Processing 00000000.tx.186: B, analyses of annexins purified from bell pepper fruits and of recombinant wild-type annexin 24(Ca32). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "analyses of annexins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0002778:Analysis [Laboratory Procedure]
   756   C0936012:Analysis [Research Activity]
   756   C1524024:analysis [Functional Concept]

Phrase: "purified from bell pepper fruits"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0446306:Bell Pepper [Food]
   760   C0016767:fruits [Food]
   760   C0453397:Pepper [Plant]
   760   C1123063:Pepper [Food]
   760   C1706917:Bell [Manufactured Object]
   760   C1998793:Purified [Functional Concept]
   726 E C1509510:fruit [Food]
   726 E C3255628:FRUIT [Pharmacologic Substance]

Phrase: "and of recombinant wild-type annexin 24"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1514798:recombinant [Organism]
   748   C1515981:And [Idea or Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.187: Left, Coomassie staining of a SDS-PAGE (12%) with different samples; 

Phrase: "Left,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "Coomassie staining of a SDS-PAGE (12%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: ")"

Phrase: "with different samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.188: annexins purified from green and red bell pepper fruits and recombinant wild-type annexin 24(Ca32). 

Phrase: "annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "purified from green"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332583:Green [Qualitative Concept]
   790   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "red bell pepper fruits"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0016767:fruits [Food]
   779 E C1509510:fruit [Food]
   779 E C3255628:FRUIT [Pharmacologic Substance]

Phrase: "and"

Phrase: "recombinant wild-type annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1883559:Wild Type [Organism Attribute]
   804   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1514798:recombinant [Organism]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.189: M indicates the marker lane with a ladder of molecular weights. 

Phrase: "M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "indicates"

Phrase: "the marker lane with a ladder of molecular weights."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.190: Right, Western blot analysis of the same samples with the serum raised against Anx(Zm33)/Anx(Zm35) maize annexins; 

Phrase: "Right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "Western blot analysis of the same samples"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   757   C1303103:Sample analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "with the serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "raised against Anx(Zm33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442818:Raised [Quantitative Concept]
   770   C0718606:Anx [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "/Anx(Zm35"

Phrase: ")"

Phrase: "maize annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.191: recombinant wild-type annexin 24(Ca32) is not recognized by the anti-maize antibodies, whereas natively purified proteins are. 

Phrase: "recombinant wild-type annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1883559:Wild Type [Organism Attribute]
   804   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1514798:recombinant [Organism]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recognized by the anti-maize antibodies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   783   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0010028:Maize [Plant]
   753   C1138842:Maize [Food]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "natively purified proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are."
Processing 00000000.tx.192: In a second experiment, the behavior of natively purified annexin (Ca) was compared with recombinant annexin 24(Ca32) wild type. 

Phrase: "In a second experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "the behavior of natively purified annexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "(Ca)"

Phrase: "was"

Phrase: "compared with recombinant annexin 24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514798:recombinant [Organism]
   760   C1707455:Compared [Activity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "wild type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.193: Anx(Ca) was purified from green and red bell pepper fruits and subjected to SDS-PAGE. 

Phrase: "Anx("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718606:Anx [Organic Chemical,Pharmacologic Substance]

Phrase: "Ca)"

Phrase: "was"

Phrase: "purified from green"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332583:Green [Qualitative Concept]
   790   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "red bell pepper fruits"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0016767:fruits [Food]
   779 E C1509510:fruit [Food]
   779 E C3255628:FRUIT [Pharmacologic Substance]

Phrase: "and"

Phrase: "subjected to SDS-PAGE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.194: As can be seen from Fig. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen from Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.195: 2B, the native material appeared at molecular masses of 32and 38kDa, whereas recombinant wild-type Anx24(Ca32) appeared at approximately 38kDa despite its molecular mass of 32kDa. 

Phrase: "2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: "the native material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "appeared at molecular masses of 32and 38kDa,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   748   C1521991:Molecular [Qualitative Concept]
   714   C0577559:Mass [Finding]
   714   C0700364:APPEAR [Qualitative Concept]
   714   C1306372:*Mass [Quantitative Concept]

Phrase: "whereas"

Phrase: "recombinant wild-type Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "appeared at approximately 38kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332232:Approximately [Qualitative Concept]
   737   C0700364:APPEAR [Qualitative Concept]

Phrase: "despite its molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]

Phrase: "of 32kDa."
Processing 00000000.tx.196: Cross-reaction with anti-annexin(Zm) antibody is only positive with natively purified material and not with the recombinant protein, strongly suggesting the presence of post-translational modifications in the native protein. 

Phrase: "Cross-reaction with anti-annexin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0010357:Cross Reaction [Molecular Function]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "(Zm) antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "is"

Phrase: "only positive with natively purified material"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "not with the recombinant protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514798:recombinant [Organism]
   760   C1518422:Not [Functional Concept]

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of post-translational modifications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the native protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0302891:Native [Functional Concept]
Processing 00000000.tx.197: General Characterization of Recombinant Proteins-- Purified proteins were characterized by mass spectrometry and amino acid sequencing. 

Phrase: "General Characterization of Recombinant Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "--"

Phrase: "Purified proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "characterized by mass spectrometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C1880022:Characterized [Activity]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "amino acid sequencing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0751971:Amino Acid Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]
Processing 00000000.tx.198: N-terminal sequencing of recombinant proteins purified via calcium-triggered binding to liposomes (Fig. 3A) indicated the lack of the first methionine, in agreement with results from mass spectrometry. 

Phrase: "N-terminal sequencing of recombinant proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0002518:protein sequencing [Amino Acid Sequence]
   767   C0751971:Protein Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]

Phrase: "purified via calcium-triggered binding"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   797   C1516144:Calcium Binding [Molecular Function]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1998793:Purified [Functional Concept]
   760   C2936886:Calcium [Pharmacologic Substance]
   726   C0032930:Trigger [Clinical Attribute]
   726   C1444748:Trigger [Qualitative Concept]

Phrase: "to liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the lack of the first methionine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "from mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.199: In SDS-PAGE, both recombinant proteins migrate as though they have a molecular mass of 38-40 kDa. 

Phrase: "In SDS-PAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "both recombinant proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514798:recombinant [Organism]

Phrase: "migrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrate [Functional Concept]

Phrase: "as though"

Phrase: "they"

Phrase: "have"

Phrase: "a molecular mass of 38-40 kDa."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   774   C0577559:A mass [Finding]
           Mass
   748   C1306372:*Mass [Quantitative Concept]
Processing 00000000.tx.200: A significant cross-reaction with an anti-annexin V antibody is observed with both recombinant proteins (data not shown). 

Phrase: "A significant cross-reaction with an anti-annexin V antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0010357:Cross Reaction [Molecular Function]
   739   C0443286:Reaction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C2828360:Cross [Conceptual Entity]

Phrase: "is"

Phrase: "observed with both recombinant proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1441672:Observed [Functional Concept]
   760   C1514798:recombinant [Organism]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.201: Results from gel filtration experiments or native PAGE (data not shown) indicate that the plant protein has a tendency to aggregate. 

Phrase: "Results from gel filtration experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C2825142:Experimental Result [Finding]
           Result
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]

Phrase: "or"

Phrase: "native PAGE (data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C3494467:Native PAGE [Laboratory Procedure]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "indicate"

Phrase: "that"

Phrase: "the plant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032089:plant protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "a tendency to"

Phrase: "aggregate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.202: Fluorescence spectra of both recombinant annexin 24(Ca32) wild type and the fusion protein indicate a hydrophilic environment of the fluorophore residues, as there is a bathochromic effect (347nm for the wild type and 345nm for the fusion protein). 

Phrase: "Fluorescence spectra of both recombinant annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1883073:Spectrum [Quantitative Concept]
   714   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "indicate"

Phrase: "a hydrophilic environment of the fluorophore residues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0014406:Environment [Spatial Concept]

Phrase: "as"

Phrase: "there"

Phrase: "is"

Phrase: "a bathochromic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(347nm for the wild type"

Phrase: "and"

Phrase: "345nm for the fusion protein"

Phrase: ")."
Processing 00000000.tx.203: Circular dichroism revealed typical annexin spectra for the recombinant wild-type and the fusion protein. 

Phrase: "Circular dichroism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "typical annexin spectra for the recombinant wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1883073:Spectrum [Quantitative Concept]
   711   C2827424:Spectrum [Conceptual Entity]

Phrase: "and"

Phrase: "the fusion protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.204: As annexins are all-helical proteins, there are two minima in the CD spectra visible, as expected. 

Phrase: "As annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "all-helical proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "there"

Phrase: "are"

Phrase: "two minima in the CD spectra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1524031:Minimum [Qualitative Concept]
   719   C1552614:minimum [Idea or Concept]
   719   C2826545:MINIMUM [Quantitative Concept]

Phrase: "visible,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205379:Visible [Qualitative Concept]

Phrase: "as"

Phrase: "expected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.205: However, there is a considerable difference in the circular dichroic spectra of the wild-type and the fusion protein. 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "a considerable difference in the circular dichroic spectra of the wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1705241:*Difference [Quantitative Concept]
   736   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "the fusion protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.206: The peak wavelengths for annexin 24(Ca32) wild type are 209nm and 219nm, whereas the peak wavelengths for the fusion protein are 208nm and 221nm. 

Phrase: "The peak wavelengths for annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449819:wavelengths [Quantitative Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "209nm"

Phrase: "and"

Phrase: "219nm,"

Phrase: "whereas"

Phrase: "the peak wavelengths for the fusion protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449819:wavelengths [Quantitative Concept]

Phrase: "are"

Phrase: "208nm"

Phrase: "and"

Phrase: "221nm."
Processing 00000000.tx.207: Moreover, the fusion protein displays a hypochromic effect. 

Phrase: "Moreover,"

Phrase: "the fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a hypochromic effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.208: The molar ellipticity is reduced to 66% (blue) and 71% (red) (Fig. 3B). 

Phrase: "The molar ellipticity"

Phrase: "is"

Phrase: "reduced to 66%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "71%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "(red"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.209: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.210: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.211: Recombinant annexin 24(Ca32). 

Phrase: "Recombinant annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514798:recombinant [Organism]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.212: A, SDS-PAGE (12%) of different fractions of the purification; 

Phrase: "A,"

Phrase: "SDS-PAGE (12%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   827   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: "of different fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "of the purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: ";"
Processing 00000000.tx.213: a, annexin V (marker); 

Phrase: "a,"

Phrase: "annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.214: b, supernatant of spheroblast preparation; 

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "supernatant of spheroblast preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1550101:Supernatant [Body Substance]

Phrase: ";"
Processing 00000000.tx.215: c, supernatant of liposome wash after Ca2+-dependent annexin binding; 

Phrase: "c,"

Phrase: "supernatant of liposome wash"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1550101:Supernatant [Body Substance]

Phrase: "after Ca2+-dependent annexin binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.216: d, first liposome wash-off with 15mM EDTA; 

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "first liposome wash-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "off"

Phrase: "with 15mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.217: e, second liposome wash-off with 15mM EDTA and Chelex. 

Phrase: "e,"

Phrase: "second liposome wash-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "off"

Phrase: "with 15mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Chelex."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055279:chelex [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.218: B, CD spectra from annexin 24(Ca32) wild-type (red) and the fusion protein His-Anx24(Ca32). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "CD spectra from annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1883073:Spectrum [Quantitative Concept]
   726   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(red"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "His-Anx24"

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.219: Peak intensities of the fusion protein with respect to the wild-type are 66% on the blue side and 71% on the red side. 

Phrase: "Peak intensities of the fusion protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444505:Peak [Quantitative Concept]
   753   C0522510:intensities [Qualitative Concept]

Phrase: "with respect to the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "66% on the blue side"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441987:Side [Spatial Concept]
   760   C1260957:Blue [Qualitative Concept]

Phrase: "and"

Phrase: "71% on the red side."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441987:Side [Spatial Concept]
   760   C0450389:71 [Intellectual Product]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.220: Structure Determination-- Similar crystals from the fusion protein were obtained by either hanging or sitting drop with the vapor diffusion method at 22C. 

Phrase: "Structure Determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]

Phrase: "--"

Phrase: "Similar crystals from the fusion protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0427896:Crystals [Body Substance]
   753   C0444626:Crystals [Chemical Viewed Structurally]
   753   C1378554:Crystals [Biomedical or Dental Material]
   753   C1533132:Crystals [Body Substance]
   753   C2699477:Crystals [Laboratory Procedure]
   719 E C1704641:Crystal [Manufactured Object]

Phrase: "were"

Phrase: "obtained by either hanging"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0544691:Hanging [Injury or Poisoning]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "sitting drop with the vapor diffusion method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1321095:Drop [Quantitative Concept]
   748   C1705648:Drop [Activity]
   748   C2347093:Drop [Quantitative Concept]
   748   C2348338:Drop [Quantitative Concept]

Phrase: "at 22C."
Processing 00000000.tx.221: Crystallization conditions are summarized in Table IV. 

Phrase: "Crystallization conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "summarized in Table IV."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.222: The crystals belong to the space group P3221 with approximate cell dimensions of a=b=98and c=172(for data collection statistics, see Table II) and contain two molecules per asymmetric unit. 

Phrase: "The crystals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0427896:Crystals [Body Substance]
  1000   C0444626:Crystals [Chemical Viewed Structurally]
  1000   C1378554:Crystals [Biomedical or Dental Material]
  1000   C1533132:Crystals [Body Substance]
  1000   C2699477:Crystals [Laboratory Procedure]
   966 E C1704641:Crystal [Manufactured Object]

Phrase: "belong to the space group P3221"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1883067:Space [Spatial Concept]

Phrase: "with approximate cell dimensions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1113663:cell dimension [Finding]
   827   C0439534:Dimensions [Quantitative Concept]
   721 E C1707753:Dimensionality [Spatial Concept]

Phrase: "of a=b=98and c=172"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C1440044:A,B [Immunologic Factor]

Phrase: "("

Phrase: "for data collection statistics,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0038215:Statistics [Occupation or Discipline]
   827   C0600673:Statistics [Intellectual Product]
   793 E C2348149:Statistic [Quantitative Concept]
   793 E C2828391:Statistic [Quantitative Concept]
   734   C0010995:Data Collection [Research Activity]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table II"

Phrase: ")"

Phrase: "and"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "two molecules per asymmetric unit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0567416:molecules [Substance]
Processing 00000000.tx.223: Molecular replacement was successful with a truncated poly(Ala) model derived from annexin VIa.  

Phrase: "Molecular replacement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035139:Replacement [Therapeutic or Preventive Procedure]
   861   C0559956:Replacement [Functional Concept]
   861   C1555302:Replacement [Idea or Concept]

Phrase: "was"

Phrase: "successful with a truncated poly(Ala) model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1272703:Successful [Qualitative Concept]

Phrase: "derived from annexin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "VIa."
Processing 00000000.tx.224: View this table: [in this window] [in a new window]  Table IV Geometrical data of annexin 24(Ca32) Root mean square fits were calculated with MAIN (15) and LSQMAN (19) using the C coordinates only. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table IV Geometrical data of annexin 24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1706074:Data Table [Intellectual Product]
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "Root mean square fits"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0036572:Fits NOS [Sign or Symptom]
   779 E C0424576:Fit [Finding]
   779 E C2349186:Fit [Activity]
   756   C2347976:Root Mean Square [Quantitative Concept]

Phrase: "were"

Phrase: "calculated with MAIN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205225:Main [Qualitative Concept]
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
   790   C1542147:Main [Qualitative Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "LSQMAN"

Phrase: "(19"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "coordinates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427184:coordinate [Finding]
  1000   C0700114:coordinate [Functional Concept]
  1000   C1707511:Coordinate [Spatial Concept]

Phrase: "only."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]
Processing 00000000.tx.225: Molecular surface and volume were calculated with GRASP (38) (probe radius, 1.4). 

Phrase: "Molecular surface"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205148:Surface [Spatial Concept]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449468:*Volume [Quantitative Concept]
  1000   C1690016:% volume [Qualitative Concept]
  1000   C1705102:Volume [Intellectual Product]
  1000   C2700258:Volume [Laboratory Procedure]

Phrase: "were"

Phrase: "calculated with GRASP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0220843:grasp [Organism Function]
   790   C0444686:Calculated [Functional Concept]
   790   C1425726:GRASP [Gene or Genome]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "(38"

Phrase: ")"

Phrase: "(probe radius,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034627:Radius [Body Part, Organ, or Organ Component]
   861   C1279083:Radius [Body Part, Organ, or Organ Component]
   861   C1306504:Radius [Quantitative Concept]

Phrase: "1.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.226: The three-dimensional crystal structure of His-tagged annexin 24(Ca32) adopts the typical annexin fold known from other members of this protein family (Fig. 4). 

Phrase: "The three-dimensional crystal structure of His-tagged annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   739   C0427896:Crystal [Body Substance]
   739   C0678594:Structure [Spatial Concept]
   739   C1533132:Crystal [Body Substance]
   739   C1704641:Crystal [Manufactured Object]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "adopts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "the typical annexin fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "known from other members of this protein family"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0015576:Family [Family Group]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205309:Known [Qualitative Concept]
   744   C0680022:members [Population Group]
   744   C1704727:Family [Conceptual Entity]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.227: The protein core is built by four domains, each comprising five -helices, four of them arranged parallel and anti-parallel to each other (helices A, B, D, and E) and the fifth (helix C) lying almost perpendicular to the four-helix bundle. 

Phrase: "The protein core"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "is"

Phrase: "built by four domains,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205450:Four [Quantitative Concept]
   737   C1707059:Build [Conceptual Entity]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "each comprising five -helices,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0018882:Helix [Eukaryote]
   827   C0229304:Helix [Body Part, Organ, or Organ Component]
   827   C1017315:helices [Eukaryote]
   827   C1704821:Helix [Spatial Concept]
   827   C1705682:Helix [Anatomical Structure]

Phrase: "four of them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205450:Four [Quantitative Concept]

Phrase: "arranged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1546854:Arranged [Idea or Concept]

Phrase: "parallel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "and"

Phrase: "anti-parallel to each other"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2348042:Parallel [Qualitative Concept]
   760   C2826345:PARALLEL [Research Activity]

Phrase: "(helices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1017315:helices [Eukaryote]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E)"

Phrase: "and"

Phrase: "the fifth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205439:Fifth [Quantitative Concept]

Phrase: "(helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "lying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038846:Lying [Spatial Concept]
  1000   C0600261:Lying [Individual Behavior]

Phrase: "almost perpendicular to the four-helix bundle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1295725:Perpendicular [Spatial Concept]
   748   C3272860:Perpendicular [Conceptual Entity]
Processing 00000000.tx.228: However, the extension of individual helices is slightly different compared with annexin V, resulting in some variations regarding particular sites within the annexin 24structure. 

Phrase: "However,"

Phrase: "the extension of individual helices"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231448:Extension [Functional Concept]
   760   C1880641:Extension [Conceptual Entity]

Phrase: "is"

Phrase: "slightly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with annexin V,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332095:ANNEXIN V [Gene or Genome]
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1707455:Compared [Activity]

Phrase: "resulting in some variations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0205419:variations [Qualitative Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "regarding"

Phrase: "particular sites within the annexin 24structure."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.229: The two molecules in the asymmetric unit adopt similar conformations. 

Phrase: "The two molecules in the asymmetric unit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0567416:molecules [Substance]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "similar conformations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.230: While the N-terminal tail is constituted by a 20-amino acid sequence, it is only visible beyond position 8in the second molecule and beyond position 6in the first molecule. 

Phrase: "While"

Phrase: "the N-terminal tail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "constituted by a 20-amino acid sequence,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0202406:Acid [Laboratory Procedure]
   748   C1519249:Sequence [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "only visible beyond position 8in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]

Phrase: "the second molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "and beyond position 6in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0733755:Position [Spatial Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "the first molecule."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.231: On the C-terminal side, molecule #1 can be traced up to residue 320and molecule #2 up to position 321.

Phrase: "On the C-terminal side,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441987:Side [Spatial Concept]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "molecule #1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "traced up to residue 320and molecule #2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0567416:Molecule [Substance]
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]
   714   C0442822:Trace [Quantitative Concept]
   714   C1524031:Trace [Qualitative Concept]
   714   C1883002:Trace [Functional Concept]

Phrase: "up to position 321."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.232: However, the poor density in the very N- and C-terminal regions indicates high flexibility. 

Phrase: "However,"

Phrase: "the poor density in the very N-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0178587:density [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal regions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "indicates"

Phrase: "high flexibility."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0242808:Flexibility [Qualitative Concept]
   789 E C0443220:Flexible [Qualitative Concept]
Processing 00000000.tx.233: Additionally, the high solvent content accounts for rather high temperature factors in both molecules. 

Phrase: "Additionally,"

Phrase: "the high solvent content accounts for rather high temperature factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C1551359:account [Idea or Concept]
   706   C2741673:Account # [Clinical Attribute]
   706   C2981730:Account [Classification]

Phrase: "in both molecules."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.234: The structure has been refined to an R-factor of 0.216at 2.8resolution; 

Phrase: "The structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "refined to an R-factor of 0.216at 2.8resolution"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0034471:R factor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0602449:R-factor [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205090:R- [Spatial Concept]
   739   C0684010:R. [Professional or Occupational Group]
   739   C1521761:Factor [Functional Concept]
   739   C2603358:R' [Clinical Attribute]
   739   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.235: refinement statistics are summarized in Table III. 

Phrase: "refinement statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0038215:Statistics [Occupation or Discipline]
   861   C0600673:Statistics [Intellectual Product]
   827 E C2348149:Statistic [Quantitative Concept]
   827 E C2828391:Statistic [Quantitative Concept]

Phrase: "are"

Phrase: "summarized in Table III."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C0439070:III [Intellectual Product]
   770   C1705160:III [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.236: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.237: 4.  

Phrase: "4."
Processing 00000000.tx.238: Overall structure of His-tagged annexin 24(Ca32). 

Phrase: "Overall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "structure of His-tagged annexin 24"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0678594:Structure [Spatial Concept]
   753   C1412323:HIS [Gene or Genome]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708632:Tagged [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.239: A ribbon plot of molecule #1 of annexin 24(Ca32). 

Phrase: "A ribbon plot of molecule #1 of annexin 24"

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.240: Domain I is shown in yellow, domain II in magenta, domain III in green, and domain IV in blue. 

Phrase: "Domain I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "shown in yellow,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0221205:Yellow [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "domain II in magenta,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C0126762:Magenta II [Clinical Drug]

Phrase: "domain III in green,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439070:III [Intellectual Product]
   770   C1705160:III [Qualitative Concept]
   770   C1880389:Domain [Functional Concept]
   770   C1883221:Domain [Conceptual Entity]
   770   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "domain IV in blue."
Processing 00000000.tx.241: Highly exposed residues within membrane binding loops are drawn explicitly: Trp-35 (IAB), His-79 (IDE), Trp-107 (IIAB), Lys-190 (IIIAB), Tyr-192 (IIIAB), Arg-262 (IVAB), Arg-263 (IVAB). 

Phrase: "Highly exposed residues within membrane binding loops"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "drawn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013113:Draw [Intellectual Product]

Phrase: "explicitly"

Phrase: ":"

Phrase: "Trp-35"

Phrase: "(IAB"

Phrase: ")"

Phrase: ","

Phrase: "His-79"

Phrase: "(IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Trp-107"

Phrase: "(IIAB"

Phrase: ")"

Phrase: ","

Phrase: "Lys-190"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(IIIAB"

Phrase: ")"

Phrase: ","

Phrase: "Tyr-192"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "(IIIAB"

Phrase: ")"

Phrase: ","

Phrase: "Arg-262"

Phrase: "(IVAB"

Phrase: ")"

Phrase: ","

Phrase: "Arg-263"

Phrase: "(IVAB"

Phrase: ")."
Processing 00000000.tx.242: B, superposition of molecule #1 (green) and molecule #2 (purple) of annexin 24(Ca32). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "superposition of molecule #1"

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "molecule #2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "(purple"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439542:Purple [Qualitative Concept]

Phrase: ")"

Phrase: "of annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.243: C, superposition of molecule #1 of annexin 24(Ca32) (red) and annexin V (blue; loop-in conformation) as viewed from the membrane binding side. 

Phrase: "C,"

Phrase: "superposition of molecule #1 of annexin 24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "(red"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: "; loop-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "in conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: ")"

Phrase: "as"

Phrase: "viewed from the membrane binding side."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0025255:Membrane [Tissue]
   753   C0243122:binding [Functional Concept]
   753   C0441987:Side [Spatial Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1706182:Membrane [Manufactured Object]
   719   C0449911:View [Spatial Concept]
Processing 00000000.tx.244: All figures were created with MOLSCRIPT (40) and rendered with RASTER3D (41). 

Phrase: "All figures"

Phrase: "were"

Phrase: "created with MOLSCRIPT"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "rendered with RASTER3D"

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.245: Despite similar overall conformations of both molecules of the present structure, the arrangement of the IAB loops differs significantly. 

Phrase: "Despite similar overall conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0026377:Conformation [Spatial Concept]

Phrase: "of both molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "of the present structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "the arrangement of the IAB loops"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449830:Arrangement [Spatial Concept]

Phrase: "differs"

Phrase: "significantly."
Processing 00000000.tx.246: Trp-35 of the second molecule is located at the very surface on the convex side, and together with residues Glu-76 and His-79, it participates in coordination of a sulfate ion. 

Phrase: "Trp-35 of the second molecule"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205436:Second [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C0567416:Molecule [Substance]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]

Phrase: "is"

Phrase: "located at the very surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205148:Surface [Spatial Concept]
   760   C0442824:Very [Qualitative Concept]

Phrase: "on the convex side,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "and together with residues Glu-76"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1515981:And [Idea or Concept]
   753   C1883357:Together [Qualitative Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "His-79,"

Phrase: "it"

Phrase: "participates in coordination of a sulfate ion."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C3536965:Sulfate Ion [Element, Ion, or Isotope]
           SULFATE
   748   C0022023:Ion [Element, Ion, or Isotope]
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0242414:Coordination [Physiologic Function]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C0700114:Coordination [Functional Concept]
   748   C1700702:ION [Functional Concept]
Processing 00000000.tx.247: The situation is completely different in the first molecule, where the sulfate ion is located in the region of the IAB and IDE loops. 

Phrase: "The situation"

Phrase: "is"

Phrase: "completely different in the first molecule,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "where"

Phrase: "the sulfate ion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3536965:Sulfate Ion [Element, Ion, or Isotope]
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "is"

Phrase: "located in the region of the IAB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "IDE loops."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0181687:loops [Medical Device]
   827 E C0419518:Loop [Medical Device]
   827 E C0445022:Loop [Spatial Concept]
Processing 00000000.tx.248: Trp-35 is forced to relocate to the outside of the first domain, sitting in a pocket that is created by a symmetry-related molecule and lined by Tyr-192, Phe-234, and Ser-193. 

Phrase: "Trp-35"

Phrase: "is"

Phrase: "forced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441722:Forced [Phenomenon or Process]
  1000   C0443221:Forced [Functional Concept]
   966 E C0563538:Force [Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "relocate to the outside of the first domain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205101:Outside [Spatial Concept]
   744   C0205435:First [Quantitative Concept]
   744   C1279901:First [Qualitative Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "sitting in a pocket"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0277814:Sitting [Finding]
   770   C2584297:Sitting [Physiologic Function]
   737 E C0728713:sit [Finding]

Phrase: "that"

Phrase: "is"

Phrase: "created by a symmetry-related molecule"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C1707531:Created By [Qualitative Concept]
   753   C0332516:Symmetry [Spatial Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C0567416:Molecule [Substance]
   753   C1706214:Created [Activity]
   753   C2825575:Symmetry [Phenomenon or Process]
   753   C2946465:Symmetry [Pharmacologic Substance]
   719 E C3244320:create [Functional Concept]

Phrase: "and"

Phrase: "lined by Tyr-192,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0205132:lined [Spatial Concept]
   770   C1421250:TYR [Gene or Genome]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "Phe-234,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031453:Phe [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Ser-193."
Processing 00000000.tx.249: Calcium-dependent Binding to Phospholipid Vesicles-- One of the most interesting features of annexin 24is the calcium-dependent binding of this protein to liposomes, since the calcium binding sites of plant-type annexins are altered relative to non-plant annexins. 

Phrase: "Calcium-dependent Binding to Phospholipid Vesicles"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   851   C1148643:calcium-dependent phospholipid binding [Molecular Function]
   783   C1148642:Phospholipid Binding [Molecular Function]
   783   C1516144:Calcium Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "--"

Phrase: "One of the most interesting features of annexin 24is"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205447:One [Quantitative Concept]

Phrase: "the calcium-dependent binding of this protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   831   C1522850:calcium-dependent protein binding [Molecular Function]
   800   C0006732:Calcium-binding protein [Amino Acid, Peptide, or Protein,Receptor]
   800   C1822659:calcium binding protein [Gene or Genome]
   774   C0033618:Protein Binding [Molecular Function]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1516144:Calcium Binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "to liposomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: "since"

Phrase: "the calcium binding sites of plant-type annexins"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0005456:Binding Sites [Receptor]
   770   C1516144:Calcium Binding [Molecular Function]
   754   C2945843:Site of [Qualitative Concept]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0205145:Sites [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C2936886:Calcium [Pharmacologic Substance]
   737 E C0682969:Binding Site [Amino Acid Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "relative to non-plant annexins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.250: As can be seen from Fig. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen from Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.251: 5A, recombinant wild-type annexin 24(Ca32) binds only moderately to PS/PE (3:1) liposomes. 

Phrase: "5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: "recombinant wild-type annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1883559:Wild Type [Organism Attribute]
   804   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1514798:recombinant [Organism]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "only moderately to PS/PE (3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205171:Only [Quantitative Concept]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C1720467:Only [Intellectual Product]
   753   C1881878:Moderately [Qualitative Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]
Processing 00000000.tx.252: A much higher degree of binding is achieved by using liposomes made from PC/PS (1:1). 

Phrase: "A much higher degree of binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "is"

Phrase: "achieved by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: "made from PC/PS (1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1414407:PC-1 [Gene or Genome]
   797   C1418599:Pc-1 [Gene or Genome]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   760   C3540812:PC [Gene or Genome]
   726   C1881534:Make [Functional Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.253: The half-maximal calcium concentration needed for binding is in the latter case c1/21.1mM. 

Phrase: "The half-maximal calcium concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   839   C2347813:Maximum Concentration [Quantitative Concept]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "needed for binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0027552:Needed [Qualitative Concept]
   790   C0243122:binding [Functional Concept]
   790   C0686904:needed [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "is in the latter case c1/21.1mM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0868928:Case [Functional Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.254: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.255: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.256: Calcium-dependent binding of recombinant annexin 24(Ca32) to lipid vesicles. 

Phrase: "Calcium-dependent binding of recombinant annexin 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1516144:Calcium Binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "to lipid vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.257: A, binding curves obtained from the centrifugation assay with PS/PE (3:1) (triangles) and PS/PC (1:1) (circles) liposomes. 

Phrase: "A,"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "obtained from the centrifugation assay"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1510438:Assay [Laboratory Procedure]
   726 E C1706701:Obtain [Activity]

Phrase: "with PS/PE (3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "PS/PC (1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1414407:PC-1 [Gene or Genome]
   901   C1418599:Pc-1 [Gene or Genome]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]
   827   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "liposomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]
Processing 00000000.tx.258: Shown as symbols are averages from three independent measurements. 

Phrase: "Shown as symbols"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0679214:symbols [Idea or Concept]
   756   C1547282:Show [Intellectual Product]
   756 E C1698987:symbol [Intellectual Product]

Phrase: "are"

Phrase: "averages from three independent measurements."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1510992:Average [Quantitative Concept]
   726   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.259: The curves were calculated by fitting a binding equation with Hill coefficient n=1.B, wavelength at the emission maximum of intrinsic protein fluorescence in the absence (red circles) or the presence (blue triangles) of PS/PE (3:1) liposomes; 

Phrase: "The curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "calculated by fitting"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0036572:Fitting [Sign or Symptom]
   790   C0441548:Fitting [Health Care Activity]
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "a binding equation with Hill coefficient n=1.B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0552449:Equation [Conceptual Entity]

Phrase: "wavelength at the emission maximum of intrinsic protein fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449819:Wavelength [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(red circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "or"

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(blue triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: "of PS/PE (3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: ";"
Processing 00000000.tx.260: excitation wavelength is exc=280nm. 

Phrase: "excitation wavelength"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449819:Wavelength [Quantitative Concept]

Phrase: "is"

Phrase: "exc"

Phrase: "=280nm."
Processing 00000000.tx.261: C, normalized intensity at emission maximum of the same samples as in B. 

Phrase: "C,"

Phrase: "normalized intensity at emission maximum of the same samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0522510:Intensity [Qualitative Concept]

Phrase: "as in B."
Processing 00000000.tx.262: Comparison of the intrinsic protein fluorescence in the absence and the presence of PS/PE (3:1) liposomes reveals a considerable blue-shift of the wavelength at maximal emission intensity (~9 nm). 

Phrase: "Comparison of the intrinsic protein fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "the presence of PS/PE (3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a considerable blue-shift of the wavelength"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "at maximal emission intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0522510:Intensity [Qualitative Concept]

Phrase: "(~9 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.263: Calcium dependence of this hypochromic effect is not significant, as seen from Fig. 

Phrase: "Calcium dependence of this hypochromic effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "is"

Phrase: "not significant,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "as"

Phrase: "seen from Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.264: 5B. 

Phrase: "5B."
Processing 00000000.tx.265: Similarly, the intensity at peak emission decreases in the presence of the lipid vesicles (hypochromic effect). 

Phrase: "Similarly,"

Phrase: "the intensity at peak emission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "decreases in the presence of the lipid vesicles"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0023779:Lipid [Lipid]
   744   C0333262:VESICLES [Acquired Abnormality]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
   711 E C1622418:vesicle [Cell Component]

Phrase: "(hypochromic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.266: There is no effect of calcium on fluorescence intensity in the presence of liposomes; 

Phrase: "There"

Phrase: "is"

Phrase: "no effect of calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: ";"
Processing 00000000.tx.267: however, in their absence, Anx24(Ca32) fluorescence intensity is decreased by high calcium concentrations (Fig. 5C). 

Phrase: "however,"

Phrase: "in their absence,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "is"

Phrase: "decreased by high calcium concentrations"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   806   C0553702:high calcium [Finding]
   797   C0860967:decreased calcium [Finding]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0086045:Concentrations [Mental Process]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.268: Carboxyfluorescein Leakage and Membrane Permeabilization Assay-- The CF leakage assay provides data about the ability of proteins to stabilize or destabilize lipid vesicles. 

Phrase: "Carboxyfluorescein Leakage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015376:Leakage [Pathologic Function]

Phrase: "and"

Phrase: "Membrane Permeabilization Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "The CF leakage assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "data about the ability of proteins to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "or"

Phrase: "destabilize"

Phrase: "lipid vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.269: With annexins, stabilization of liposomes in this assay validate results from the FURA-2-based calcium influx assay (23). 

Phrase: "With annexins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stabilization of liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "in this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "validate"

Phrase: "results from the FURA-2-based calcium influx assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.270: Numbers of the stability parameter /0 lower than 1.0account for more stable liposomes relative to the control experiment. 

Phrase: "Numbers of the stability parameter /0 lower"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "than 1.0account"

Phrase: "for more stable liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023828:Liposomes [Lipid]

Phrase: "relative to the control experiment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.271: The results for human recombinant annexin V and recombinant wild-type annexin 24(Ca32) clearly indicate that both proteins stabilize liposomes in the presence of calcium (Fig. 6A). 

Phrase: "The results for human recombinant annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "recombinant wild-type annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1883559:Wild Type [Organism Attribute]
   804   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1514798:recombinant [Organism]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "clearly"

Phrase: "indicate"

Phrase: "that"

Phrase: "both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "liposomes in the presence of calcium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023828:Liposomes [Lipid]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.272: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.273: 6.  

Phrase: "6."
Processing 00000000.tx.274: Results from the CF leakage and the calcium influx assay. 

Phrase: "Results from the CF leakage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "the calcium influx assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.275: A, results from the CF leakage assay for human annexin V (AV) and recombinant annexin 24(Ca32) (A24) in the presence of 500M CaCl2 and a control without CaCl2. 

Phrase: "A,"

Phrase: "results from the CF leakage assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0015376:Leakage [Pathologic Function]
   753   C0243073:assay [Qualitative Concept]
   753   C1274040:Result [Functional Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "for human annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332095:ANNEXIN V [Gene or Genome]
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(AV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "recombinant annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514798:recombinant [Organism]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "(A24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548686:A24 [Intellectual Product]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 500M CaCl2"

Phrase: "and"

Phrase: "a control without CaCl2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.276: 1M protein was mixed with PS/PE (3:1) liposomes. 

Phrase: "1M protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "mixed with PS/PE (3"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205430:Mixed [Functional Concept]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]
Processing 00000000.tx.277: Data shown are the average of three independent measurements. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the average of three independent measurements."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1510992:Average [Quantitative Concept]
   753   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.278: Normalization was carried out against a sample with 500M CaCl2 in the absence of protein (/0=1). 

Phrase: "Normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalization [Research Activity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out against a sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0370003:Sample [Substance]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "with 500M CaCl2"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(/0"

Phrase: "=1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.279: B, data obtained from the calcium influx assay with human annexin V (AV), Anx24(Ca32) (A24), Anx24(Ca32) with 1mM dithiothreitol (A24/DTT), Anx24(Ca32) with 1mM -mercaptoethanol (A24/ME), and His-Anx24(Ca32) (HA24). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained from the calcium influx assay"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0243073:assay [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C2936886:Calcium [Pharmacologic Substance]
   737   C0553702:increased calcium [Finding]
   719 E C1706701:Obtain [Activity]

Phrase: "with human annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332095:ANNEXIN V [Gene or Genome]
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(AV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "(A24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548686:A24 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "with 1mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "(A24/DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "with 1mM -mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "(A24/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548686:A24 [Intellectual Product]

Phrase: "ME"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "His-Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "(HA24"

Phrase: ")."
Processing 00000000.tx.280: The data are averages from three independent measurements and are normalized with respect to a sample without protein. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "averages from three independent measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1510992:Average [Quantitative Concept]
   726   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "normalized with respect to a sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0370003:Sample [Substance]
   753   C0679133:respect [Social Behavior]
   753   C1882115:Normalized [Research Activity]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "without protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.281: The control activity is therefore /0=1. 

Phrase: "The control activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "therefore /0"

Phrase: "=1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.282: The ability of recombinant wild-type annexin 24(Ca32) to induce calcium influx into PS/PE (3:1) liposomes was elucidated with a calcium influx assay. 

Phrase: "The ability of recombinant wild-type annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "calcium influx into PS/PE (3"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: "was"

Phrase: "elucidated with a calcium influx assay."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.283: The lipid composition was chosen to maintain compatibility with previous permeabilization measurements in our laboratory. 

Phrase: "The lipid composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0486616:Composition [Clinical Attribute]
   861   C1555710:composition [Idea or Concept]

Phrase: "was"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "compatibility with previous permeabilization measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237519:compatibility [Qualitative Concept]
   760   C1881693:COMPATIBILITY [Event]

Phrase: "in our laboratory."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]
Processing 00000000.tx.284: Annexin 24(Ca32) was shown to be the most active wild-type annexin in a comparative study with more than seven different proteins from this family (34). 

Phrase: "Annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the most active wild-type annexin in a comparative study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than seven different proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from this family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.285: It displays a 1.4-fold higher normalized activity than annexin II, the most active mammalian annexin in our hands (Fig. 6B). 

Phrase: "It"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a 1.4-fold higher normalized activity than annexin II,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "the most active mammalian annexin in our hands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.286: Surprisingly, the activity induced by the His-tag fusion protein is substantially decreased; 

Phrase: "Surprisingly,"

Phrase: "the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "induced by the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "His-tag fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "substantially"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.287: the activity parameter /0 is only 4% that of the activity displayed by recombinant annexin 24(Ca32) wild type. 

Phrase: "the activity parameter /0"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C0549193:Parameter [Spatial Concept]
   827   C1561536:*Activity [Idea or Concept]
   827   C1704769:Parameter [Conceptual Entity]
   827   C2350001:Parameter [Quantitative Concept]

Phrase: "is"

Phrase: "only 4%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "that of the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "displayed by recombinant annexin 24"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0870432:displayed [Functional Concept]
   760   C1514798:recombinant [Organism]
   726 E C1705417:Display [Manufactured Object]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "wild type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.288: ATPase Activity-- Although annexins from maize and tomato have already been reported to display phosphodiesterase activity (29, 31), nothing was known so far about the behavior of annexin 24from C.annuum or mammalian annexins. 

Phrase: "ATPase Activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148926:ATPase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "-"

Phrase: "-"

Phrase: "Although"

Phrase: "annexins from maize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "tomato"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242772:Tomato [Food]
  1000   C0885519:tomato [Pharmacologic Substance]
  1000   C1140676:Tomato [Plant]

Phrase: "have"

Phrase: "already"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "phosphodiesterase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1753334:phosphodiesterase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(29,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "nothing"

Phrase: "was"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "so far about the behavior of annexin 24from C.annuum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0004927:Behavior [Individual Behavior]
   739   C0037640:SO [Geographic Area]
   739   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205108:far [Spatial Concept]
   739   C2707008:Behavior [Clinical Attribute]

Phrase: "or"

Phrase: "mammalian annexins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.289: Using the protocol described in the experimental section, the hydrolase activity of recombinant wild-type annexin 24(Ca32) from C.annuum was tested with Na2ATP as substrate. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "described in the experimental section,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205155:Section [Spatial Concept]
   760   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   760   C1517586:Experimental [Qualitative Concept]
   760   C1522472:Section [Substance]
   760   C1552738:described [Idea or Concept]
   760   C1552923:Section [Quantitative Concept]
   760   C1705191:Section [Physical Object]

Phrase: "the hydrolase activity of recombinant wild-type annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C0459205:Type of activity [Intellectual Product]
   764   C1149632:hydrolase activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "from C.annuum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "tested with Na2ATP"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "as substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.290: The activity was determined by analyzing the amount of monophosphate generated from ATP2 by the enzyme. 

Phrase: "The activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined by analyzing"

Phrase: "the amount of monophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "generated from ATP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "by the enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.291: A sample of recombinant wild-type annexin 24yielded a specific activity of = 0.7mol/(mgh), which is slightly but insignificantly increased by the addition of 10mM CaCl2. 

Phrase: "A sample of recombinant wild-type annexin 24yielded"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C2347029:Sample Type [Qualitative Concept]
   744   C0370003:Sample [Substance]
   744   C2347026:Sample [Conceptual Entity]

Phrase: "a specific activity of = 0.7mol/"

Phrase: "(mgh"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "but"

Phrase: "insignificantly"

Phrase: "increased by the addition of 10mM CaCl2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1883712:Addition [Functional Concept]
Processing 00000000.tx.292: However, in the presence of 10mM EDTA, the specific activity nearly vanished (Fig. 7). 

Phrase: "However,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "the specific activity nearly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0205369:Specific [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1552740:specific [Intellectual Product]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "vanished"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.293: This leads to the conclusion that in the pure protein sample there is either some divalent metal ion present, or the hydrolase activity is catalyzed by Mg2+ present in the ATPase buffer. 

Phrase: "This"

Phrase: "leads to the conclusion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1707478:Conclusion [Idea or Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that in the pure protein sample there"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0370003:Sample [Substance]
   748   C2247561:PurE [Molecular Function]
   748   C2347026:Sample [Conceptual Entity]

Phrase: "is"

Phrase: "either"

Phrase: "some divalent metal ion present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0150312:Present [Quantitative Concept]
   812   C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "the hydrolase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149632:hydrolase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "catalyzed by Mg2+ present"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1417500:MG2 [Gene or Genome]
   770   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in the ATPase buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.294: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.295: 7.  

Phrase: "7."
Processing 00000000.tx.296: ATPase activity of recombinant annexin 24(Ca32) and human annexin V.Shown is the specific activity for the pure proteins (a), in the presence of 10mM CaCl2 (b), and in the presence of 10mM EDTA (c). 

Phrase: "ATPase activity of recombinant annexin 24"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1148926:ATPase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "and"

Phrase: "human annexin V."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332095:ANNEXIN V [Gene or Genome]
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "the specific activity for the pure proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0205369:Specific [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1552740:specific [Intellectual Product]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "a"

Phrase: ")"

Phrase: ","

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10mM CaCl2"

Phrase: "(b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and in the presence of 10mM EDTA ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1515981:And [Idea or Concept]

Phrase: "c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.297: All experiments were carried out as triplicate. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "triplicate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]
Processing 00000000.tx.298: As a control, we also tested recombinant human annexin V under the same conditions, which did not display hydrolase activity. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "we also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "recombinant human annexin V under the same conditions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1332095:ANNEXIN V [Gene or Genome]
   744   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "hydrolase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149632:hydrolase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.299: A sample of recombinant (Na+-K+)-ATPase from pig kidney was tested in this assay yielding a specific activity of =14.3mol/(mgh) with 3mM MgCl2 present. 

Phrase: "A sample of recombinant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "(Na+-K+)-ATPase from pig kidney"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0001479:NA K ATPASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0525416:Na ATPase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "tested in this assay"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0392366:tested [Intellectual Product]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "yielding"

Phrase: "a specific activity of =14.3mol/"

Phrase: "(mgh"

Phrase: ")"

Phrase: "with 3mM MgCl2 present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0150312:Present [Quantitative Concept]
   827   C0449450:Present [Idea or Concept]
Processing 00000000.tx.300: Folding Stability-- Folding stability of both recombinant proteins, annexin 24(Ca32) wild-type and His-Anx24, was investigated by urea-induced unfolding monitored by fluorescence spectroscopy. 

Phrase: "Folding Stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "--"

Phrase: "Folding stability of both recombinant proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C2350440:Protein Stability [Qualitative Concept]
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "His-Anx24,"

Phrase: "was"

Phrase: "investigated by urea-induced unfolding"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C0205263:Induced [Functional Concept]
   760   C1292732:investigated [Functional Concept]
   704 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "monitored by fluorescence spectroscopy."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0242506:Fluorescence Spectroscopy [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0037812:spectroscopy [Laboratory Procedure]
   770   C2713504:Spectroscopy [Occupation or Discipline]
   770   C2984732:SPECTROSCOPY [Functional Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.301: The comparison of both proteins is particularly interesting, since the fusion protein crystallizes while the wild-type protein precipitates. 

Phrase: "The comparison of both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "is"

Phrase: "particularly"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: ","

Phrase: "since"

Phrase: "the fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "crystallizes"

Phrase: "while"

Phrase: "the wild-type protein precipitates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1882443:PRECIPITATE [Phenomenon or Process]
Processing 00000000.tx.302: For the wild-type protein, 4.65M urea is required for half-maximal unfolding, whereas the unfolding curve of the fusion protein yields c1/2(urea)= 3.82M. 

Phrase: "For the wild-type protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "4.65M urea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   771 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "required for half-maximal unfolding,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205289:Maximal [Qualitative Concept]
   760   C0806909:Maximal [Quantitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C2825407:Half [Quantitative Concept]

Phrase: "whereas"

Phrase: "the unfolding curve of the fusion protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205134:Curve [Spatial Concept]

Phrase: "yields"

Phrase: "c1/2"

Phrase: "(urea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   944 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "= 3.82M."
Processing 00000000.tx.303: Measurements of the free stability energy show a significantly higher value for the fusion protein than for the wild type. 

Phrase: "Measurements of the free stability energy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:measurements [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a significantly higher value for the fusion protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1522609:Value [Quantitative Concept]

Phrase: "than"

Phrase: "for the wild type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.304: G(H2O)wt=4.69kJ/mol (+/ 0.96kJ/mol), and G(H2O)His=9.32kJ/mol (+/ 0.07kJ/mol).  

Phrase: "G(H2O"

Phrase: ")"

Phrase: "wt=4.69kJ/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: "(+/ 0.96kJ/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "G(H2O"

Phrase: ")"

Phrase: "His"

Phrase: "=9.32kJ/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: "(+/ 0.07kJ/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ")."
Processing 00000000.tx.305: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES General Features and Comparison with Annexin V-- Several biochemical properties of annexin 24(Ca32), like electrophoretic migration or aggregation behavior, clearly distinguish this plant annexin from its typical non-plant relatives, for example, annexin V.

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "General Features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "Comparison with Annexin V"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "--"

Phrase: "Several biochemical properties of annexin 24"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: ","

Phrase: "like electrophoretic migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "or"

Phrase: "aggregation behavior,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]

Phrase: "clearly"

Phrase: "distinguish"

Phrase: "this plant annexin from its typical non-plant relatives,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "annexin V."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.306: Topologically, the most prominent difference between this plant annexin and other well known mammalian annexins is certainly the lack of the endonexin sequence in domains II, III, and IV. 

Phrase: "Topologically,"

Phrase: "the most prominent difference between this plant annexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "other well known mammalian annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "certainly"

Phrase: "the lack of the endonexin sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "in domains II,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "IV."
Processing 00000000.tx.307: Despite these differences, cross-reaction with an anti-annexin V antibody emphasizes the overall similarity of different members of the annexin protein family even throughout different organisms; 

Phrase: "Despite these differences,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "cross-reaction with an anti-annexin V antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0010357:Cross Reaction [Molecular Function]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C2828360:Cross [Conceptual Entity]

Phrase: "emphasizes"

Phrase: "the overall similarity of different members"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similarity [Qualitative Concept]

Phrase: "of the annexin protein family even throughout different organisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0029235:Organisms [Organism]

Phrase: ";"
Processing 00000000.tx.308: however, post-translational modification of Anx24(Ca32) in vivo seems likely, since anti-maize antibodies are able to recognize the native protein only (Fig. 2B). 

Phrase: "however,"

Phrase: "post-translational modification of Anx24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0033666:Post-Translational Modification [Molecular Function]
   760   C0392747:Modification [Functional Concept]
   760   C0687676:Post [Temporal Concept]
   760   C1519614:Translational [Genetic Function]
   760   C1554963:modification [Qualitative Concept]
   760   C1704687:Post [Manufactured Object]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "seems"

Phrase: "likely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "since"

Phrase: "anti-maize antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "recognize"

Phrase: "the native protein only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0302891:Native [Functional Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.309: Comparison of the present structure with the crystal structure of annexin V (Fig. 4C) shows distinct local differences in various regions of the proteins; 

Phrase: "Comparison of the present structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "with the crystal structure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   861   C0427896:Crystal [Body Substance]
   861   C0678594:Structure [Spatial Concept]
   861   C1533132:Crystal [Body Substance]
   861   C1704641:Crystal [Manufactured Object]

Phrase: "of annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "distinct local differences in various regions of the proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   720   C0682132:regional differences [Finding]
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.310: for example, a shortening of the IIIDE loop by four amino acids, which renders the convex side of the intermodular space more accessible. 

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "a shortening of the IIIDE loop"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441636:Shortening [Therapeutic or Preventive Procedure]

Phrase: "by four amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "which"

Phrase: "renders"

Phrase: "the convex side of the intermodular space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0441987:Side [Spatial Concept]

Phrase: "more accessible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0814423:accessibility [Qualitative Concept]

Phrase: "."
Processing 00000000.tx.311: Several sulfate ions are found within this area, providing evidence that the higher accessibility of this region can be a distinctive feature of annexin 24(Ca32). 

Phrase: "Several sulfate ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C3536965:Sulfate Ion [Element, Ion, or Isotope]
   827   C0022023:Ions [Element, Ion, or Isotope]
   793 E C1700702:ION [Functional Concept]

Phrase: "are"

Phrase: "found within this area,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017446:Area [Geographic Area]
   770   C0150312:Found [Quantitative Concept]
   770   C0205146:Area [Spatial Concept]
   737 E C0243095:Find [Finding]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the higher accessibility of this region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814423:accessibility [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "a distinctive feature of annexin 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.312: The presence of several polar residue side chains and the proposed conformational flexibility in this region provides an excellent environment for the phosphodiesterase activity of this protein. 

Phrase: "The presence of several polar residue side chains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the proposed conformational flexibility in this region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0242808:Flexibility [Qualitative Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "an excellent environment for the phosphodiesterase activity of this protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.313: Additionally, the molecular surfaces of both proteins are strikingly different in shape and also in surface potential. 

Phrase: "Additionally,"

Phrase: "the molecular surfaces of both proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0025252:Surface Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1521991:Molecular [Qualitative Concept]
   719   C0205148:Surface [Spatial Concept]

Phrase: "are"

Phrase: "strikingly different in shape"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   885   C1268727:Difference in shape [Finding]
   770   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "also in surface potential."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205148:Surface [Spatial Concept]
   770   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.314: The overall structure of annexin 24(Ca32) appears to be much more fissured, presenting several clefts and pockets (see Fig. 9) not observed with annexin V.

Phrase: "The overall structure of annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "much more"

Phrase: "fissured"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332469:Fissured [Body Space or Junction]

Phrase: ","

Phrase: "presenting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presenting [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "several clefts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205242:Cleft [Spatial Concept]

Phrase: "and"

Phrase: "pockets"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed with annexin V."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332095:ANNEXIN V [Gene or Genome]
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1441672:Observed [Functional Concept]
Processing 00000000.tx.315: This is also supported by the calculated geometrical extensions of annexin 24and annexin V, which reveal a larger molecular surface area for annexin 24(Ca32), whereas the volumes of both proteins are very similar (see Table IV). 

Phrase: "This"

Phrase: "is"

Phrase: "also"

Phrase: "supported by the calculated geometrical extensions of annexin 24and annexin V,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   754   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1332095:ANNEXIN V [Gene or Genome]
   738   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0231448:extensions [Functional Concept]
   738   C0444686:Calculated [Functional Concept]
   738   C1441506:Calculated [Activity]
   738   C1443182:Calculated [Laboratory Procedure]
   738   C1521721:Supported [Conceptual Entity]
   704 E C0183683:Support [Medical Device]
   704 E C1880641:Extension [Conceptual Entity]

Phrase: "which"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a larger molecular surface area for annexin 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0017446:Area [Geographic Area]
   744   C0205146:Area [Spatial Concept]
   744   C0205148:Surface [Spatial Concept]
   744   C1521991:Molecular [Qualitative Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the volumes of both proteins"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0449468:volumes [Quantitative Concept]
   726 E C1690016:% volume [Qualitative Concept]
   726 E C1705102:Volume [Intellectual Product]
   726 E C2700258:Volume [Laboratory Procedure]

Phrase: "are"

Phrase: "very similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similar [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table IV"

Phrase: ")."
Processing 00000000.tx.316: Of remarkable interest is the association of the N-terminal domain with the protein core in the present structure, since this has not been observed in other annexin structures so far. 

Phrase: "Of remarkable interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0543488:Interest [Mental Process]

Phrase: "is"

Phrase: "the association of the N-terminal domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with the protein core"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "in the present structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "since"

Phrase: "this"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "observed in other annexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1441672:Observed [Functional Concept]

Phrase: "structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "so far."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]
Processing 00000000.tx.317: The N-terminal tail in both molecules of the annexin 24(Ca32) structure is attached to the core via H-bonding between His-48 and backbone carbonyl CO-13 (Fig. 8). 

Phrase: "The N-terminal tail in both molecules of the annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "attached to the core"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0231441:Attached [Finding]
   770   C0444669:Core [Spatial Concept]
   770   C1167518:core [Cell Component]
   770   C1706352:Core [Medical Device]
   770   C1882467:Core [Manufactured Object]
   770   C3274653:Core [Body Substance]
   737 E C1314972:ATTACH [Intellectual Product]

Phrase: "via H-bonding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028758:BONDING [Mental Process]

Phrase: "between His-48"

Phrase: "and"

Phrase: "backbone carbonyl CO-13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037949:Backbone [Body Part, Organ, or Organ Component]
   812   C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.318: Furthermore, stability measurements indicate that the fusion protein is more stable than the wild-type (G=4.6kJ/mol). 

Phrase: "Furthermore,"

Phrase: "stability measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "the fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "more stable than the wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205360:Stable [Qualitative Concept]
   753   C1547311:Stable [Intellectual Product]

Phrase: "(G=4.6kJ/mol"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   902   C2348885:g/mol [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ")."
Processing 00000000.tx.319: According to results from CD spectroscopy, the artificial elongation of the N-terminal tail also affects the overall conformation of the protein. 

Phrase: "According to results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "from CD spectroscopy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "the artificial elongation of the N-terminal tail also"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the overall conformation of the protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033625:Protein Conformation [Spatial Concept]
   753   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.320: This further emphasizes the modulatory role of the N-terminal region on the protein core, as already proposed from a mutation study with N-terminal annexin V truncations.2 View larger version (56K): [in this window] [in a new window]  Fig. 

Phrase: "This further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "emphasizes"

Phrase: "the modulatory role of the N-terminal region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "on the protein core,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "as"

Phrase: "already"

Phrase: "proposed from a mutation study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0026882:Mutation [Genetic Function]
   760   C0557651:Study [Manufactured Object]
   760   C1441414:PROPOSED [Idea or Concept]
   760   C1553874:Proposed [Qualitative Concept]
   760   C1578820:Proposed [Idea or Concept]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
   760   C2603343:Study [Research Activity]

Phrase: "with N-terminal annexin V truncations.2 View larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0333052:Version [Functional Concept]
   791   C2607870:Version [Spatial Concept]

Phrase: "(56K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.321: 8.  

Phrase: "8."
Processing 00000000.tx.322: Electron density map around His-48. 

Phrase: "Electron density map around His-48."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0024779:Map [Manufactured Object]
   753   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.323: Stereo drawing of the 2FoFc electron density map contoured at 1. 

Phrase: "Stereo drawing of the 2FoFc electron density map"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0013113:drawing [Intellectual Product]

Phrase: "contoured"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302821:contoured [Inorganic Chemical]
  1000   C0876954:contoured [Spatial Concept]

Phrase: "at 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]
Processing 00000000.tx.324: CO-13 is hydrogen-bonded to His-48, which in turn is in close vicinity to Glu-320 (distance of His-N to the carboxylate group is 3.3). 

Phrase: "CO-13"

Phrase: "is"

Phrase: "hydrogen-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020275:Hydrogen [Element, Ion, or Isotope]
  1000   C0523702:HYDROGEN [Laboratory Procedure]
  1000   C0885426:hydrogen [Inorganic Chemical]

Phrase: "bonded to His-48,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1412323:HIS [Gene or Genome]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "is in close vicinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0587267:Close [Functional Concept]

Phrase: "to Glu-320"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(distance of His-N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012751:Distance [Quantitative Concept]

Phrase: "to the carboxylate group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "3.3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.325: The density plot was prepared with O (19). 

Phrase: "The density plot"

Phrase: "was"

Phrase: "prepared with O (19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1521827:Prepare [Functional Concept]

Phrase: ")."
Processing 00000000.tx.326: Membrane Binding Loops-- Of major interest are, of course, the membrane binding loops located on the convex side of the protein. 

Phrase: "Membrane Binding Loops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0181687:loops [Medical Device]
   793 E C0419518:Loop [Medical Device]
   793 E C0445022:Loop [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "Of major interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0543488:Interest [Mental Process]

Phrase: "are"

Phrase: ","

Phrase: "of course,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "the membrane binding loops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0181687:loops [Medical Device]
   793 E C0419518:Loop [Medical Device]
   793 E C0445022:Loop [Spatial Concept]

Phrase: "located on the convex side of the protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0441987:Side [Spatial Concept]
   744   C0521163:Convex [Spatial Concept]
Processing 00000000.tx.327: The AB loops of domains I, II, and III each contain an aromatic residue capable of effective interaction with a membranous lipid layer. 

Phrase: "The AB"

Phrase: "loops of domains I,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0021966:I- [Inorganic Chemical]
   770   C0181687:loops [Medical Device]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0419518:Loop [Medical Device]
   770   C0445022:Loop [Spatial Concept]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "II,"

Phrase: "and"

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "each"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an aromatic residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "capable of effective interaction"

Phrase: "with a membranous lipid layer."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C2338391:Membranous layer [Body Part, Organ, or Organ Component]
   871 E C0682533:membrane layer [Cell Component]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]
Processing 00000000.tx.328: Analysis of the canonical calcium binding sites, as defined by annexin V, shows a complete disruption within annexin 24(Ca32). 

Phrase: "Analysis of the canonical calcium binding sites,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "as"

Phrase: "defined by annexin V,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332095:ANNEXIN V [Gene or Genome]
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a complete disruption within annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.329: None of the four calcium ions from annexin V could be bound because of structural divergence of the loops, believed to contribute to calcium coordination. 

Phrase: "None of the four calcium ions"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0596235:calcium ions [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0022023:Ions [Element, Ion, or Isotope]
   753   C0205450:Four [Quantitative Concept]
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C2936886:Calcium [Pharmacologic Substance]
   719 E C1700702:ION [Functional Concept]

Phrase: "from annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "be"

Phrase: "bound because of structural divergence of the loops,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   744   C0181687:loops [Medical Device]
   744   C0332297:bound [Spatial Concept]
   744   C0443204:Divergence [Spatial Concept]
   744   C0678594:Structural [Spatial Concept]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]
   711 E C0419518:Loop [Medical Device]
   711 E C0445022:Loop [Spatial Concept]

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to calcium coordination."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C0242414:Coordination [Physiologic Function]
   770   C0700114:Coordination [Functional Concept]
   770   C1880177:Contribute [Activity]
   770   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.330: It is known from the primary structure that the endonexin fold is only conserved within the first domain of annexin 24(Ca32). 

Phrase: "It"

Phrase: "is"

Phrase: "known from the primary structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205225:Primary [Qualitative Concept]
   760   C0205309:Known [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C0678594:Structure [Spatial Concept]

Phrase: "that"

Phrase: "the endonexin fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "conserved within the first domain of annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205435:First [Quantitative Concept]
   744   C1279901:First [Qualitative Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.331: Still, canonical calcium binding within this site is doubtful, as Lys-40 with its positive charge prevents coordination of a cation. 

Phrase: "Still,"

Phrase: "canonical calcium binding within this site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1516144:Calcium Binding [Molecular Function]
   783   C0005456:Binding Site [Receptor]
   783   C0682969:Binding Site [Amino Acid Sequence]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "doubtful,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0750558:Doubtful [Conceptual Entity]
   928 E C0870444:doubt [Mental Process]

Phrase: "as"

Phrase: "Lys-40 with its positive charge"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C2825490:Positive Charge [Qualitative Concept]
           Positive
   753   C0007961:Charge [Quantitative Concept]
   753   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0439178:% Positive [Quantitative Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C1706211:Charge [Organism Attribute]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "coordination of a cation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242414:Coordination [Physiologic Function]
   770   C0700114:Coordination [Functional Concept]
Processing 00000000.tx.332: The strict conservation of Trp-35 in the IAB loop within the plant-type annexins (see Fig. 1) indicates a major role of this residue for membrane binding or annexin oligomerization (see the next paragraph). 

Phrase: "The strict conservation of Trp-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347858:Conservation [Qualitative Concept]

Phrase: "in the IAB loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "within the plant-type annexins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "indicates"

Phrase: "a major role of this residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "for membrane binding"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0025255:Membrane [Tissue]
   861   C0243122:binding [Functional Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "or"

Phrase: "annexin oligomerization"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "the next paragraph"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0871028:Paragraph [Intellectual Product]
   761 E C0234492:Paragraphia [Finding]

Phrase: ")."
Processing 00000000.tx.333: The present structure anticipates that the switching mechanism from the loop-in to the loop-out conformation of the IAB loop might be a conserved feature of all plant-type annexins. 

Phrase: "The present structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "anticipates"

Phrase: "that"

Phrase: "the"

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "mechanism from the loop-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "in to the loop-out conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "of the IAB loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "might"

Phrase: "be"

Phrase: "a conserved feature of all plant-type annexins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.334: A possible scenario transforming both conformers would involve a relocation of the sulfate ion along the protein surface to the position in molecule #1, where it prevents the loop-in conformation of Trp-35. 

Phrase: "A possible scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683579:scenario [Functional Concept]

Phrase: "transforming"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510411:Transforming [Pathologic Function]

Phrase: "both conformers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0180093:Conformer [Medical Device]

Phrase: "would"

Phrase: "involve"

Phrase: "a relocation of the sulfate ion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2699029:Relocation [Activity]

Phrase: "along the protein surface"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025252:protein surface [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205148:Surface [Spatial Concept]

Phrase: "to the position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "in molecule #1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "where"

Phrase: "it"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the loop-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "in conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "of Trp-35."
Processing 00000000.tx.335: The creation of a binding pocket by a second annexin molecule further contributes to energetically stabilizing the loop-out conformation of the IAB loop in molecule #1 in the crystal structure. 

Phrase: "The creation of a binding pocket"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441513:Creation [Therapeutic or Preventive Procedure]
   753   C1706214:Creation [Activity]

Phrase: "by a second annexin molecule further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:Molecule [Substance]
   741 E C1521991:Molecular [Qualitative Concept]

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to energetically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "stabilizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilizing [Qualitative Concept]

Phrase: "the loop-out conformation of the IAB loop"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0026377:Conformation [Spatial Concept]

Phrase: "in molecule #1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "in the crystal structure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   861   C0427896:Crystal [Body Substance]
   861   C0678594:Structure [Spatial Concept]
   861   C1533132:Crystal [Body Substance]
   861   C1704641:Crystal [Manufactured Object]
Processing 00000000.tx.336: Interaction with Calcium and Membranes-- Binding of annexin 24(Ca32) to PS/PE (3:1) liposomes as monitored by intrinsic protein fluorescence results in a blue-shift of the wavelength at the emission maximum. 

Phrase: "Interaction with Calcium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "Binding of annexin 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "to PS/PE (3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: "as"

Phrase: "monitored by intrinsic protein fluorescence"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205102:Intrinsic [Spatial Concept]
   760   C0439674:Intrinsic [Functional Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "results in a blue-shift of the wavelength"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0333051:Shift [Functional Concept]
   744   C0449819:Wavelength [Quantitative Concept]
   744   C1260957:Blue [Qualitative Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2347509:Shift [Phenomenon or Process]
   744   C2825142:Result [Finding]

Phrase: "at the emission maximum."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0806909:Maximum [Quantitative Concept]
   861   C1552615:maximum [Quantitative Concept]
   861   C2826546:MAXIMUM [Quantitative Concept]
   789 E C0205289:Maximal [Qualitative Concept]
Processing 00000000.tx.337: It seems likely that this is due to the residues Trp-35, Trp-107, and Tyr-192, all located on the convex side of the protein within the AB loops. 

Phrase: "It"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "is due to the residues Trp-35,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0678226:Due to [Functional Concept]
           due
   748   C3146286:Due [Idea or Concept]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "Trp-107,"

Phrase: "and"

Phrase: "Tyr-192,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "all"

Phrase: "located on the convex side of the protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0441987:Side [Spatial Concept]
   744   C0521163:Convex [Spatial Concept]

Phrase: "within the AB loops."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0181687:loops [Medical Device]
   827 E C0419518:Loop [Medical Device]
   827 E C0445022:Loop [Spatial Concept]
Processing 00000000.tx.338: This agrees well with the structural data and strongly suggests that these loops serve as membrane binding regions, with the aromatic residues penetrating the lipid layer. 

Phrase: "This"

Phrase: "agrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3641827:Agree [Intellectual Product]

Phrase: "well with the structural data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205170:Well [Qualitative Concept]
   760   C0678594:Structural [Spatial Concept]
   760   C1511726:Data [Idea or Concept]
   760   C3146287:Well [Manufactured Object]
   760   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "strongly"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these loops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0181687:loops [Medical Device]
   966 E C0419518:Loop [Medical Device]
   966 E C0445022:Loop [Spatial Concept]

Phrase: "serve as membrane binding regions,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0025255:Membrane [Tissue]
   760   C0243122:binding [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1706182:Membrane [Manufactured Object]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "with the aromatic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "penetrating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:Penetrating [Functional Concept]

Phrase: "the lipid layer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]
Processing 00000000.tx.339: The annexin-membrane interaction observed here is not strongly dependent on calcium, emphasizing differences in the protein-membrane interaction mechanisms between annexin 24(Ca32) and annexin V.

Phrase: "The annexin-membrane interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "here"

Phrase: "is"

Phrase: "not strongly dependent on calcium,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "emphasizing differences in the protein-membrane interaction mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "between annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "and"

Phrase: "annexin V."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.340: However, calcium-induced structural rearrangements are suggested by the observed changes in the intrinsic protein fluorescence in the absence of lipids. 

Phrase: "However,"

Phrase: "calcium-induced structural rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511695:Rearrangements [Genetic Function]

Phrase: "are"

Phrase: "suggested by the observed changes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
   726 E C1705241:Change [Quantitative Concept]
   726   C1705535:Suggest [Idea or Concept]

Phrase: "in the intrinsic protein fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of lipids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]
Processing 00000000.tx.341: With increasing calcium concentration we observe a decrease in emission intensity, indicating enhanced access of quencher molecules (like e.g. solvent) to the fluorophores. 

Phrase: "With increasing calcium concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "we"

Phrase: "observe"

Phrase: "a decrease in emission intensity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "indicating"

Phrase: "enhanced access of quencher molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444454:Access [Spatial Concept]
   760   C1554204:access [Idea or Concept]

Phrase: "("

Phrase: "like"

Phrase: "e.g. solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "to the fluorophores."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0598447:fluorophore [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.342: This effect is nearly absent in the presence of lipids, suggesting a protection of fluorophores by surrounding lipid layers. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "nearly absent in the presence of lipids,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332197:Absent [Quantitative Concept]
   748   C2699517:ABSENT [Finding]
   738   C1709643:Present Absent [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a protection of fluorophores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "by surrounding lipid layers."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0934502:layers [Body Part, Organ, or Organ Component]
   793 E C1522408:Layer [Qualitative Concept]
   793 E C1561599:Layer [Intellectual Product]
Processing 00000000.tx.343: One possible explanation is a calcium-induced interaction of two annexin proteins either in the membrane-bound or soluble form. 

Phrase: "One possible explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "a calcium-induced interaction of two annexin proteins either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0872079:interaction protein [Molecular Function]
   742   C1704675:Interaction [Functional Concept]

Phrase: "in the membrane-bound"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0025255:Membrane [Tissue]
   861   C0332297:bound [Spatial Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1145667:Bound [Activity]
   861   C1167622:Bound [Molecular Function]
   861   C1689898:% bound [Quantitative Concept]
   861   C1706182:Membrane [Manufactured Object]
   861   C2349209:Bound [Conceptual Entity]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "or"

Phrase: "soluble form."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]
Processing 00000000.tx.344: To compensate for the unfavorable situation of exposure of aromatic residues, these might interact with a second annexin molecule, thereby accounting for the observed spectroscopic behavior. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compensate for the unfavorable situation of exposure of aromatic residues,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0205432:compensate [Qualitative Concept]
   739   C0274281:Exposure, NOS [Injury or Poisoning]
   739   C0332157:Exposure [Clinical Attribute]
   739   C0772162:Aromatic [Organic Chemical,Pharmacologic Substance]
   739   C3640815:Unfavorable [Qualitative Concept]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "these"

Phrase: "might"

Phrase: "interact with a second annexin molecule,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205436:Second [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C0567416:Molecule [Substance]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]

Phrase: "thereby"

Phrase: "accounting for the observed spectroscopic behavior."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0000938:Accounting [Occupational Activity]
   753   C0004927:Behavior [Individual Behavior]
   753   C1441672:Observed [Functional Concept]
   753   C2707008:Behavior [Clinical Attribute]
   719 E C1551359:account [Idea or Concept]
   719 E C2741673:Account # [Clinical Attribute]
   719 E C2981730:Account [Classification]
Processing 00000000.tx.345: In the membrane-bound form, this would result in a membrane-supported two-dimensional protein layer (triggered by calcium). 

Phrase: "In the membrane-bound form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "this"

Phrase: "would"

Phrase: "result in a membrane-supported two-dimensional protein layer"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   764   C1705052:2-Dimensional [Spatial Concept]
   762   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C0682533:membrane layer [Cell Component]
   742   C0025255:Membrane [Tissue]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205448:Two [Quantitative Concept]
   742   C0596901:Membrane [Cell Component]
   742   C0934502:Layer [Body Part, Organ, or Organ Component]
   742   C1274040:Result [Functional Concept]
   742   C1521721:Supported [Conceptual Entity]
   742   C1522408:Layer [Qualitative Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1561599:Layer [Intellectual Product]
   742   C1706182:Membrane [Manufactured Object]
   742   C2825142:Result [Finding]
   726 E C2338391:Membranous layer [Body Part, Organ, or Organ Component]
   708 E C0183683:Support [Medical Device]

Phrase: "("

Phrase: "triggered by calcium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C1444748:Triggered by [Qualitative Concept]
           Trigger
   790   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   790   C0006726:Calcium [Inorganic Chemical]
   790   C2936886:Calcium [Pharmacologic Substance]
   756   C0032930:Trigger [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.346: Interestingly, a similar mechanism has been suggested for Trp-187 in annexin V recently (35). 

Phrase: "Interestingly,"

Phrase: "a similar mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "has"

Phrase: "been"

Phrase: "suggested for Trp-187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1705535:Suggest [Idea or Concept]

Phrase: "in annexin V recently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332095:ANNEXIN V [Gene or Genome]
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.347: Differences between annexin V and annexin 24(Ca32) are also observed regarding the affinity for certain constituents of a phospholipid bilayer. 

Phrase: "Differences between annexin V"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "are"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "regarding"

Phrase: "the affinity for certain constituents of a phospholipid bilayer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.348: The degree of binding observed with PS/PE (3:1) liposomes is only 30% in the case of the plant annexin. 

Phrase: "The degree of binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "observed with PS/PE (3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1418867:Ps [Gene or Genome]
   760   C1441672:Observed [Functional Concept]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: "is"

Phrase: "only 30% in the case of the plant annexin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0032098:Plant [Plant]
   742   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205171:Only [Quantitative Concept]
   742   C0868928:Case [Functional Concept]
   742   C1706255:CASE [Medical Device]
   742   C1706256:Case [Conceptual Entity]
   742   C1720467:Only [Intellectual Product]
Processing 00000000.tx.349: Nearly complete binding, however, is observed with PS/PC (1:1) liposomes. 

Phrase: "Nearly complete binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "however,"

Phrase: "is"

Phrase: "observed with PS/PC (1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1414407:PC-1 [Gene or Genome]
   806   C1418599:Pc-1 [Gene or Genome]
   797   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418867:Ps [Gene or Genome]
   760   C1441672:Observed [Functional Concept]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   760   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]
Processing 00000000.tx.350: The affinity for PS is therefore much lower for annexin 24(Ca32) than for annexin V.

Phrase: "The affinity for PS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "therefore much lower for annexin 24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "than"

Phrase: "for annexin V."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.351: Neglecting any calcium effect on membrane binding, an interesting view is obtained from a closer look at the protein surface potential on the convex side (Fig. 9). 

Phrase: "Neglecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521874:neglecting [Finding]

Phrase: "any calcium effect on membrane binding,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "an interesting view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "is"

Phrase: "obtained from a closer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "look at the protein surface potential"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025252:protein surface [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205148:Surface [Spatial Concept]
   753   C0233426:look [Organism Attribute]
   753   C3245505:Potential [Qualitative Concept]

Phrase: "on the convex side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.352: In addition to aromatic residues being able to interact with a membrane bilayer after conformational rearrangements, there are positively charged residues present on the convex side that might well be able to interact with the glycerol backbone/ester region of the membrane bilayer. 

Phrase: "In addition to aromatic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "being"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "interact with a membrane bilayer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "after conformational rearrangements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangements [Genetic Function]

Phrase: "there"

Phrase: "are"

Phrase: "positively charged residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "present on the convex side"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150312:Present [Quantitative Concept]
   760   C0441987:Side [Spatial Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0521163:Convex [Spatial Concept]

Phrase: "that"

Phrase: "might"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "interact with the glycerol backbone/ester region of the membrane bilayer."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   738   C0014898:Ester [Organic Chemical]
   738   C0017446:Region [Geographic Area]
   738   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   738   C0025255:Membrane [Tissue]
   738   C0037949:Backbone [Body Part, Organ, or Organ Component]
   738   C0205147:Region [Spatial Concept]
   738   C0596901:Membrane [Cell Component]
   738   C1267072:Backbone [Body Part, Organ, or Organ Component]
   738   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.353: The very surface of the protein on the convex side, however, is highly negatively charged. 

Phrase: "The very surface of the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0025252:protein surface [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205148:Surface [Spatial Concept]

Phrase: "on the convex side,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "however,"

Phrase: "is"

Phrase: "highly negatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205250:Highly [Qualitative Concept]

Phrase: "charged."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706211:Charged [Organism Attribute]
   966 E C0007961:Charge [Quantitative Concept]
Processing 00000000.tx.354: This agrees well with the preference of positively charged lipid head-groups, as observed in the liposome binding assay. 

Phrase: "This"

Phrase: "agrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3641827:Agree [Intellectual Product]

Phrase: "well with the preference of positively charged lipid head-groups,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   739   C0018670:Head [Body Location or Region]
   739   C0023779:Lipid [Lipid]
   739   C0205170:Well [Qualitative Concept]
   739   C0441833:Group [Idea or Concept]
   739   C0558295:preference [Idea or Concept]
   739   C0687744:group [Population Group]
   739   C1257890:Group [Population Group]
   739   C1281590:Head [Body Part, Organ, or Organ Component]
   739   C1549513:Preference [Idea or Concept]
   739   C1552516:Group [Health Care Related Organization]
   739   C1552839:groups [Idea or Concept]
   739   C1705428:Group [Conceptual Entity]
   739   C1705429:Group [Population Group]
   739   C1706211:Charged [Organism Attribute]
   739   C1706305:Head [Manufactured Object]
   739   C3146287:Well [Manufactured Object]

Phrase: "as"

Phrase: "observed in the liposome binding assay."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0023828:Liposome [Lipid]
   753   C0243073:assay [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1441672:Observed [Functional Concept]
   753   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.355: View larger version (54K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.356: 9.  

Phrase: "9."
Processing 00000000.tx.357: Surface potential map of His-tagged annexin 24(Ca32). 

Phrase: "Surface potential map of His-tagged annexin 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0024779:Map [Manufactured Object]
   744   C1706473:Map [Conceptual Entity]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.358: The molecular surfaces of both molecules #1 and #2 are colored according to the electrostatic potential (red, negative; blue, positive). 

Phrase: "The molecular surfaces of both molecules #1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1521991:Molecular [Qualitative Concept]
   714   C0205148:Surface [Spatial Concept]

Phrase: "and #"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "are"

Phrase: "colored according to the electrostatic potential"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0376534:electrostatic [Natural Phenomenon or Process]
   753   C0522507:colored [Qualitative Concept]
   753   C0680240:according [Social Behavior]
   753   C3245505:Potential [Qualitative Concept]
   719 E C0009393:Color [Natural Phenomenon or Process]
   719 E C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   719 E C1705245:Color [Pharmacologic Substance]

Phrase: "(red,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: "; blue,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.359: The figure was created with GRASP (38). 

Phrase: "The figure"

Phrase: "was"

Phrase: "created with GRASP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0220843:grasp [Organism Function]
   790   C1425726:GRASP [Gene or Genome]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.360: Asp-297 and Glu-68, which have both been identified in a recent study as being important for membrane binding of Anx(Le35) (5), are also conserved in Anx24(Ca32) (residues Asp-304 and Glu-76). 

Phrase: "Asp-297"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]

Phrase: "and"

Phrase: "Glu-68,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450387:68 [Intellectual Product]

Phrase: "which"

Phrase: "have"

Phrase: "both"

Phrase: "been"

Phrase: "identified in a recent study"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205396:Identified [Qualitative Concept]
   760   C0332185:Recent [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C2603343:Study [Research Activity]

Phrase: "as"

Phrase: "being"

Phrase: "important for membrane binding of Anx(Le35"

Phrase: ")"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "also"

Phrase: "conserved in Anx24"

Phrase: "(Ca32"

Phrase: ")"

Phrase: "(residues Asp-304"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0206293:Asp [Reptile]
   827   C3541260:ASP [Gene or Genome]
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "Glu-76"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.361: These amino acids align to the more distant residues of the endonexin sequence and are responsible for bidentate coordination of calcium in the case of vertebrate annexins. 

Phrase: "These amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "align to the more distant residues of the endonexin sequence"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0443203:Distant [Spatial Concept]
   739   C0597867:endonexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1519249:Sequence [Functional Concept]
   739   C2369992:Align [Pharmacologic Substance]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "are"

Phrase: "responsible for bidentate coordination of calcium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of vertebrate annexins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.362: In the present structure Glu-76 in both molecules is involved in coordination of a sulfate ion, which might be substituted by a phosphate group in the membrane-bound state. 

Phrase: "In the present structure Glu-76"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0150312:Present [Quantitative Concept]
   812   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0449450:Present [Idea or Concept]
   812   C0678594:Structure [Spatial Concept]

Phrase: "in both molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "is"

Phrase: "involved in coordination of a sulfate ion,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C3536965:Sulfate Ion [Element, Ion, or Isotope]
           SULFATE
   748   C0022023:Ion [Element, Ion, or Isotope]
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0242414:Coordination [Physiologic Function]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C0700114:Coordination [Functional Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1700702:ION [Functional Concept]

Phrase: "which"

Phrase: "might"

Phrase: "be"

Phrase: "substituted by a phosphate group"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   797   C0441835:Group A [Classification]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "in the membrane-bound state."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
Processing 00000000.tx.363: Functional Properties-- Assays characterizing the membrane activity of annexin 24(Ca32) show a peculiar behavior of this protein. 

Phrase: "Functional Properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "--"

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "characterizing"

Phrase: "the membrane activity of annexin 24"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0596897:membrane activity [Cell Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a peculiar behavior of this protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.364: On one hand, the calcium concentration needed for half-maximal binding to PS/PE (3:1) liposomes is about 10-fold higher than for annexin V, the degree of binding is much lower, and the results from the CF leakage assay indicate no vesicle destabilization by annexin 24.

Phrase: "On one hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: "the calcium concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "needed for half-maximal binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0027552:Needed [Qualitative Concept]
   760   C0205289:Maximal [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C0686904:needed [Functional Concept]
   760   C0806909:Maximal [Quantitative Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C2825407:Half [Quantitative Concept]

Phrase: "to PS/PE (3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "liposomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]

Phrase: "is"

Phrase: "about 10-fold higher than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "for annexin V,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the degree of binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "is"

Phrase: "much lower,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]

Phrase: "and"

Phrase: "the results from the CF leakage assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "no vesicle destabilization by annexin 24."
Processing 00000000.tx.365: On the other hand, membrane permeabilization activity as measured by the calcium influx assay is higher by a factor of 10for recombinant wild-type annexin 24(Ca32) than for annexin V and about 1.5-fold higher than for annexin II, the most active non-plant type annexin measured in our laboratory. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "membrane permeabilization activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0596897:membrane activity [Cell Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "measured by the calcium influx assay"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0243073:assay [Qualitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C2936886:Calcium [Pharmacologic Substance]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "is"

Phrase: "higher by a factor of 10for recombinant wild-type annexin 24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   704   C0205250:High [Qualitative Concept]
   704   C1299351:High [Qualitative Concept]
   704   C2700149:HIGH [Intellectual Product]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "than"

Phrase: "for annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "about 1.5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0205250:High [Qualitative Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]
   750 E C0489786:Height [Organism Attribute]

Phrase: "for annexin II,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0103404:Annexin II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412420:ANNEXIN II [Gene or Genome]

Phrase: "the most active non-plant type annexin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "measured in our laboratory."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C0444706:Measured [Qualitative Concept]
   770   C3244292:laboratory [Functional Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.366: This high increase in membrane permeabilization ability can not be explained by the amino acid sequence. 

Phrase: "This high increase in membrane permeabilization ability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "can"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "explained by the amino acid sequence."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0202406:Acid [Laboratory Procedure]
   753   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.367: All pore residues conserved among the non-plant annexins are also conserved within annexin 24(Ca32); 

Phrase: "All pore residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "conserved among the non-plant annexins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0032098:Plant [Plant]
   753   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1518422:Non [Functional Concept]

Phrase: "are"

Phrase: "also"

Phrase: "conserved within annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.368: the only exception is E120 (AnxV), which is replaced in annexin 24by a lysine, resulting in a change of charge at this position. 

Phrase: "the only exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1554961:exception [Idea or Concept]
   861   C1705847:Exception [Conceptual Entity]

Phrase: "is"

Phrase: "E120"

Phrase: "(AnxV"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "replaced in annexin 24by"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "a lysine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "resulting in a change of charge"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332294:Resulting in [Functional Concept]
   753   C0007961:Charge [Quantitative Concept]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1705241:Change [Quantitative Concept]
   753   C1706211:Charge [Organism Attribute]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "at this position."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.369: In light of other results from calcium influx experiments with annexins, the most likely explanation is an allosteric regulation of this membrane activity (23). 

Phrase: "In light of other results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "from calcium influx experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "with annexins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the most likely explanation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0681841:Explanation [Intellectual Product]
   734   C0750501:most likely [Idea or Concept]

Phrase: "is"

Phrase: "an allosteric regulation of this membrane activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0002145:Allosteric Regulation [Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.370: This conclusion is further supported by the extremely reduced activity of the His-tag fusion protein, where the elongation of the N-terminal domain may affect the structure and dynamics of the membrane active species. 

Phrase: "This conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by the extremely reduced activity of the"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0086439:Reduced Activity [Sign or Symptom]
   744   C0205177:Activity [Functional Concept]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1521721:Supported [Conceptual Entity]
   744   C1561536:*Activity [Idea or Concept]
   711 E C0183683:Support [Medical Device]

Phrase: "His-tag fusion protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "where"

Phrase: "the elongation of the N-terminal domain"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "dynamics of the membrane active species."
Processing 00000000.tx.371: The differences in the CD spectra of wild-type and fusion protein agree well with this explanation. 

Phrase: "The differences in the CD spectra of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "agree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3641827:Agree [Intellectual Product]

Phrase: "well with this explanation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C0681841:Explanation [Intellectual Product]
   770   C3146287:Well [Manufactured Object]
Processing 00000000.tx.372: Phosphodiesterase activity has been already reported for annexins from maize (31) and tomato (29). 

Phrase: "Phosphodiesterase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1753334:phosphodiesterase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "already"

Phrase: "reported for annexins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "from maize"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010028:Maize [Plant]
  1000   C1138842:Maize [Food]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "tomato"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242772:Tomato [Food]
  1000   C0885519:tomato [Pharmacologic Substance]
  1000   C1140676:Tomato [Plant]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.373: As the presence of MgCl2/Na2ATP or BDA452 has no effect on the membrane permeabilization assay, the ATPase activity or a possible complex formation between the benzodiazepine derivative and annexin 24does not interfere with the permeabilization behavior. 

Phrase: "As the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of MgCl2/Na2ATP"

Phrase: "or"

Phrase: "BDA452"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0670792:BDA452 [Organic Chemical]

Phrase: "has"

Phrase: "no effect on the membrane permeabilization assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "the ATPase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148926:ATPase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "a possible complex formation between the benzodiazepine derivative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "annexin 24does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with the permeabilization behavior."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0004927:Behavior [Individual Behavior]
   760   C0521102:Interfere [Qualitative Concept]
   760   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.374: The former result agrees well with a recent study (5), presenting evidence for the independence of the phospholipid binding and phosphodiesterase activity of tomato annexin Anx(Le35). 

Phrase: "The former result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "agrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3641827:Agree [Intellectual Product]

Phrase: "well with a recent study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205170:Well [Qualitative Concept]
   760   C0332185:Recent [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   760   C3146287:Well [Manufactured Object]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "presenting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presenting [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "evidence for the independence of the phospholipid binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "phosphodiesterase activity of tomato annexin Anx(Le35"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1753334:phosphodiesterase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.375: The present work is the first report of this enzymatic activity for recombinant wild-type annexin from C.annuum. 

Phrase: "The present work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "the first report of this enzymatic activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "for recombinant wild-type annexin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from C.annuum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.376: Compared with recombinant (Na+-K+)-ATPase, the enzymatic activity of annexin 24is about 5%. 

Phrase: "Compared with recombinant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514798:recombinant [Organism]
   790   C1707455:Compared [Activity]

Phrase: "(Na+-K+)-ATPase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001479:NA K ATPASE [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0525416:Na ATPase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the enzymatic activity of annexin 24is"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2267219:Enzymatic Activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "about 5%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.377: It is important to note that annexin V does not hydrolyze ATP2 under these conditions. 

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "hydrolyze"

Phrase: "ATP2 under these conditions."
Processing 00000000.tx.378: Conclusion-- The present work provides the first three-dimensional structure of a member of the plant annexin family and correlates these findings with the biochemical properties of this protein. 

Phrase: "Conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The present work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "the first three-dimensional structure of a member of the plant annexin family"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C0450363:3-Dimensional [Spatial Concept]
   749   C0680034:family structure [Family Group]
   749   C2713306:Plant structure [Plant]
   735   C0205449:Three [Quantitative Concept]
   735   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "correlates"

Phrase: "these findings with the biochemical properties of this protein."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   745   C0428132:Biochemical finding [Laboratory or Test Result]
   742   C2607943:findings [Functional Concept]
   742   C2926606:Findings [Clinical Attribute]
   742   C3539655:Findings [Intellectual Product]
   708 E C0037088:Finding [Sign or Symptom]
   708 E C0243095:Finding [Finding]
   708 E C2825141:Finding [Finding]
Processing 00000000.tx.379: Annexin 24(Ca32), as purified in its native form or recombinant from bacterial expression, shows distinct variations when compared with vertebrate annexins like annexin V.

Phrase: "Annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ca32"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "purified in its native form"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0302891:Native [Functional Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "or"

Phrase: "recombinant from bacterial expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514798:recombinant [Organism]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "distinct variations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variations [Qualitative Concept]

Phrase: "when"

Phrase: "compared with vertebrate annexins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0042567:Vertebrate [Vertebrate]
   770   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1707455:Compared [Activity]

Phrase: "like annexin V."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.380: Post-translational modifications of annexin 24(Ca32) are very likely to occur since anti-maize antibody recognizes the native purified protein only. 

Phrase: "Post-translational modifications of annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0033666:Post-Translational Modifications [Molecular Function]
   753   C0687676:Post [Temporal Concept]
   753   C1519614:Translational [Genetic Function]
   753   C1704687:Post [Manufactured Object]
   719   C0392747:Modification [Functional Concept]
   719   C1554963:modification [Qualitative Concept]

Phrase: "(Ca32"

Phrase: ")"

Phrase: "are"

Phrase: "very likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332148:Likely [Qualitative Concept]
   827   C0442824:Very [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "since anti-maize antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizes"

Phrase: "the native purified protein only."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.381: Though adopting the same overall fold, the detailed structure is very different from annexin V, resulting in a much less compact shape with high intrinsic flexibility. 

Phrase: "Though"

Phrase: "adopting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopting [Finding]

Phrase: "the same overall fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "the detailed structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "very different from annexin V,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "resulting in a much less compact shape"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0332294:Resulting in [Functional Concept]
   748   C0332479:Shape [Spatial Concept]
   748   C0348078:shape [Qualitative Concept]
   748   C0522512:Shape [Spatial Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1333134:Compact [Finding]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "with high intrinsic flexibility."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0242808:Flexibility [Qualitative Concept]
   755 E C0443220:Flexible [Qualitative Concept]
Processing 00000000.tx.382: The N-terminal region has a considerable effect on the protein core, since the His-tag elongation stabilizes the protein in unfolding experiments and is required for successful crystallization. 

Phrase: "The N-terminal region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0017446:Region [Geographic Area]
   827   C0205088:Terminal [Temporal Concept]
   827   C0205147:Region [Spatial Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "has"

Phrase: "a considerable effect on the protein core,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "since"

Phrase: "the His-tag elongation"

Phrase: "stabilizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "the protein in unfolding experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1655065:Protein Unfolding [Cell Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "is"

Phrase: "required for successful crystallization."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010423:Crystallization [Natural Phenomenon or Process]
   770   C1272703:Successful [Qualitative Concept]
   770   C1514873:Required [Functional Concept]
Processing 00000000.tx.383: Concerning this modification, one might argue that some structural features of the recombinant wild-type protein remain unrevealed. 

Phrase: "Concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "this modification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "might"

Phrase: "argue"

Phrase: "that"

Phrase: "some structural features of the recombinant wild-type protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   745   C1514562:Protein Feature [Amino Acid Sequence]
   708   C1521970:Feature [Qualitative Concept]
   708   C1706388:Feature [Conceptual Entity]
   708   C2346469:Feature [Qualitative Concept]
   708   C2348519:Feature [Qualitative Concept]

Phrase: "remain"

Phrase: "unrevealed."
Processing 00000000.tx.384: However, we would rather suggest that the effect of the N-terminal elongation is mainly an overall stabilization of the otherwise flexible structure of annexin 24(Ca32). 

Phrase: "However,"

Phrase: "we"

Phrase: "would"

Phrase: "rather"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effect of the N-terminal elongation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "mainly"

Phrase: "an overall stabilization of the otherwise flexible structure of annexin 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.385: From the present structure, the observed membrane binding behavior can be explained, and even the prediction of the most important residues is possible. 

Phrase: "From the present structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "the observed membrane binding behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0004927:Behavior [Individual Behavior]
   812   C2707008:Behavior [Clinical Attribute]
   741 E C2986890:Behavioral [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "explained"

Phrase: ","

Phrase: "and"

Phrase: "even"

Phrase: "the prediction of the most important residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681842:Prediction [Idea or Concept]

Phrase: "is"

Phrase: "possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.386: The absence of calcium within the structure prevents insights into the calcium binding mechanism. 

Phrase: "The absence of calcium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "within the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "insights into the calcium binding mechanism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:insights [Mental Process]
Processing 00000000.tx.387: Binding of calcium certainly requires structural rearrangements in the membrane binding loops; 

Phrase: "Binding of calcium certainly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1516144:Calcium Binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "requires"

Phrase: "structural rearrangements in the membrane binding loops"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511695:Rearrangements [Genetic Function]

Phrase: ";"
Processing 00000000.tx.388: these conformational changes are likely to occur as the two molecules in the present structure already adopt different conformations of the IAB loop, forced by different positions of a sulfate ion and crystal packing effects. 

Phrase: "these conformational changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0301641:Conformational change [Molecular Function]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "occur as the two molecules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205448:Two [Quantitative Concept]
   760   C0567416:molecules [Substance]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "in the present structure already"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "different conformations of the IAB loop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0026377:Conformation [Spatial Concept]

Phrase: "forced by different positions of a sulfate ion"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C3536965:Sulfate Ion [Element, Ion, or Isotope]
           SULFATE
   744   C0022023:Ion [Element, Ion, or Isotope]
   744   C0038720:Sulfate [Inorganic Chemical]
   744   C0441722:Forced [Phenomenon or Process]
   744   C0443221:Forced [Functional Concept]
   744   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   744   C0733755:positions [Spatial Concept]
   744   C1700702:ION [Functional Concept]
   744   C1705242:Different [Qualitative Concept]
   711 E C0563538:Force [Phenomenon or Process]

Phrase: "and"

Phrase: "crystal packing effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.389: Domain I is supposed to play an important role for protein-membrane and protein-protein interactions, since the switching tryptophan residue observed in the present structure is conserved throughout all plant annexins. 

Phrase: "Domain I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "supposed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role for protein-membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "protein-protein interactions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704675:Interaction [Functional Concept]

Phrase: "since"

Phrase: "the"

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "tryptophan residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "observed in the present structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0678594:Structure [Spatial Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "conserved throughout all plant annexins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032098:Plant [Plant]
   760   C0065042:Annexins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.390: Calcium influx activity as well as phosphodiesterase activity were demonstrated with recombinant wild-type annexin 24(Ca32). 

Phrase: "Calcium influx activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "as well as"

Phrase: "phosphodiesterase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1753334:phosphodiesterase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "demonstrated with recombinant wild-type annexin 24"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1514798:recombinant [Organism]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "(Ca32"

Phrase: ")."
Processing 00000000.tx.391: Future experiments aiming at structural location of the enzymatic activity of this annexin will contribute to clarification of the physiological role of these plant representatives of the annexin family of proteins.  

Phrase: "Future experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "aiming at structural location of the enzymatic activity of this annexin"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   756   C2267219:Enzymatic Activity [Molecular Function]
   738   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C0450429:Location [Spatial Concept]
   738   C0678594:Structural [Spatial Concept]
   738   C1515974:Location [Body Location or Region]
   738   C1561536:*Activity [Idea or Concept]
   704   C1947946:Aim [Idea or Concept]
   704   C2948600:Aim [Pharmacologic Substance]
   704   C3540471:AIM [Gene or Genome]
   704   C3540472:AIM [Functional Concept]

Phrase: "will"

Phrase: "contribute to clarification of the physiological role of these plant representatives"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   754   C1266845:Role clarification [Therapeutic or Preventive Procedure]
   738   C0032098:Plant [Plant]
   738   C0035820:Role [Social Behavior]
   738   C0205463:Physiological [Functional Concept]
   738   C1705810:Role [Conceptual Entity]
   738   C1880177:Contribute [Activity]
   738   C2986669:Clarification [Activity]
   718   C0243056:Plant Physiology [Physiologic Function]
   704   C1882932:Representative [Activity]

Phrase: "of the annexin family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "of proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.392: ACKNOWLEDGEMENTS We thank Michael Groll for the generous gift of a sample of (Na+-K+)-ATPase of pig kidney and Lissy Weyher for kindly recording the CD and mass spectra. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Michael Groll for the generous gift"

Phrase: "of a sample of (Na+-K+)-ATPase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0001479:NA K ATPASE [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0525416:Na ATPase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "of pig kidney"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1135183:Pig [Mammal]
   861   C1136016:PIG [Mammal]
   861   C1265533:Pig [Mammal]
   861   C1270360:Pig [Mammal]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "Lissy Weyher for kindly"

Phrase: "recording"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "the CD"

Phrase: "and"

Phrase: "mass spectra."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0037813:Mass Spectrum [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.393: Josef Kellermann and Kerstin Andersson helped tremendously by performing protein analysis, and DNA sequencing was done by Marius Boicu. 

Phrase: "Josef Kellermann"

Phrase: "and"

Phrase: "Kerstin Andersson"

Phrase: "helped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0018896:Help [Social Behavior]
   966   C1552861:help [Idea or Concept]

Phrase: "tremendously by performing protein analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "DNA sequencing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162326:DNA sequencing [Nucleotide Sequence]
  1000   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "was"

Phrase: "done by Marius Boicu."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1272695:Done [Qualitative Concept]
   770   C2746065:Done [Temporal Concept]
Processing 00000000.tx.394: We thank Hans Bartunik (DESY) for assistance at the beamline, Tarmo Ploom for the help with using MAIN, and Jrg Benz, Hans-Georg Beisel, and Sasha Zdanov for helpful discussions.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Hans Bartunik"

Phrase: "(DESY"

Phrase: ")"

Phrase: "for assistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018896:Assistance [Social Behavior]

Phrase: "at the beamline,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0872107:beamline [Manufactured Object]
  1000   C1655209:beam line [Manufactured Object]

Phrase: "Tarmo Ploom for the"

Phrase: "help with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0018896:Help [Social Behavior]
   833   C1552861:help [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MAIN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205225:Main [Qualitative Concept]
  1000   C1542147:Main [Qualitative Concept]

Phrase: "and"

Phrase: "Jrg Benz,"

Phrase: "Hans-Georg Beisel,"

Phrase: "and"

Phrase: "Sasha Zdanov for helpful discussions."
Processing 00000000.tx.395: FOOTNOTES * This work was sponsored by the European Council Grant ERBBIO4CT960083 (Biotechnology).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "sponsored by the European Council Grant ERBBIO4CT960083"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0018173:Grant [Quantitative Concept]
   748   C0239307:European [Population Group]
   748   C1535514:European [Population Group]
   748   C1548284:Grant [Idea or Concept]
   748   C1551807:Council [Population Group]
   714   C1711305:Sponsor [Human]
   714   C2347796:SPONSOR [Organization]

Phrase: "(Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.396: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.397: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.398: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.399: The atomic coordinates and structure factors (code 1dk5) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).  

Phrase: "The atomic coordinates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0427184:coordinates [Finding]
   861   C0700114:coordinates [Functional Concept]
   861   C1707511:Coordinates [Spatial Concept]

Phrase: "and"

Phrase: "structure factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678594:Structure [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(code 1dk5"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "deposited in the Protein Data Bank,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1705318:Protein Data Bank [Intellectual Product]
   790   C0242356:Data Bank [Intellectual Product]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0333562:deposited [Functional Concept]
   753   C0442598:Bank [Manufactured Object]
   753   C0872261:Bank [Manufactured Object]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "Research Collaboratory for Structural Bioinformatics,"

Phrase: "Rutgers University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "New Brunswick,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027963:New Brunswick [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.rcsb.org/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.400: This author gratefully acknowledges financial support by the Fonds der Chemischen Industrie and access to resources of MSL (ABL-NCIFCRDC) by kind permission of Alex Wlodawer. 

Phrase: "This author gratefully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0221193:Author [Professional or Occupational Group]

Phrase: "acknowledges"

Phrase: "financial support by the Fonds der Chemischen Industrie"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016118:Financial Support [Idea or Concept]
   744   C0183683:Support [Medical Device]
   744   C0376243:financial [Quantitative Concept]
   744   C1521721:Support [Conceptual Entity]
   744   C2350008:Financial [Qualitative Concept]

Phrase: "and"

Phrase: "access to resources of MSL (ABL-NCIFCRDC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0444454:Access [Spatial Concept]
   748   C1554204:access [Idea or Concept]

Phrase: ")"

Phrase: "by kind permission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521104:permission [Qualitative Concept]
   861   C1524004:Permission [Intellectual Product]

Phrase: "of Alex Wlodawer."
Processing 00000000.tx.401: To whom correspondence should be addressed: Macromolecular Crystallography Laboratory, Program in Structural Biology, NCI-FCRDC, Frederick, MD 21702.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Macromolecular Crystallography Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C3244292:laboratory [Functional Concept]

Phrase: "Program in Structural Biology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1709697:Program [Conceptual Entity]
   770   C2728259:Program [Pharmacologic Substance]
   770   C3484370:Program [Functional Concept]

Phrase: "NCI-FCRDC,"

Phrase: "Frederick,"

Phrase: "MD 21702.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.402: 301-846-5033; 

Phrase: "301-846-5033"

Phrase: ";"
Processing 00000000.tx.403: Fax: 301-846-7101; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "301-846-7101"

Phrase: ";"
Processing 00000000.tx.404: E-mail: hofmanna@ncifcrf.gov. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "hofmanna@ncifcrf.gov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1419208:GOV [Gene or Genome]
Processing 00000000.tx.405: 2 J. 

Phrase: "2 J."
Processing 00000000.tx.406: Benz, personal communication.  

Phrase: "Benz,"

Phrase: "personal communication."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]
Processing 00000000.tx.407: ABBREVIATIONS The abbreviations used are: PS, phosphatidylserine; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418867:Ps [Gene or Genome]
  1000   C1518860:PS [Geographic Area]
  1000   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "phosphatidylserine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: ";"
Processing 00000000.tx.408: PE, phosphatidylethanolamine; 

Phrase: "PE,"

Phrase: "phosphatidylethanolamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.409: Ca, C. annuum, Chelex, chelating resin (iminodiacetic acid); 

Phrase: "Ca,"

Phrase: "C. annuum,"

Phrase: "Chelex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055279:chelex [Organic Chemical,Pharmacologic Substance]

Phrase: "chelating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3537131:Chelating [Molecular Function]

Phrase: "resin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035191:Resin [Biomedical or Dental Material]

Phrase: "(iminodiacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0063397:iminodiacetic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.410: MES, 4-morpholineethanesulfonic acid; 

Phrase: "MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265215:MES [Congenital Abnormality]
  1000   C1417092:MES [Gene or Genome]

Phrase: "4-morpholineethanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.411: Nt, Nicotiana tabacum; 

Phrase: "Nt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "Nicotiana tabacum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0740009:Nicotiana tabacum [Plant]
   861   C0086707:Nicotiana [Plant]

Phrase: ";"
Processing 00000000.tx.412: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.413: Sp, Solanaceae proteins; 

Phrase: "Sp,"

Phrase: "Solanaceae proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.414: Zm, Zea mays; 

Phrase: "Zm,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043445:ZM [Geographic Area]
  1000   C2346517:zm [Quantitative Concept]

Phrase: "Zea mays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010028:Zea mays [Plant]
  1000   C1095906:zea mays [Pharmacologic Substance]
   861   C0087179:Zea [Plant]

Phrase: ";"
Processing 00000000.tx.415: CF leakage, carboxyfluorescein leakage; 

Phrase: "CF leakage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015376:Leakage [Pathologic Function]

Phrase: "carboxyfluorescein leakage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015376:Leakage [Pathologic Function]

Phrase: ";"
Processing 00000000.tx.416: PC, phosphatidylcholine.  

Phrase: "PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540812:PC [Gene or Genome]

Phrase: "phosphatidylcholine."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.417: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.418: Boustead, C. 

Phrase: "Boustead,"

Phrase: "C."
Processing 00000000.tx.419: M., Smallwood, M., Small, H., Bowles, D. 

Phrase: "M."

Phrase: ","

Phrase: "Smallwood,"

Phrase: "M."

Phrase: ","

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bowles,"

Phrase: "D."
Processing 00000000.tx.420: J., and Walker, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "J."
Processing 00000000.tx.421: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.422: (1989) FEBS Lett. 

Phrase: "(1989"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.423: 244, 456-460[CrossRef] 2. 

Phrase: "244,"

Phrase: "456-460"

Phrase: "[CrossRef"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.424: Delmer, D. 

Phrase: "Delmer,"

Phrase: "D."
Processing 00000000.tx.425: P., and Potikha, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Potikha,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.426: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.427: (1997) Cell. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.428: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.429: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.430: (Experientia) 53, 546-553[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "(Experientia"

Phrase: ")"

Phrase: "53,"

Phrase: "546-553"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.431: Proust, J., Houlne, G., Schantz, M.-L., Shen, W.-H., and Schantz, R. 

Phrase: "Proust,"

Phrase: "J.,"

Phrase: "Houlne,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schantz,"

Phrase: "M.-L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Shen,"

Phrase: "W.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Schantz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.432: (1999) Plant Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Plant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.433: Biol. 

Phrase: "Biol."
Processing 00000000.tx.434: 39, 361-372[CrossRef][Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "39,"

Phrase: "361-372"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.435: Geisow, M. 

Phrase: "Geisow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: J., Fritsche, U., Hexham, J. 

Phrase: "J.,"

Phrase: "Fritsche,"

Phrase: "U.,"

Phrase: "Hexham,"

Phrase: "J."
Processing 00000000.tx.437: M., Dash, B., and Johnson, T. 

Phrase: "M."

Phrase: ","

Phrase: "Dash,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827624:DASH [Intellectual Product]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Johnson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.438: (1986) Nature 320, 636-638[Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Nature 320,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "636-638"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.439: Kovacs, I., Ayaydin, F., Oberschall, A., Ipacs, I., Bottka, S., Pongor, S., Dudits, D., and Toth, E. 

Phrase: "Kovacs,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ayaydin,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Oberschall,"

Phrase: "A.,"

Phrase: "Ipacs,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bottka,"

Phrase: "S."

Phrase: ","

Phrase: "Pongor,"

Phrase: "S."

Phrase: ","

Phrase: "Dudits,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Toth,"

Phrase: "E."
Processing 00000000.tx.440: C. 

Phrase: "C."
Processing 00000000.tx.441: (1998) Plant. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Plant."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]
   907 E C0006038:Botany [Occupation or Discipline]
   888 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.442: J. 

Phrase: "J."
Processing 00000000.tx.443: 15, 185-197[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "15,"

Phrase: "185-197"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.444: Lim, E.-K., Roberts, M. 

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "E.-K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.445: R., and Bowles, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Bowles,"

Phrase: "D."
Processing 00000000.tx.446: J. 

Phrase: "J."
Processing 00000000.tx.447: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.448: Biol. 

Phrase: "Biol."
Processing 00000000.tx.449: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.450: 273, 34920-34925[Abstract/Free FullText] 7. 

Phrase: "273,"

Phrase: "34920-34925"

Phrase: "[Abstract/Free FullText"

Phrase: "] 7."
Processing 00000000.tx.451: Clark, G. 

Phrase: "Clark,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.452: B., Turnwald, S., Tirlapur, U. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Turnwald,"

Phrase: "S."

Phrase: ","

Phrase: "Tirlapur,"

Phrase: "U."
Processing 00000000.tx.453: K., van der Mark, K., Roux, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "van der Mark,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0522501:mark [Qualitative Concept]
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]
   755 E C1706089:Marked [Qualitative Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Roux,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.454: J., and Scheuerlein, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Scheuerlein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.455: (1995) Planta 197, 376-384[Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Planta 197,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0230463:Planta [Body Location or Region]
   789 E C0442036:Plantar [Body Location or Region]

Phrase: "376-384"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.456: Schoepfer, R. 

Phrase: "Schoepfer,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.457: (1993) Gene 124, 83-85[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gene 124,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "83-85"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.458: Burger, A., Berendes, R., Voges, D., Huber, R., and Demange, P. 

Phrase: "Burger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0452929:Burger [Food]

Phrase: "A.,"

Phrase: "Berendes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Voges,"

Phrase: "D."

Phrase: ","

Phrase: "Huber,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Demange,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.459: (1993) FEBS Lett. 

Phrase: "(1993"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.460: 329, 25-28[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "329,"

Phrase: "25-28"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.461: Leslie, A. 

Phrase: "Leslie,"

Phrase: "A."
Processing 00000000.tx.462: G.W. 

Phrase: "G.W."
Processing 00000000.tx.463: (1998) MOSFLM, Version 5.51 , Medical Research Council Laboratory of Molecular Biology, Cambridge, UK 11. 

Phrase: "(1998"

Phrase: ")"

Phrase: "MOSFLM,"

Phrase: "Version 5.51 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "Medical Research Council Laboratory of Molecular Biology,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0022886:Laboratory Research [Research Activity]
   774   C1552406:Medical Laboratory [Intellectual Product]
   774   C3242770:Medical Laboratory [Health Care Related Organization,Manufactured Object]
   748   C0022877:Laboratory [Manufactured Object,Organization]
   748   C3244292:laboratory [Functional Concept]

Phrase: "Cambridge,"

Phrase: "UK 11."
Processing 00000000.tx.464: CCP4. 

Phrase: "CCP4."
Processing 00000000.tx.465: (1996) Acta Crystallogr. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.466: Sec. 

Phrase: "Sec."
Processing 00000000.tx.467: D 50, 760-763 12. 

Phrase: "D 50,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "760-763 12."
Processing 00000000.tx.468: Tong, L., and Rossmann, M. 

Phrase: "Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183964:Tong [Medical Device]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Rossmann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.469: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.470: (1990) Acta Crystallogr. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.471: Sec. 

Phrase: "Sec."
Processing 00000000.tx.472: A 46, 783-792[CrossRef][Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "A 46,"

Phrase: "783-792"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.473: Navazza, J. 

Phrase: "Navazza,"

Phrase: "J."
Processing 00000000.tx.474: (1994) Acta Crystallogr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.475: Sec. 

Phrase: "Sec."
Processing 00000000.tx.476: A 50, 157-163[CrossRef] 14. 

Phrase: "A 50,"

Phrase: "157-163"

Phrase: "[CrossRef"

Phrase: "] 14."
Processing 00000000.tx.477: Vagin, A., and Teplyakov, A. 

Phrase: "Vagin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522570:VAGIN [Functional Concept]

Phrase: "A.,"

Phrase: "and"

Phrase: "Teplyakov,"

Phrase: "A."
Processing 00000000.tx.478: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.479: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.480: Crystogr. 

Phrase: "Crystogr."
Processing 00000000.tx.481: 30, 1022-1025[CrossRef] 15. 

Phrase: "30,"

Phrase: "1022-1025"

Phrase: "[CrossRef"

Phrase: "] 15."
Processing 00000000.tx.482: Turk, D. 

Phrase: "Turk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337911:Turk [Population Group]

Phrase: "D."
Processing 00000000.tx.483: (1992) Weiterentwicklung eines Programmes fr Molekgraphik und Elektronendichte- Manipulation und seine Anwendung auf verschiedene Protein-Strukturaufklrungen.Ph.D. thesis , Technische Universitt Mnchen 16. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Weiterentwicklung eines"

Phrase: "Programmes"

Phrase: "fr Molekgraphik und Elektronendichte- Manipulation und seine Anwendung auf verschiedene Protein-Strukturaufklrungen.Ph.D. thesis ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   785   C0039828:thesis [Intellectual Product]

Phrase: "Technische Universitt Mnchen 16."
Processing 00000000.tx.484: Jones, T. 

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.485: A. 

Phrase: "A."
Processing 00000000.tx.486: (1976) J. 

Phrase: "(1976"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.487: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.488: Crystogr. 

Phrase: "Crystogr."
Processing 00000000.tx.489: 15, 24-31 17. 

Phrase: "15,"

Phrase: "24-31 17."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450355:31 [Intellectual Product]
Processing 00000000.tx.490: Brnger, A. 

Phrase: "Brnger,"

Phrase: "A."
Processing 00000000.tx.491: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.492: (1998) X-PLOR, A system for X-ray Crystallography and NMR, Version 3.851 , Yale University Press, New Haven, CT 18. 

Phrase: "(1998"

Phrase: ")"

Phrase: "X-PLOR,"

Phrase: "A system for X-ray Crystallography"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "NMR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024485:NMR [Diagnostic Procedure]
  1000   C0028580:NMR [Natural Phenomenon or Process]

Phrase: "Version 3.851 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "Yale University Press,"

Phrase: "New Haven,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205314:New [Temporal Concept]

Phrase: "CT 18."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]
Processing 00000000.tx.493: Brnger, A. 

Phrase: "Brnger,"

Phrase: "A."
Processing 00000000.tx.494: T., Adams, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.495: D., Clore, G. 

Phrase: "D."

Phrase: ","

Phrase: "Clore,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.496: M., Delano, W. 

Phrase: "M."

Phrase: ","

Phrase: "Delano,"

Phrase: "W."
Processing 00000000.tx.497: L., Gros, P., Grosse-Kunstleve, R. 

Phrase: "L., Gros,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1332652:GRO [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1705593:GRO [Gene or Genome]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Grosse-Kunstleve,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.498: W., Jiang, J.-S., Kuszewski, J., Nilges, N., Pannu, N. 

Phrase: "W., Jiang,"

Phrase: "J.-S.,"

Phrase: "Kuszewski,"

Phrase: "J.,"

Phrase: "Nilges,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Pannu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.499: S., Read, R. 

Phrase: "S."

Phrase: ","

Phrase: "Read"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Read [Daily or Recreational Activity]
  1000   C1705179:read [Finding]

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.500: J., Rice, L. 

Phrase: "J.,"

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.501: M., Simonson, T., and Warren, G. 

Phrase: "M."

Phrase: ","

Phrase: "Simonson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Warren,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.502: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.503: (1998) Acta Crystallogr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.504: Sec. 

Phrase: "Sec."
Processing 00000000.tx.505: D 54, 905-921[CrossRef][Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "D 54,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "905-921"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.506: Jones, T. 

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.507: A., Zou, J.-Y., Cowan, S., and Kjeldgaard, M. 

Phrase: "A.,"

Phrase: "Zou,"

Phrase: "J.-Y.,"

Phrase: "Cowan,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kjeldgaard,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.508: (1991) Acta Crystallogr. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.509: Sec. 

Phrase: "Sec."
Processing 00000000.tx.510: A 47, 110-119[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "A 47,"

Phrase: "110-119"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.511: Engh, R., and Huber, R. 

Phrase: "Engh,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Huber,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.512: (1991) Acta Crystallogr. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.513: Sec. 

Phrase: "Sec."
Processing 00000000.tx.514: A 47, 392-400[CrossRef] 21. 

Phrase: "A 47,"

Phrase: "392-400"

Phrase: "[CrossRef"

Phrase: "] 21."
Processing 00000000.tx.515: Laskowski, R.A., MacArthur, M.W., Smith, D.K., Jones, D.T., Hutchinson, E.G., Morris, A.L., Naylor, D., Moss, D.S., and Thornton, J.(1994) PROCHECK, Programs to check the Stereochemical Quality of Protein Structures, Version 3.0 22. 

Phrase: "Laskowski,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "MacArthur,"

Phrase: "M."

Phrase: "W., Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "D."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "D.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hutchinson,"

Phrase: "E.G."

Phrase: ","

Phrase: "Morris,"

Phrase: "A.L., Naylor,"

Phrase: "D."

Phrase: ","

Phrase: "Moss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282635:Moss [Plant]

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Thornton,"

Phrase: "J.(1994"

Phrase: ")"

Phrase: "PROCHECK,"

Phrase: "Programs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0376691:Programs [Intellectual Product]
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "check"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Check [Activity]

Phrase: "the Stereochemical Quality of Protein Structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332306:Quality [Qualitative Concept]

Phrase: "Version 3.0 22."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0333052:Version [Functional Concept]
   812   C2607870:Version [Spatial Concept]
Processing 00000000.tx.516: Reeves, J. 

Phrase: "Reeves,"

Phrase: "J."
Processing 00000000.tx.517: P., and Dowben, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Dowben,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.518: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.519: (1968) J. 

Phrase: "(1968"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.520: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.521: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.522: 73, 49-60 23. 

Phrase: "73,"

Phrase: "49-60 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.523: Hofmann, A., Escherich, A., Lewit-Bentley, A., Benz, J., Raguenes, N., Russo-Marie, F., Gerke, V., Moroder, L., and Huber, R. 

Phrase: "Hofmann,"

Phrase: "A.,"

Phrase: "Escherich,"

Phrase: "A.,"

Phrase: "Lewit-Bentley,"

Phrase: "A.,"

Phrase: "Benz,"

Phrase: "J.,"

Phrase: "Raguenes,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Russo-Marie,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gerke,"

Phrase: "V.,"

Phrase: "Moroder,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Huber,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.524: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.525: Biol. 

Phrase: "Biol."
Processing 00000000.tx.526: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.527: 273, 2885-2894[Abstract/Free FullText] 24. 

Phrase: "273,"

Phrase: "2885-2894"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.528: Wilschut, J., Dzgnes, N., Fraley, R., and Papahadjopoulos, D. 

Phrase: "Wilschut,"

Phrase: "J.,"

Phrase: "Dzgnes,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fraley,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Papahadjopoulos,"

Phrase: "D."
Processing 00000000.tx.529: (1980) Biochemistry 19, 6011-6021[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Biochemistry 19,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "6011-6021"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.530: Berendes, R., Burger, A., Voges, D., Demange, P., and Huber, R. 

Phrase: "Berendes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Burger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0452929:Burger [Food]

Phrase: "A.,"

Phrase: "Voges,"

Phrase: "D."

Phrase: ","

Phrase: "Demange,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Huber,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.531: (1993) FEBS Lett. 

Phrase: "(1993"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.532: 317, 131-134[CrossRef][Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "317,"

Phrase: "131-134"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.533: Goossens, E. 

Phrase: "Goossens,"

Phrase: "E."
Processing 00000000.tx.534: L., Reutelingsperger, C. 

Phrase: "L., Reutelingsperger,"

Phrase: "C."
Processing 00000000.tx.535: P., Jongsma, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jongsma,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.536: H., Kraayenhof, R., and Hermens, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kraayenhof,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hermens,"

Phrase: "W."
Processing 00000000.tx.537: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.538: (1995) FEBS Lett. 

Phrase: "(1995"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.539: 359, 155-158[CrossRef][Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "359,"

Phrase: "155-158"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.540: Grynkiewicz, G., Poenie, M., and Tsien, R. 

Phrase: "Grynkiewicz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Poenie,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Tsien,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.541: Y. 

Phrase: "Y."
Processing 00000000.tx.542: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.543: Biol. 

Phrase: "Biol."
Processing 00000000.tx.544: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.545: 260, 3440-3450[Abstract] 28. 

Phrase: "260,"

Phrase: "3440-3450"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 28."
Processing 00000000.tx.546: Ames, B. 

Phrase: "Ames,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.547: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.548: (1966) Methods Enzymol. 

Phrase: "(1966"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.549: 8, 115-118 29. 

Phrase: "8,"

Phrase: "115-118 29."
Processing 00000000.tx.550: Calvert, C. 

Phrase: "Calvert,"

Phrase: "C."
Processing 00000000.tx.551: M., Gant, S. 

Phrase: "M."

Phrase: ","

Phrase: "Gant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0238198:gant [Neoplastic Process]
  1000   C2931518:GANT [Neoplastic Process]

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.552: J., and Bowles, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Bowles,"

Phrase: "D."
Processing 00000000.tx.553: J. 

Phrase: "J."
Processing 00000000.tx.554: (1996) Plant Cell 8, 333-342[Abstract/Free FullText] 30. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Plant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]

Phrase: "Cell 8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "333-342"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.555: Pace, C. 

Phrase: "Pace,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:PACE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1552930:Pace [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.556: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.557: (1995) Methods Enzymol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.558: 259, 538-554[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "259,"

Phrase: "538-554"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.559: McClung, A. 

Phrase: "McClung,"

Phrase: "A."
Processing 00000000.tx.560: D., Carroll, A. 

Phrase: "D."

Phrase: ","

Phrase: "Carroll,"

Phrase: "A."
Processing 00000000.tx.561: D., and Battey, N. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Battey,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.562: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.563: (1994) Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.564: J. 

Phrase: "J."
Processing 00000000.tx.565: 303, 709-712[Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "303,"

Phrase: "709-712"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.566: Battey, N. 

Phrase: "Battey,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.567: H., James, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "James,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.568: C., and Greenland, A. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Greenland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018229:Greenland [Geographic Area]

Phrase: "A."
Processing 00000000.tx.569: J. 

Phrase: "J."
Processing 00000000.tx.570: (1996) Plant Physiol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Plant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]

Phrase: "Physiol."
Processing 00000000.tx.571: 112, 1391-1396[Abstract/Free FullText] 33. 

Phrase: "112,"

Phrase: "1391-1396"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.572: Thonat, C., Mathieu, C., Crevecoeur, M., Penel, C., Gaspar, T., and Boyer, N. 

Phrase: "Thonat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mathieu,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Crevecoeur,"

Phrase: "M."

Phrase: ","

Phrase: "Penel,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gaspar,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Boyer,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.573: (1997) Plant Physiol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Plant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032098:Plant [Plant]

Phrase: "Physiol."
Processing 00000000.tx.574: 114, 981-988[Abstract/Free FullText] 34. 

Phrase: "114,"

Phrase: "981-988"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.575: Hofmann, A. 

Phrase: "Hofmann,"

Phrase: "A."
Processing 00000000.tx.576: (1998) Structurelle und funktionelle Untersuchungen an Annexinen.Ph.D. thesis , Technische Universitt Mnchen 35. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Structurelle und funktionelle Untersuchungen"

Phrase: "an Annexinen.Ph.D. thesis ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0039828:thesis [Intellectual Product]

Phrase: "Technische Universitt Mnchen 35."
Processing 00000000.tx.577: Pigault, C., Follenius-Wund, A., and Chabbert, M. 

Phrase: "Pigault,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Follenius-Wund,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Chabbert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.578: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.579: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.580: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.581: Commun. 

Phrase: "Commun."
Processing 00000000.tx.582: 254, 484-489[CrossRef][Medline] [OrderarticleviaInfotrieve] 36. 

Phrase: "254,"

Phrase: "484-489"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 36."
Processing 00000000.tx.583: Genetics Computer Group. 

Phrase: "Genetics Computer Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
Processing 00000000.tx.584: (1996) Wisconsin Package, Version 9.0 , Genetics Computer Group Inc., Madison, WI 37. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Wisconsin Package,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013194:Package [Medical Device]
   861   C2700580:Package [Manufactured Object]

Phrase: "Version 9.0 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "Genetics Computer Group Inc.,"

Phrase: "Madison,"

Phrase: "WI 37."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043193:WI [Geographic Area]
Processing 00000000.tx.585: Brnger, A. 

Phrase: "Brnger,"

Phrase: "A."
Processing 00000000.tx.586: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.587: (1992) Nature 355, 472-475[CrossRef] 38. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 355,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "472-475"

Phrase: "[CrossRef"

Phrase: "] 38."
Processing 00000000.tx.588: Nicholls, A., Bharadwaj, R., and Honig, B. 

Phrase: "Nicholls,"

Phrase: "A.,"

Phrase: "Bharadwaj,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Honig,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.589: (1993) Biophys. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.590: J. 

Phrase: "J."
Processing 00000000.tx.591: 64, 166 (abstr.) 

Phrase: "64,"

Phrase: "166"

Phrase: "(abstr."

Phrase: ")"
Processing 00000000.tx.592: 39. 

Phrase: "39."
Processing 00000000.tx.593: Barton, G. 

Phrase: "Barton,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.594: J. 

Phrase: "J."
Processing 00000000.tx.595: (1993) Protein Eng. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Protein Eng."
Processing 00000000.tx.596: 6, 37-40[Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "6,"

Phrase: "37-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.597: Kraulis, P. 

Phrase: "Kraulis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.598: J. 

Phrase: "J."
Processing 00000000.tx.599: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.600: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.601: Crystogr. 

Phrase: "Crystogr."
Processing 00000000.tx.602: 24, 946-950[CrossRef] 41. 

Phrase: "24,"

Phrase: "946-950"

Phrase: "[CrossRef"

Phrase: "] 41."
Processing 00000000.tx.603: Merrit, E. 

Phrase: "Merrit,"

Phrase: "E."
Processing 00000000.tx.604: A., and Bacon, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Bacon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052889:BACON [Therapeutic or Preventive Procedure]
  1000   C0452861:Bacon [Food]

Phrase: "D."
Processing 00000000.tx.605: J. 

Phrase: "J."
Processing 00000000.tx.606: (1997) Methods Enzymol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.607: 277, 505-524 Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "277,"

Phrase: "505-524 Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0009993:Copyright [Intellectual Product]
   744   C0037455:society [Organization]
   744   C0596070:American [Population Group]
   744   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

